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Abstract 
 
Interest in the concept of ‘precision’ or ‘personalized’ medicine has grown over the 
last three decades. While much of the literature published appears to support the 
notion that clinically-relevant individual response differences exist in phenotypes 
such as maximal aerobic capacity and weight loss, much of this research is based 
upon the observed response, as opposed to the ‘true’ inter-individual variation.  
 
In this doctoral research programme, I investigated ‘true’ inter-individual variation 
in response to exercise interventions. The difference between observed and ‘true’ 
individual differences is that measurement error and other sources of random 
variation are fully considered in order to quantify ‘true’ individual differences. These 
were investigated due to the recent focus on ‘individual responses and precision and 
personalised approaches. This was achieved through a number of approaches, 
including a critical review of literature, a systematic review and meta-analysis, and 
both secondary analysis of randomised controlled trial (RCT) data and primary data 
collection through the novel use of a replicate crossover trial. 
 
 A critical review of the relevant literature on responses of maximal oxygen uptake 
to exercise training revealed that when the correct method for statistical analysis is 
utilised on data from published research claiming substantial inter-individual 
variability in response, it was actually observed that there was greater variability in 
the control sample versus the intervention sample. This finding implies that there is 
no substantial true individual training response variance, though the uncertainty in 
the estimate of true inter-individual variability in response is marked with the small 
sample sizes involved. The review also revealed that the vast majority of published 
research purporting to show individual variation in response does not utilise the most 
robust trial design (RCT) or statistical methods (comparison of the standard 
deviations of the changes in all groups).  
 
A meta-analysis of supervised exercise RCT’s revealed that evidence is limited for 
clinically relevant ‘true’ inter-individual variation in weight change in response to an 
exercise intervention, once the random variability in weight over time in the control 
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group is accounted for. This was the first systematic review and meta-analysis of 
individual response variance. The pooled mean weight loss (-1.4 kg) was much 
smaller than a conservative threshold for a clinically important change (2.5 kg), and 
inter-individual variation in weight change standard deviation (SD) was only 0.8 kg. 
A novel approach using a prediction interval revealed that in a future study in similar 
settings, the 95% plausible range for mean weight change vs. control would be -
5.0 to 2.1 kg. The probability that the mean weight change in a future study would be 
clinically relevant was 26% (possibly clinically important). For the individual 
response variability, the prediction interval ranged from small negative to small 
positive, and the probability that the individual response variance was clinically 
relevant was 23% (unlikely).  
 
A secondary analysis of data from dietary and lifestyle advice interventions 
(PREMIER trial) revealed substantial inter-individual variations in the body weight 
and blood pressure responses.  Paradoxically, this response variance was not even 
partially accounted for by including a sex-by-treatment interaction term in the model, 
despite substantial sex differences in mean treatment effect.  When analyses were 
stratified by sex, much larger true individual response variance for weight loss and 
blood pressure changes were observed in men compared to women, explaining the 
paradox. The observed effect in women is relatively consistent, whilst in men it is 
much more variable, reinforcing the requirement for thorough exploration of data 
prior to undertaking full analyses. 
 
In a novel replicate crossover trial designed to properly partition variance and 
quantify ‘true’ inter-individual variation in response to acute high intensity aerobic 
exercise, results suggest the presence of substantial ‘true’ inter-individual variation 
in response. There were large sex differences in mean response, with greater blood 
pressure and heart rate response variables in females in comparison to males. This 
was the first replicate crossover designed and analysed in this way, using a specific 
model to elucidate the acute response to exercise.  
 
Evidence from these studies indicates that, when quantified appropriately, chronic 
exercise interventions appear to elicit limited ‘true’ inter-individual variation in 
response in peak oxygen uptake and weight loss. Conversely, there appear to 
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substantial inter-individual variations in blood pressure and heart rate responses to 
acute, high intensity aerobic bouts of exercise.  Furthermore, with multicomponent 
interventions there appear to be substantial individual responses for blood pressure 
and weight loss in men, based on secondary analysis of existing trial data. It is clear 
that much of the research purporting to evidence individual variation in response is 
lacking a suitable control sample. To that end, in chronic exercise intervention trials, 
it is likely appropriate to focus upon the mean change, whilst for acute exercise 
interventions, further quantification of the magnitude of inter-individual variation in 
response may well be warranted.  
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Chapter 1: Introduction 
 
1.1 Background 
 
1.1.1 Inter-Individual Variation in Response to Exercise 
 
Within the field of ‘personalised’, ‘precision’, or ‘stratified’ medicine, it is intuitive 
to think that different individuals respond to health interventions in different ways. A 
given health intervention may be beneficial, ineffective, or even harmful for different 
people (Rasool et al., 2015). The issue of inter-individual variation in response to an 
exercise intervention is, therefore, very important. Identifying those personal 
characteristics that may account for any clinically relevant variation in response may 
ultimately allow more efficient and ethical targeting of interventions to different 
people.  
 
Interest in the concept of ‘precision’ or ‘personalized’ medicine has grown over the 
last three decades (Williamson et al., 2017). My own Scopus search has indicated 
that the number of published papers that include the words ‘personalized medicine’ 
or ‘precision medicine’ in the titles or abstract has risen from 4 in 1999 to 5772 in 
2016 and 4747 in 2017. While much of the literature published on this topic over the 
last 30 years may appear to support the notion that clinically-relevant individual 
response differences exist, some researchers have based their conclusions on 
observed rather than ‘true’ individual differences in response. Essentially, the 
difference between observed and ‘true’ individual differences is that measurement 
error and other sources of random variation are fully considered in order to quantify 
‘true’ individual differences.  
 
The individual observed response that is often attributed to the intervention per se 
can include numerous sources of sometimes uncontrollable variability such as 
random (biological and measurement) variability, between-subject variability (if 
unadjusted for baseline), subject-by-treatment interaction and within-subject 
variability (Senn, 2016). However, it has previously been suggested that within-
subject random variation can be so substantial that it actually explains all apparent 
individual variation in response (Atkinson & Batterham, 2015). Taking these factors 
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into account to derive the ‘true’ individual response difference is vital for robust 
inferences, conclusions and recommendations to be made in precision medicine 
(Atkinson & Batterham, 2015). Whilst this approach is a robust methodology for the 
quantification of the presence of inter-individual variation in response, the field has, 
so far, been slow to adopt this approach. This may be due to its novel nature, or its 
potential impact upon the findings presented within the literature. 
 
1.1.2 The Concept of ‘Precision’ Medicine 
 
Personalized, or precision, medicine has been forwarded as an alternative approach 
to current health models. This approach has the potential to reduce the prevalence of 
non-response.  
 
This concept is often called P4 medicine (predictive, preventive, personalized, 
participatory). The overarching practical promise of ‘P4’ systems medicine is a 
revolutionary paradigm shift leading to a better overall utility of medicine, a better 
balance of benefits and harms. If successfully implemented, it could also allow for 
precise prescription of interventions to improve outcomes based upon technologies 
such as personal DNA–based testing, genotyping, and wearable micro-technologies, 
and allow decision making tailored to patients’ individual requirements (Feero, 2007, 
Joyner et al., 2016). At the same time, it is envisioned as being based in primary 
care, and its promise of a revolution therefore depends on its ability to meet the 
challenges of current research, prior to implementation.  
 
In 2015, President Obama launched the Precision Medicine Initiative (NIH, 2015), 
funded by an initial budget of $215 million. The initiative was described as having 
an ‘innovative approach, that considers individual differences in people’s genes, 
lifestyles, and environments’, bringing us ‘closer to curing diseases like cancer and 
diabetes’. He went on to describe how this approach would ‘give all of us access to 
the personalized information we need to keep ourselves and our families heathier’, in 
a ‘new era, of medicine - one that delivers the right treatment at the right time’. 
Although precision medicine makes claims of changing the medical landscape, it 
currently exists mostly as a vision. 
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Some approaches in precision medicine have also been adopted for exercise research 
and prescription, and there have been attempts to quantify the inter-individual 
variation in response of human physiology, in order to identify moderators (such as 
sex and age) and mediators (changes in status from baseline) governing response 
variance. Unfortunately, in the exercise domain, this approach is based upon the as 
yet untested claim that clinically relevant ‘true’ inter-individual variation in response 
will always exist in an intervention. However, the current lack of robust research and 
the cost and highly specific nature of dedicated RCTs aimed at targeting and 
confirming intervention strategies mean that it is likely to be premature to state that 
precision medicine is the answer, especially given that without variation in 
phenotype response, further investigations to identify genetic interactions are 
pointless. 
1.1.3 Health Implications of Exercise and Physical Activity 
 
For many decades, there has been a public health burden incurred by poor diet, 
excess energy intake (EI), and sedentary lifestyles. These factors have been 
implicated in the higher risk of developing chronic diseases such as type 2 diabetes, 
cardiovascular disease, and an increased incidence of cancers (Alberti et al., 2007, 
Deram & Villares, 2009). The impact that these lifestyle-related diseases have on 
both society and individual quality of life remains substantial, as does the resulting 
financial burden (Douglas et al., 2016). 
 
Physical activity, defined as any bodily movement produced by skeletal muscles that 
result in exergy expenditure (Casperson et al., 1985) and exercise – planned, 
structured and repetitive and with an objective (Casperson et al., 1985) have wide-
ranging physiological benefits, such as improved maximal aerobic capacity, which 
can lead to primary and secondary prevention of a number of chronic diseases such 
as cardiovascular disease, diabetes, cancer, hypertension and obesity, and premature 
death (Warburton et al., 2006), in addition to decreased symptoms of depression 
(Craft & Perna, 2004). Whist the influence of physical activity and exercise is clearly 
wide-ranging, much of the focus of research has been on maximal aerobic capacity 
and cardiorespiratory fitness, as it is far more prognostic of future all-cause mortality 
(Kodama et al., 2009, Imboden et al., 2018).  
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Regular physical activity and exercise are the usually prescribed means of improving 
V̇O2max, with improvements recommended for both primary and secondary 
prevention of cardiovascular disease. The results of research indicate that a 1-MET 
(3.5 mL.kg-1.min-1) increase in cardiorespiratory fitness equates to a 12% reduction 
in cardiovascular disease and all-cause mortality risk (Myers et al., 2002). Similarly, 
an appropriate minimal clinically important difference (MCID) regarding a change in 
cardiorespiratory fitness of 1.1 mL.kg-1.min-1 can confer a 10% relative risk 
reduction in mortality (Laukkanen et al., 2016). 
 
Healthcare has previously been delivered with a ‘one-size-fits-all’ approach 
(Bouchard & Rankinen, 2001, Pencina & Peterson, 2016), and research has reflected 
this approach in terms of the focus on the group mean effect of an intervention 
(Bouchard & Rankinen, 2001). Whilst this statistic informs the quantification of the 
general effect of an intervention, it may mask a range of responses for different 
people (Karavirta et al., 2011). Recent suggestions that traditional therapies may be 
ineffective for those with epigenetic causes of disease highlight the requirement for 
further study of the concept of inter-individual variation in response, with treatment 
for those individuals impacted potentially requiring personalized interventions 
(Rasool et al., 2015). The completion of the Human Genome Project has seen 
scientists prioritise the requirement to ensuring interventions are personalized, 
tailoring medical treatment away from the previously mentioned ‘one-size-fits-all’ 
towards interventions or treatments more likely to benefit the requirements of the 
specific participant.  
 
1.1.4 Current Evidence 
 
There have been reports that training studies consistently report a high variability in 
the effects of regular exercise training (Hecksteden et al., 2018), with reports of 
inter-individual variation of many physical characteristics, or phenotype, in response 
to various forms of exercise, such as aerobic training (Bouchard et al., 1999, 
Bouchard et al., 2000, Bouchard & Rankinen, 2001), resistance training (Hubal et 
al., 2005) and combined/concurrent training (Hautala et al., 2006); reports that 
exercise often results in less than expected weight loss for some individuals, or 
ranges of V̇O2max response of no change to 40% improvement (Lortie et al., 1984, 
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Bouchard & Rankinen, 2001). Additionally, researchers present plots and analyses 
that suggest large variation in physiological response, even when the magnitude of 
response variance is the same for all (Atkinson & Batterham, 2015).  
 
However, there have been concerns raised in regard to the methodological approach 
of much of the previous body of research (Hopkins, 2015, Atkinson & Batterham, 
2015, Williamson et al., 2017). The identification of factors that may explain inter-
individual response variance should come only after true, substantial inter-individual 
differences in response have been demonstrated and quantified properly (Atkinson & 
Batterham, 2015, Williamson et al., 2017). This quantification requires an 
appropriate control/ comparator group, preferably within a randomised trial design, 
and comparison of the standard deviation of the change in outcome (SDchange) for 
each relevant group. Much of the published literature claims substantial treatment 
response heterogeneity based on analyses of changes in outcome in a single 
intervention group, with no inclusion of a comparator sample in the research design. 
Even worse is the ignoring the control data when available, when it is the presence of 
such that would provide the required counterfactual (Williamson et al., 2017).  
 
Claims that precision medicine is the answer to this current hot topic are likely 
premature, based upon the lack of evidence obtained utilising the RCT approach, as 
this methodology allows for comparison of the intervention arm with a relevant 
control group, over the same time course (Hopkins, 2015, Atkinson & Batterham, 
2015). Variability in the responses to exercise exists if the variability in observed 
response exceeds the variability in observed responses in a control sample (Atkinson 
& Batterham, 2015) However, if, following an RCT, substantial variation in 
phenotype response does not exist, it is pointless looking for genetic interactions 
(Senn, 2004). Additionally, it could be questioned whether further investigation in 
this case would be ethically sound.  
 
1.2 Rationale for the Thesis Topic and Research Questions 
 
Given the claims of inter-individual variation in response in a number of studies, and 
the recent criticisms of the analysis of these (Hopkins, 2015, Atkinson & Batterham, 
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2015), it is clear that proper quantification of the ‘true’ inter-individual variation in 
response to exercise interventions is required.  
 
Outcomes in maximal aerobic capacity, weight loss and blood pressure are 
investigated due to their prognostic value for health. Additionally, the bulk of 
published research in this area focus upon maximal aerobic capacity and weight loss. 
The primary focus of this research project is to interrogate these claims, and to fully 
elucidate the presence of ‘true’ inter-individual variation in response to exercise 
interventions, based upon the methods of analysis recently suggested (Hopkins, 
2015, Atkinson & Batterham, 2015). 
 
Several common limitations can be identified within many of the studies 
investigating the inter-individual variation in response to a chronic exercise 
intervention.  
 
Almost exclusively in these studies, a control group is either absent or discarded in 
the data analysis (Williamson et al., 2017, Williamson et al., 2018). As is 
highlighted in this thesis, the inclusion of data from a comparator group to compare 
the inter-individual response to the given intervention is of principal importance in a 
chronic response trial. In this thesis I aim to rectify this gap in the literature. 
Additionally, in the investigation of acute effects of exercise, no study with a 
replicate crossover design has been undertaken in order to elucidate the inter-
individual variation in blood pressure response immediately post-exercise, nor has 
any research been undertaken purporting to investigate the inter-individual variation 
in acute blood pressure response to exercise. This thesis includes an original study 
and a secondary data analysis that applies an appropriate method to achieve this aim 
and is accompanied by discussion and practical implications of the findings of this 
novel approach.  
 
1.3 Aims and Objectives of this PhD and Experimental Approach 
 
The main aim of this PhD is to investigate the appropriate quantification of inter-
individual differences in the response to exercise interventions, as well as the 
exploration of putative moderators and mediators of both the mean intervention 
 10 
effect and the individual response, where appropriate. Approaches to identifying 
‘positive responders’, ‘non-responders’ and ‘adverse responders’ to interventions 
will also be investigated where appropriate.  
 
Specific objectives: 
1. To critically review the literature on inter-individual variation in maximal 
aerobic capacity response to exercise. 
2. To undertake a systematic review and meta-analysis of weight change 
literature, with a focus upon quantifying the inter-individual variation in 
weight loss.  
3. To conduct detailed and rigorous secondary data analysis of previously 
published data set from the PREMIER research project, using state-of-the-art 
analysis techniques to identify and quantify ‘true’ inter-individual variation 
in weight loss and blood pressure response to the interventions. 
4. Design and undertake a pilot/’proof-of-concept’ investigation to investigate 
the acute inter-individual variation of blood pressure and heart rate variables 
in response to high-intensity aerobic interval training, using a replicate 
crossover design, in order to test and validate a statistical model to fully 
partition the various sources of variance and to isolate ‘true’ inter-individual 
variation in response to high-intensity aerobic interval training, an approach 
that has not been previously achieved. Successful partitioning of variance in 
the repliucate crossover will provide a model that can be used as a basis for 
future research. 
 
1.4 Structure of the Thesis 
 
This thesis consists of eight chapters. This chapter (Chapter 1) constitutes the 
introduction, and discusses the background, rationale, and aims and objectives of the 
study. Chapter 2 presents a focused literature review, providing a historical 
overview, key concepts, a review of previous research, and background to the 
utilisation of analysis of the inter-individual variation in response to exercise. The 
reader will find a detailed review discussing precision medicine, aerobic capacity 
and the investigations carried out in this area, obesity and its genetic base, the effects 
of exercise on blood pressure, the underpinning physiology, and outlining the 
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previously published research purporting to investigate the inter-individual 
variability in response to exercise interventions upon these variables. Chapters 3 – 7 
consist of investigations of the relevant outcome measures that were studied as part 
of this doctoral programme. This work includes a critical review of the inter-
individual variation of maximal oxygen uptake in response to exercise training 
(Chapter 3), a systematic review and meta-analysis into the exercise and weight loss 
literature (Chapter 4), a secondary data analysis of blood pressure and weight loss 
variation (Chapter 5), and findings from a proof-of-concept pilot replicate crossover 
design study investigating the acute inter-individual variation in blood pressure 
response to high intensity aerobic exercise(Chapter 6). Chapter 7 forms the overall 
discussion, bringing together the findings of the thesis, as well as strengths of the 
findings presented. In this chapter, I also elaborate and critically synthesize the 
findings of the thesis and discuss limitations and provide directions for future 
research.  
 
Recommendations for both practice and research are provided, in addition to 
justification of how this research provided an original contribution to knowledge. 
Finally, appendices are attached, including published papers and abstracts from 
conference proceedings, with complete details provided of items discussed within 
the thesis.  
 
1.5 Potential Impact 
 
Given the stated rationale for this thesis, it is important at this time for the claims of 
inter-individual differences in response to an exercise intervention, with a particular 
focus on maximal oxygen uptake, weight loss, and blood pressure response, to be 
scrutinised in the context of recent criticisms. Identification of the presence of 
clinically important inter-individual variation in response would allow for the 
development of appropriate research design for investigation of potential moderators 
and mediators. Alternatively, confirmation of the absence of such would allow for 
research funding to be diverted to more appropriate sources. 
 
The findings from the work presented in this thesis have the potential to increase the 
understanding of the methods and statistical approaches that may be employed to 
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correctly quantify the ‘true’ inter-individual variation in response to an exercise 
intervention in both acute and chronic training studies. This, in turn, will help to 
clarify the classification of ‘non-responders’, and to guard against spurious 
assumptions or incorrect methodological approaches. Furthermore, given the focus 
upon precision medicine, policy and both applied and academic practice may be 
changed based upon the findings of this programme of work. If clinically-relevant 
individual response differences are not supported, then the commitment to funding 
further research on aspects of this topic may be questionable. 
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Chapter 2: Literature Review 
 
2.1 General Overview 
 
It is generally assumed that individuals respond in a consistent manner to treatment 
(Senn, 2004). However, all individuals acquire a variety of characteristics (Hopkins, 
2015). The potential that this could lead to gene-polymorphisms accounting for inter-
individual differences in response has been discussed previously (Mori et al., 2009). 
Nevertheless, it is important not to overreact to apparent differences (Senn, 2016), as 
these may be due to a number of factors, such as random within-subjects’ variation, 
from sources such as technical error and random within subjects’ biological 
variation. In this literature review I begin by addressing ‘precision medicine’ before 
discussing the concept of individual variation of maximal aerobic capacity, body 
mass, and blood pressure variables in response to chronic and acute exercise. 
 
2.2 Precision Medicine 
 
Until recently, healthcare interventions such as medication and exercise have been 
undertaken with a ‘one-size-fits-all’ approach (Bouchard & Rankinen, 2001, Pencina 
& Peterson, 2016).  Most researchers focus upon ‘main effects’ and mean group 
changes (Bouchard & Rankinen, 2001), without analysis of individual participants. 
The focus on individual response may be of benefit (Pencina & Peterson, 2016), 
particularly if clear differences in response between an intervention sample and a 
comparator sample are evident. This approach is useful but does not allow us to 
distinguish between individuals (Senn, 2004), and may hide a wide range of 
responses (Karavirta et al., 2011), as effects documented at group level may not 
apply equally to every individual within the group. Large amounts of empirical 
evidence may have been ignored due to this focus upon mean changes, and it has 
been proposed that standard statistical analysis and methodological training has left 
researchers unaware of the significance of response heterogeneity (Bryk & 
Raudenbush, 1988). Over the last three decades, interest has grown exponentially, 
with Scopus searches revealing that papers published including the words 
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‘personalized medicine’ or ‘precision medicine’ have risen from 4 in 1999 to 5772 in 
2016. 
 
It has been suggested that traditional therapies may be ineffective for those with 
epigenetic causes of disease, and treatment for these individuals may require 
personalized or genomic medicine (Rasool et al., 2015). Over the past decade, 
following the completion of the Human Genome Project (www.genome.gov), an 
international, collaborative research program (Collins & McKusick, 2001) which 
entailed the mapping and understanding of all human genes to determine the 
sequence of the human genome and identify its components parts, there has been a 
move by scientists and officials towards ensuring medicine is more personalized 
(Hamburg & Collins, 2010, Blaus et al., 2015, Buford et al., 2013, Collins & 
Varmus, 2015). This practice involves tailoring medical treatment away from ‘one-
size-fits-all’ towards treatment strategies most likely to benefit the individual (Blaus 
et al., 2015), using the technological and scientific advancements in the fields of 
genetics, medicine, science and health care (Marcon et al., 2018). 
 
In his State of the Union address in 2015, President Obama launched the Precision 
Medicine Initiative (NIH, 2015, Precision Medicine Initiative Working Group, 2015) 
, an “innovative approach, that takes into account individual differences in people’s 
genes, lifestyles and environments” to “bring us closer to curing diseases like cancer 
and diabetes, and to give all of us access to the personalized information we need to 
keep ourselves and our families heathier”, in a “new era, of medicine-one that 
delivers the right treatment at the right time”. An initial budget of $215 million was 
invested to support these efforts. Similarly, then-Prime Minister of the United 
Kingdom, David Cameron, had previously announced the coalition government’s 
effort to sequence the 100,000 human genomes (100,000 Genome Project, 
genomicsengland.co.uk) by the end of 2017, aimed at making the National Health 
Service the world’s first healthcare system to launch a genomics medicine service. 
This initiative was then to be built upon and a focus upon permanently embedding 
genomics in care was suggested (National Health England, 2015). However, this 
approach has numerous obstacles. Scientific challenges, such as the accurate 
determination of specific genes with clinical importance, policy challenges such as 
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regulating genetic testing and ensuring rigorous validity and reliability of such tests 
are paramount (Hamburg & Collins, 2010).  
 
2.2.1 Definition of ‘Precision Medicine’ 
 
The terms ‘precision medicine’ and ‘personalized medicine’ have been used 
interchangeably in the US and the UK (McCartney, 2017). Whilst as yet undefined, 
the National Institutes of Health currently states that it is ‘an emerging approach for 
disease treatment and prevention that considers individual variability in environment, 
lifestyle and genes’ (NIH, 2015), whilst a National Research Council report suggests 
it ‘refers to the tailoring of medical treatment to the individual characteristics of each 
patient’ (NRC, 2011). It has also been described as ‘prevention and treatment 
strategies that take individual variability into account’ (Collins & Varmus, 2015). 
Precision medicine may allow the combination of components from various 
emerging sub-disciplines such as real-time monitoring, diagnostic tests, and data 
analytics to improve desired outcomes (Montalvo et al., 2017). 
 
2.2.2 Use of Precision Medicine 
 
Precision medicine has been suggested as an alternative solution to current health 
models, under the premise of improved prediction, prevention, diagnosis and 
treatment of disease, based upon wearable technology (Feero, 2017), genotyping, 
and DNA variants (Joyner, 2016). It is currently claimed that personalized medicine 
has improved diagnostics, drug development, and risk assessment and modification 
(Chan & Ginsburg, 2011); however, the number of variants and the relative impact 
of each of these on disease development is yet to be clearly elucidated, meaning that, 
at best, it may be prudent to target groups (stratify) rather than individuals. It has 
also been assumed that this approach will reduce the cost of healthcare; however, it 
is still an expensive concept (Kittles, 2012) and the cost of screening for specific 
genotypes and specialized healthcare cover may, conversely, increase healthcare 
costs.  
 
Successful precision medicine, therefore, would allow for the optimization and 
customization of health care, using emergent technologies to make decisions tailored 
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to the patients’ individual requirements (Arnason, 2012, Mauri et al., 2014, Jameson 
& Longo, 2015, Collins & Varmus, 2015), enabling patients and general public to 
participate in both treatment decisions and preventative behaviour (Collins & 
Varmus, 2015). If successful identification of a precise biomarker is achieved, those 
that may benefit from a specific intervention may be recognised. Tailored 
pharmacokinetic (the time course of drug absorption, metabolism and excretion) or 
pharmacodynamic (the relationship between drug concentration and the relative 
effect) response-based therapies could then be applied (Blaus et al., 2015), if the 
drug response of an individual were accurately predicted (Spear et al., 2001). If this 
is, indeed, the case, predictive methods of directing individuals towards treatments 
with likely higher treatment efficacy could then also be derived, with small increases 
in resulting response having dramatic effects upon disease burden.  
 
It has been suggested that precision or personalized medicine claims hint at radical 
transformation in medical care and public health (Joyner & Paneth, 2015). This 
change would occur through reducing system costs and improving health care 
efficiency (Keogh, 2012, Flores et al., 2013, Hood et al., 2015), treatment and 
disease prevention programmes developed by the creation of large biobanks, genome 
sequencing, and the use of biological information to link to medical records. 
Conversely, criticisms of precision medicine question the value of its use in many 
contexts (Joyner, 2016, Prasad, 2016). It has been highlighted that inappropriate 
shifts in emphasis from public health initiatives to individual focus (Arnason, 2012, 
Tedstone, 2016), and the lack of a definition of ‘normality’ (Manrai et al., 2018), 
may result in over diagnosis and unnecessary testing (Diamanndis & Li, 2016). A 
further drawback is that much of the gene data collected is focused upon individuals 
of European ancestry (Kittles, 2012), and it is unknown as the extent of regional 
differences in health risk profile. 
 
2.2.3 Precision Medicine and Exercise? 
 
Whilst precision medicine has primarily been concerned with the heterogeneity of 
response to medication (Buford et al., 2013), the use of exercise for precision 
treatment is a novel concept. As the focus on ‘main effects’ may miss important 
individual level information, a focus upon the quantification of inter-individual 
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variation in response has grown in recent years (Williamson et al., 2017). It has been 
postulated that precision medicine may be used to personalize training for elite 
performance (Montalvo et al., 2017), as several single nucleotide polymorphisms 
(SNP) associated with exercise induced muscle damage have been identified; with 
knowledge of this, a practitioner could potentially maximise training prescription 
and reduce injury risk (Baumert et al., 2016). 
 
The interest in precision medicine has also stimulated attention in the exercise and 
public health domain, and the quantification of inter-individual variation in response 
of human physiology (Deighton et al., 2017, Hecksteden et al., 2018). The purpose 
of research around precision medicine is to identify genetic factors governing 
response variance; however, this is founded on fundamentally untested (as yet) 
assumptions that ‘true’ inter-individual variation in response exists. Currently, given 
the lack of information regarding the impact of genetics on many diseases or 
population health outcome variables, the cost and highly specific nature of dedicated 
RCTs aimed at targeting and confirming intervention strategies (Pletcher & 
McCulloch, 2017), and the incredibly complex nature of disease pathogenesis 
(Khoury & Galea, 2016), it is likely to be premature to state the case that precision 
medicine is the answer to this current hot topic. Furthermore, if the required 
variation in phenotype response does not exist, it is pointless looking for genetic 
interactions (Senn, 2004). 
 
2.3 Previously Utilised Methodological Approaches 
 
2.3.1 Use of Comparator Arm 
The concept of inter-individual variability in response to exercise was first mooted 
during the 1980s (Prud’homme et al., 1984, Despres et al, 1984, Lortie et al., 1984, 
Savard et al., 1985, Bouchard et al., 1986, Hamel et al., 1986, Simoneau et al., 
1986), with claims of inter-individual response in cardiorespiratory fitness, lipolysis, 
glucose conversion, and fibre-type conversion. These variations were attributed to 
genotype dependency. However, despite an apparently growing body of evidence, in 
recent years the veracity of the approach to quantifying inter-individual variability in 
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response to exercise has been questioned (Hopkins, 2015, Hecksteden et al., 2015, 
Atkinson & Batterham, 2015, Williamson et al., 2017).  
Based upon these early studies, it is now assumed that there are considerable inter-
individual differences in response (Bouchard et al., 2015); however, this may or not 
be true for any particular study (Atkinson & Batterham, 2015, Williamson et al., 
2017). Previous studies have assumed that the inter-individual variability in response 
for a given trait is solely a consequence of exercise interventions. Others maintain 
that the presence of inter-individual variation in response to an intervention must be 
properly quantified before the exploration of moderators and mediators of variation 
in response are investigated (Atkinson & Batterham, 2015). Indeed, the often-
utilised, no-comparator sample approach ignores the random variability (biological 
and measurement error) over the time course of the intervention.  
Much research has claimed the presence of inter-individual variation in response, by 
analysing data from an intervention sample only (Bouchard & Rankinen, 2001, 
Sisson et al., 2009, Pandey et al., 2015). This approach is wasteful and likely 
misleading (Atkinson & Batterham, 2015). It has been stated that comparison of 
intervention group variability with control group variability is necessary to 
adequately quantify inter-individual variability in response to exercise (Hopkins, 
2015, Hecksteden et al., 2015, Atkinson & Batterham, 2015, Williamson et al., 
2017). For chronic training interventions, it has recently been described how the 
most appropriate approach to quantifying the inter-individual variation in response is 
by conducting a randomized control trial (RCT), as this methodology allows for 
comparison of the intervention arm with a relevant control group, over the same time 
course (Hopkins, 2015, Atkinson & Batterham, 2015). Specifically, variability in the 
responses to exercise exists if the variability in observed response to exercise 
exceeds the variability in observed responses to a control sample (Atkinson & 
Batterham, 2015, Williamson et al., 2017). Without the comparator arm, it cannot be 
stated with any confidence that any individual in the intervention arm may be a 
responder, as what would have happened to that person had they been in the control 
sample – the counterfactual -is not known (Williamson et al., 2017).  
It has been posited that focusing solely on the intervention arm to determine 
responders and non-responders turns a parallel group RCT into a ‘single arm’ study 
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(Norbury & Seymour, 2018). However, the parallel group RCT allows for 
interpretation of what would likely happen, on average, to participants in the 
intervention arm if, contrary to the fact, they were in the comparator sample 
(Atkinson & Batterham, 2015). Exclusively, previous trials have ignored this 
comparison and, therefore, have not accounted for the contribution of random 
variability over time for the given outcome under study. Thus, whether inter-
individual variability attributed to exercise exists after accounting for random 
variability is unknown.  
The analytical limitations of prior trials have been addressed by proposing a standard 
statistical approach that separates the random variability from the intervention 
variability by using standard deviations (SD) of the changes from both the control 
and intervention groups (Atkinson & Batterham, 2015). Therefore, to fully 
investigate the magnitude of inter-individual response and separate the variation due 
to random error (present in both control and intervention) from the variation due 
intervention alone, the appropriate method to quantify ‘true’ individual response 
variability in a parallel group study involves the application of the following 
equation; 𝑆𝐷𝐼𝑅 = √𝑆𝐷𝐼
2 −  𝑆𝐷𝐶
2 (Atkinson & Batterham, 2015, Hopkins, 2015). In 
this equation, SDIR is the true inter-individual response variability, I is the 
intervention sample and C is the comparator (control) sample. The SDIR
 should be 
interpreted as the amount by which the mean effect of the intervention (intervention 
minus control) differs between individuals (Hopkins, 2015). The SD describes the 
‘typical’ inter-individual variation in response between each participant (Atkinson & 
Batterham, 2015), and when SDIR is calculated, it represents the typical ‘true’ inter-
individual variability, adjusted for random biological variation and measurement 
error (Hopkins, 2015). This approach controls for regression to the mean (Atkinson 
& Taylor, 2011, Atkinson et al., 2015). A larger SD of changes in outcome in the 
intervention group would indicate a greater magnitude of inter-individual variation 
vs the control sample (Hopkins, 2015), and may therefore indicate further 
investigation of the moderators (effect modifiers) and mediators of this variation is 
warranted.  
The standard analysis of a parallel-arm RCT is an ANCOVA analysis adjusting for 
chance imbalances in the outcome at baseline. In this analysis, the SDIR is derived 
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using a linear mixed model, as described in Atkinson & Batterham, 2015. In essence, 
in this model the SD of the changes in intervention and control arms are adjusted for 
chance imbalances at baseline.  
2.3.2 Identifying ‘Responders’ and ‘Non-Responders’ 
The concept of inter-individual variability creates the issue of how to characterize 
‘responsiveness’ in individuals. Dichotomously characterising in such a way is 
inherently irrelevant to prognostic risk, as this is most likely continuous, rather than 
binary, in nature (Sisson et al., 2009). Furthermore, insufficient information on the 
partitioning of variance is elicited (Norbury & Seymour, 2018), meaning 
consideration of data presented in this manner may be inappropriate. 
Individuals have been described as ‘responders’ or ‘non-responders’ based on the 
changes seen in a single phenotype (Mann et al., 2014). This approach may help 
identify individuals or ‘sub-groups’ that benefit from an intervention (despite no 
apparent mean improvement). However, there is a lack of clarity regarding the 
criteria used to categorise individuals. Labelling individuals as ‘non-responders’ 
based on the change in a single variable can be also misleading, given the various 
physiological adaptations often observed in response to acute and chronic exercise. 
To that end, the magnitude of response across a range of phenotypes should be 
investigated (Mann et al., 2014).  
An often-utilised approach to determining non-response to exercise is the setting of a 
statistical quantification of test-retest variability, such as 2 x typical error (TE) 
(Alvarez et al., 2017, Bonafiglia et al., 2016, Gurd et al., 2016) or technical error of 
measurement (TEM) (Bouchard et al., 2012) as a threshold for response. The 
proportion of individuals whose response is identified to be below this arbitrary 
threshold are then often defined as ‘non-responders’. This sample is then compared 
between various intervention groups, instead of a relevant comparator sample taken 
over the same duration as the intervention, in the belief that a comparison of inter-
individual responders is being undertaken. Using this test-retest variability is 
problematic, as that used is often based upon 3-day variability (Gagnon et al., 1996), 
as opposed to the same duration as the training intervention. Random within-
subjects’ variation would be expected to be substantially greater over an intervention 
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lasting, say, 12-24 weeks than over 3 days. Even when this 3-day test-retest technical 
error of measurement value has been used to set a threshold, random within-subjects 
variability is disregarded when portions of ‘non-responders’ are calculated. There 
will naturally be individuals showing changes of lesser magnitude than the test-rest 
variability but are not considered when calculating portions of ‘non-responders’. The 
TE will also likely not coincide with a threshold for clinical or practical importance. 
Ideally, magnitude of response should be compared to a minimal clinically important 
difference (MCID), anchored to a clinically relevant risk reduction. This MCID is 
often derived from the epidemiological literature, however, if it is not, an acceptable 
default approach is to use 0.2SD of the baseline pooled SD is an acceptable approach 
for identifying the smallest worthwhile change (SWC) (Hopkins, 2004).  Similar 
concerns can be raised about other studies (Bonafiglia et al., 2016, Alvarez et al., 
2017) using this approach, or the use of observed changes greater than the coefficient 
of variation (CV) for a particular phenotype (Astorino & Schubert, 2014) to 
determine ‘responders’ and ‘non-responders’. 
It should also be considered that whilst the main outcome of any intervention may 
produce some who do not ‘respond’ as much as others, other physiological variables 
may well show improvement (Buford et al., 2013). Additionally, response may well 
be dose-dependent. Greater intensity (Ross et al., 2015) and volume (Pandey et al., 
2015) have both reduced incidence of ‘non-response’, and these individuals 
presenting lower sensitivity or adaptation to an intervention may simply require a 
greater stimulus. This may be a further confounding variable to be addressed. 
2.3.3 Eliminating ‘Non-Responders’ or Shifts in the Mean? 
 
The effects of exercise training dose in cardiorespiratory fitness responsiveness in 
healthy young males after selected repeated 6-week interventions was recently 
explored (Montero & Lundby, 2017). These authors reported a decrease in the 
incidence of ‘non-response’ to endurance training with higher exercise dose, which 
they claimed was completely absent in those undertaking the highest doses of 
exercise (240 and 300 minutes per week) after the first 6 weeks. Based upon these 
findings, the authors suggested that the lower levels of the current exercise 
guidelines may not provide a sufficient stimulus to evoke positive adaptations in all 
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individuals (69%, 40% and 29% respectively classified as ‘non-responders’ for 
groups 1, 2 and 3, compared to 0% and 0% for groups 4 and 5 when considering 
maximal power output). It was also stated that the incidence of ‘non-response’ to 
endurance training was completely eliminated following a second 6-week training 
period, therefore concluding that improvements may be elicited in ‘non-responders’ 
by using higher training stimuli. 
 
However, similarly to many previously reported studies, no control group was 
included in the study, instead using data from a short-term test-retest reliability 
study; the inclusion of a suitable comparator sample is crucial to separate inter-
individual variability in CRF response to endurance training from the random error 
component and, thus, control the sources of variation that may affect the study 
results. Indeed, in this case, variation will likely be conflated over time, highlighting 
why comparator data collected over the same time period as the intervention in 
crucial. Additionally, the self-selecting intervention group removes the highly 
important randomization process from the trial design. 
 
Whilst claims for elimination of ‘non-response’ are made, the authors overlook the 
fact that the whole distribution of responses changes when the mean response itself 
changes, hence the decreasing proportion of non-responders as the mean response 
increases. The authors appear to confuse shifts in the whole distribution as exercise 
volume increases with true individual differences in the response to a given 
intervention. Essentially, as the distribution shifts to the right, everyone becomes a 
responder.  
 
Furthermore, the authors appear to have run a ‘replicated’ intervention study to 
facilitate eradication of ‘non-response’ in those showing less than 1xTE 
improvement in peak power output (without the proper design that would have 
allowed them to quantify the subject-by-training interaction (Hecksteden et al., 
2015)). Five intervention groups were included, but, as stated, no control group, 
thereby assuming that the threshold concept for individual training response would 
have been a valid approach to draw solid conclusions about inter-individual variation 
in cardiorespiratory fitness response. This approach to distinguish between 
‘responders’ and ‘non-responders’ is clearly flawed, as pre-post design studies 
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require analysis of the SD of the respective change scores in comparison with that of 
a suitable comparator sample (Hopkins, 2015, Atkinson & Batterham, 2015), whilst 
replicate crossover studies to elucidate inter-individual variation in response require 
specific statistical modelling, such as that proposed by Stephen Senn (2016). 
Additionally, the study was not actually a replicated crossover designed for the 
identification of inter-individual differences, as the different conditions used were at 
different exercise intensities rather than the same intensities replicated. It is also 
clear that a crossover-based trial cannot be used for chronic training studies, given 
participants are starting from a different baseline, due to chronic adaptations 
(Williamson et al., 2017). It can, however, be employed in the investigation of acute 
responses to exercise.  
2.3.4 Consideration of Within-Subject Variability  
Although the equation presented by Hopkins (2015) and Atkinson & Batterham 
(2015) accounts for random variability, the within-subject variability in treatment 
response remains. It is important to note that the implicit assumption for exercise 
interventions examining individual response is that the training effects among 
individuals are highly reproducible. It is possible that the observed individual 
variability is, in fact, due to variable responsiveness to treatment within each 
individual. This begs the question - would an individual respond similarly if they 
were to repeat the same intervention? This question remains unanswered.  
To assess within-subject variability, participants would have to repeat the 
intervention after an appropriate washout period to determine whether individuals 
would respond in a similar manner. Thus, the proper separation of subject-by-
treatment interaction from within-subject variability can only be achieved through 
repeat administrations of the intervention to the same individuals. Furthermore, a 
large scale multi-period (replicate) crossover intervention design is, in fact, the only 
study design that can adequately identify all forms of variability discussed above 
with the addition of treatment variability as well (variability of the differences 
between each treatment phase). However, this type of intervention design is not 
practical or may not even be feasible to carry out due to high participant burden, 
cost, and uncertainty regarding washout periods for training adaptions that may or 
may not become permanent. As it stands, it remains difficult to delineate potential 
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within- subject variability from subject-by-treatment variability with current RCT 
designs due to the inability of an RCT to fully partition variance. 
As an alternative solution, Hecksteden et al. (2015) suggest that repeat testing of 
outcome measures throughout the duration of the intervention can help account for 
within-subject variability by comparing segmental slopes of change scores for 
shorter durations across the treatment period. However, this approach is also limited. 
First, the close temporal proximity of the measures may lead to high amounts of 
autocorrelation (measure of randomness) and a violation of the assumption of 
random errors. Additionally, training adaptions may not necessarily be linear over 
the course of the intervention and repeat measures may be expensive and impractical 
for some interventions. When this repeated assessment approach was recently 
utilised (Hecksteden et al., 2018), the analysis and inferences made appear flawed, as 
exercise response at 12 months is compared with control response at six months; 
given that the rise in SD from months 6-12 in the exercise is clear, it would be 
prudent to suggest that similar increases would therefore also be expected in a non-
exercise control sample during the same period, therefore resulting in an inflated SD 
at 12 months. This highlights the folly of attempting to make inferences from 
different time points in exercise vs control. The authors also state that that non-
responders are labelled such if they show a response in "an unexpected direction", 
when realistically, if non-responders were present, they would be identified by either 
not improving as much as a threshold for clinical relevance, or, when using Hopkins’ 
approach (2015), when a substantially lower probability of being an individual 
responder may be assigned. For now, doubts remain over whether this approach 
provides a plausible alternative to conducting a repeated cross-over design 
intervention or conducting a separate reliability intervention trial. In an applied 
setting, practitioners may look to utilise either approach, as long as they are aware 
and state the strengths and limitations of the methodology they select, and make 
appropriate inferences based upon these strengths and limitations. 
2.3.5 The 50% Heritability Claim 
There is a growing interest in individual response differences and exploring potential 
predictors of these individual responses. A recent opinion piece (Pickering & Kiely, 
2017) discussed talent identification, and the ability to adapt to exercise. Key within 
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their discussion was a focus on the inter-individual variation in capacity to improve 
physical characteristics as a key to future talent identification programmes. They 
went on to discuss genetic profiling which may, in their view, allow identification of 
those with the greatest potential for improvement, based upon the assertion that 
exercise adaptation is partially genetically driven. 
 
The argument for selecting athletes based upon future athletic potential, rather than 
current high-performance, has its merits, given the non-linear nature of maturation. 
However, use of genetic profiling and the companies purporting to provide such 
information as to predict future athletic development is virtually meaningless. It is 
also largely without scientific foundation, and the use of direct-to-consumer (DTC) 
genetic testing to define or measure genetic risk for common diseases or developing 
personalized diet and lifestyle recommendations (Janssens et al., 2008), alter 
training, or for talent identification has previously been warned against due to lack of 
evidence on their efficacy and possible commercial misrepresentation (Webborn et 
al., 2015). Results from a recent study indicated that 40% of variants used in a 
diagnostic approach in a variety of genes reported in DTC raw data were false 
positives, whilst some genes classified as ‘increased risk’ were, in fact, benign or 
noted to be common variants (Tandy-Connor et al., 2018). Whilst having access to 
raw genotyping data may be informative and empowering for individuals, this 
information can be misinterpreted, misleading and wholly inaccurate. Those 
providing DTC testing also often ignore both the weak predictive power of the tested 
genes and the complexity of relevant genetics, with minimal information provided on 
how one might use the test results to makes changes to lifestyle or why the testing is 
effective. It is clear that this approach adds little in terms of value to individual or 
population health at this time.  
 
The claims that "approximately 50% of baseline maximal oxygen uptake (V̇O2max) 
is heritable” (Pickering & Kiely, 2017) appear to be re-interpreted to suit the 
argument presented by these authors. The study this information is taken from 
actually states that "the heritability of V̇O2max among sedentary adults could be as 
high as 50% although this value is undoubtedly inflated by non-genetic familial 
factor” (Bouchard et al., 2000). Indeed, this study was an ACE gene study in which 
it was concluded that there was no association at all between genes and response, 
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concluding that although there is no direct evidence to support the notion that ACE 
genes were involved in human trainability, it could be hypothesized that they 
contribute to inter-individual variation in training response.  
 
The aforementioned claims are also similar to those made in a recent meta-analysis, 
where it was stated that ‘it has been estimated that V̇O2max trainability has a 
significant heritable component of around 50%’ (Williams et al., 2017), and which 
worryingly have now been progressed to ‘at least 50% of adaptation responses to 
endurance training are heritable (Vellers et al., 2018). Conversely, whilst ranges of 
44-68% heritability have been described in a recent meta-analysis (Miyamoto-
Mikami et al., 2018), due to the lack of explanation elucidated through analysis of 
the studies included in their meta-analysis, these authors suggest further studies are 
required in order to clarify this heterogeneity.  
 
I have questioned the findings of much of the published literature from the 
HERITAGE Family Study, from which these ‘50%’ claims originate, in regard to 
change in V̇O2max in Chapter 3 of this thesis and in a published critical review 
(Williamson et al., 2017). Many of the highlighted limitations centre upon the lack 
of a control group with which to make comparison of the SDchange, and therefore 
elucidation of any inter-individual variation in response to exercise. As is discussed 
repeatedly in this thesis, in order to calculate the true inter-individual variation in 
response to an intervention, in a parallel group study, true inter-individual difference 
in response is only present if the response variance in the intervention group is 
substantially larger than that in the control. The square root of the difference in 
response variance (intervention minus control) gives the SD of the individual 
response, or the variability in response which surpasses expected random within-
subjects variability (Atkinson & Batterham, 2015). If there are no substantial 
differences between the two, the observations of inter-individual variation in 
response can actually be described as baseline-to-follow-up within-subjects 
variability (Atkinson & Batterham, 2015), which may be influenced by growth, 
maturation and physical development. 
 
Pickering & Kiely suggest that the magnitude of training response differs greatly 
between individuals, and this information can assist in the identification of the 
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‘talent’ of adaptation. Again, this statement is based upon the findings presented in 
the HERITAGE Family Study (Skinner et al., 2001) and I discuss how response 
should be defined in regard to a minimal clinically worthwhile difference (MCID) in 
Chapters 3 and 4. In brief, for a given individual, the observed change in phenotype 
following an intervention can be combined with knowledge of the natural random 
variation in that phenotype over the same time period (from a control group or 
similar reliability study) to derive the probability that this individual’s true response 
is greater than the MCID (Atkinson & Batterham, 2015). 
 
Pickering & Kiely also suggest that the X allele of the α-actinin-3 (ACTN3) gene 
may be responsible for those with larger adaptations in V̇O2max, whilst Williams et 
al., (2017) state that 97 genes are identified as possible predictors of V̇O2max 
trainability. However, it is concerning that data mining in this manner, presumption 
of this figure of (now ‘at least’) 50% heritability in regard to V̇O2max training 
response, and subsequent research into the genetic mediators of this response, may 
be unwarranted and potentially misleading. It must also be remembered, that while 
genetic factors may influence training response, due to their individual small effect 
sizes, any one genetic variant will likely only contribute a tiny amount to any 
variability. Rather, further research should be carried out to test the ‘50%’ 
hypothesis, in the presence of a suitable comparator sample, observed over the same 
duration of any intervention group. 
 
Such claims of genetic basis for individual variation in response, or trainability of 
phenotypes such as maximal oxygen uptake should be made with caution and based 
solely upon research that has reported these findings utilizing suitable research 
design. Assumptions of ‘50% of heritability in trainability’ should also be made with 
the utmost of caution, and the use of DTC genetic testing for talent identification 
should not be recommended at this time. 
2.3.6 Partitioning Variance 
If we wish to use an individual’s results, such as that seen in an n-of-1 trial, in order 
to prescribe an appropriate exercise intervention, response measurement in isolation 
is not sufficient. We must first understand the components of variation. The design 
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of a multi-period crossover with a mixed (fixed and random effects) analysis model 
would be more suitable for the efficient estimation of treatment effect (Senn, 1993). 
This would allow for the partitioning of various components (between treatments, 
between patients, patient-by-treatment, within patients) of variance (Senn, 2016). 
This approach is also useful for quantifying the inter-individual variation in acute 
response to exposure to exercise, and is an approach utilized in Chapter 6 of this 
thesis. 
2.4 Genetics, Heritability and Maximal Oxygen Uptake 
It has been proposed that genetic variations may determine change in aerobic fitness 
(Zadro et al., 2017). ACE polymorphisms have been suggested to be linked to elite 
aerobic (rowing) performance (Gayagay et al., 1998), whilst SNPs rs2267668 in 
peroxisome proliferator-activated receptor- (PPARD) and Gly482Ser in peroxisome 
proliferator-activated receptor- coactivator 1 (PPARGC1A) have been claimed to 
have independent impacts upon the effectiveness of exercise to improve physical 
fitness (Stefan et al., 2007), and PPARGC1A and Gly482Ser have been suggested to 
predict exceptional endurance capacity (Lucia et al., 2005).  
Recent suggestions include the need for research into the contribution the 
mitochondrial genome may have on genetic regulation of the variation in exercise 
adaptation (Vellers et al., 2018). Specific genes responsible are yet to be identified, 
but Bouchard (2012) suggested that a genomic predictor score based on alleles 
carried at 21 single nucleotide polymorphisms may assist in identifying high and low 
training responders. However, further confounding these claims, to date, only a few 
genome-wide association studies have been published using V̇O2max response as a 
trait, and all of these have been based upon the data collected from the HERITAGE 
participants (Timmons et al., 2010, Bouchard et al., 2011, Ghosh et al., 2013). 
2.4.1 Use of Siblings to Understand Heritability 
Studies of siblings have been used to make inferences about the importance of 
genetic influence in heritability (Simoneau et al., 1986), where the reported F-ratios 
suggested 5-10 times more variance between twin pairs than within pairs. Similarly, 
genetic determination has been claimed for several different aerobic performance 
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measures from the results of studies in which brothers, and monozygotic and 
dizygotic twins were compared (Bouchard et al., 1986). The heritability for gains in 
aerobic capacity elicited during these studies have previously been reported to be 
estimated in the region of 50% (Bouchard et al., 1999, Bouchard et al., 2000, 
Bouchard & Rankinen, 2001). However, while various polymorphisms are reported 
to be associated with a phenotype increase, they account, individually, for only a 
small proportion of the observed inter-individual variation in response to exercise 
training when added to a working model for V̇O2max trainability (Sarzynski et al., 
2017). 
2.4.2 Inter-Individual Variability of Maximal Oxygen Uptake in Response to 
Exercise 
It has been suggested that training studies consistently report a high variability in the 
effects of regular exercise training (Hecksteden et al., 2018). While many 
phenotypes have been investigated, V̇O2max response has often been a focus for 
studies investigating claims of inter-individual variation in response to exercise. 
Wide inter-individual differences in the trainability of the cardiorespiratory system 
have been claimed for over 30 years (Lortie et al., 1984, Bouchard, 1995, Feitosa et 
al.,2002). Individual differences in the response to standardized regular aerobic 
exercise, measured as V̇O2max, have been reported in several studies in healthy 
subjects (Lortie et al., 1984, Bouchard & Rankinen, 2001), in which mean changes 
ranged from 10-15%, but inter-individual variation in response was reported to range 
from no change to 40% (Bouchard, 1995, Bouchard & Rankinen, 2001, Hautala et 
al., 2003, Hautala et al., 2006). However, such variation is consistent with the fact 
that biochemical and physiological functions vary in all humans (Vollaard et al., 
2009). Nevertheless, these studies almost exclusively lack the crucial comparator 
sample, with which to make formal comparison of the SDchange, or disregard the data 
from such, therefore limiting the inferences that can be drawn from the pre-post 
single group trials. Those that have included a comparator sample (Prud’homme et 
al., 1984) have been shown to actually present more variation in the control sample, 
in comparison to the intervention (Williamson et al., 2017).  Given these 
aforementioned claims of genetic background contributing to observed variation in 
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V̇O2max, it has recently been conceded that no specific genetic factors have been 
identified that explain the differential response to exercise (Vellers et al., 2018). 
2.4.2.1 Initial Claims 
Several formative studies on this topic were conducted in the 1980s, with the aim of 
identifying the inter-individual response to exercise. A further aim was to elucidate 
genotype dependency of the inter-individual variation in response (Prud’homme et 
al., 1984, Despres et al., 1984, Lortie et al., 1984, Savard et al., 1985, Bouchard et 
al., 1986, Hamel et al., 1986, Simoneau et al., 1986). These studies are discussed at 
length in Chapter 3. 
 
2.4.2.2 Physiological and Molecular Factors at Play? 
A recent review (Sparks, 2017) sought to provide insight into the physiological and 
molecular factors surrounding the inter-individual variation in response to exercise 
interventions and provide insight into some of the statistical issues in this area. 
However, several inaccuracies can be identified, and these factors are crucial for 
answering the fundamental question of whether there are ‘true’ and clinically 
important individual differences in the response to exercise.  
‘True’ inter-individual differences in response can be defined as inter-individual 
variations in response that are not merely random trial-to-trial variability. Instead, 
changes must be free of measurement error and random trial-to-trial within-subjects’ 
variability, and then anchored to a rational and justified threshold for the minimal 
clinically important difference (MCID). It is also maintained that, in the ‘roadmap’ 
for researching this topic, true and clinically relevant individual response differences 
should be confirmed empirically before any putative moderators and mediators of 
the exercise response are explored (Atkinson & Batterham, 2015). The definition of 
‘non-response’ given by these authors as “the lack of a difference between a control 
and a treatment condition with respect to a specific variable” (Sparks, 2017) raises 
concern, as it implies that non-responders can be identified by observing their data 
from a two-condition (control and exercise) experiment and concluding that those 
with a treatment-control difference of zero or less are ‘non-responders’. The fallacy 
of this approach has been alluded to (Barker & Schofield, 2008), and a full account 
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of the pitfalls in non-responder identification has previously been provided 
(Atkinson & Batterham, 2015, Schubert et al., 2014). 
 
The observed response comprises the ‘true’ response in addition random trial-to-trial 
within-subjects’ variability and measurement error (Atkinson & Batterham, 2015). 
Therefore, observed non-response to exercise does not automatically mean that there 
has been a true non-response. Random variability in biological measurements from 
day-to-day or week–to-week is always present. It is, unfortunately, also essentially 
uncontrollable. This component of variance on its own often appears to provide 
evidence of inter-individual variation in exercise response, when in reality this is not 
the case.  
 
The optimal approach for quantifying individual response differences in repeated 
trial studies has previously been described (Senn et al., 2011). This replicate 
crossover design involves control and exercise conditions that are both administered 
at least twice to each participant, usually in a balanced randomised sequence. Using 
this approach allows the exercise/control x participant interaction term to be derived 
from the statistical model (Senn et al., 2011), however this methodology can only be 
employed for acute exercise interventions and creates an increased burden on 
participants. This is an approach that had not been utilised in the exercise sciences 
until the proof-of-concept reported in Chapter 6. 
 
2.4.2.3 The METAPREDICT Study 
 
A recent multi-centre RCT focused on the evaluation of a new time-efficient and 
genuinely practical high-intensity interval training (HIIT) protocol in men and 
women with pre-existing risk factors for type 2 diabetes in the METAPREDICT 
study (Phillips et al., 2017), wherein participants were randomised to one of two 
interventions or a control group.  
 
Intervention groups comprised of 7 by 1 (n=31) undertaking three cycling sessions 
per week for 6 weeks (2-min warm-u p at 50 W followed by seven sets of 1-min 
high-intensity cycling work with 90 s recovery between sets), 5 by 1 (n=129), (2-min 
warm-up at 50 W followed by five sets of 1 min high-intensity cycling work with 90 
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s recovery between sets), or a comparator group (n=11), which was described as 
“serving to complement the short-term test–retest variability data collected in the 
intervention groups at the two baseline sessions with “test–retest” data covering the 
full duration of the study”.  
 
Participants who showed responses large enough to surpass certain thresholds were 
presented, in addition to the use of a regression model to describe the association 
between measurements made at baseline and the magnitude of response. A 
comparison of each individual is presented, with a range of apparent ‘true’ 
responses; however, this is absent the range of responses from the comparator 
sample. It has previously been described how this approach fails to accurately 
quantify the presence of ‘true’ inter-individual variation in intervention response 
(Hopkins, 2015, Atkinson and Batterham, 2015). It is noted that this approach is 
alluded to in the ‘Data Processing and Statistical Analysis’ section of the study. 
However, the use of a paired t test to further describe p values for a test of statistical 
significance is questioned; given these SDs are a single value, and not paired; this 
approach is not grounded in statistical rigour, and within-group paired t-tests were 
used in intervention(s) and control. This is bad practice in any analysis of trial data.  
Additional questions regarding the authors inferences are presented when 
considering that baseline data were not corrected for in analysis, where the use of 
ANCOVA is preferential, in order to identify differences at baseline which may 
account for any observed inter-individual variation.  
 
These control data are reported to be either baseline 7-day variability data (n=201) 
OR control data (n=11). Weighting of control data is obviously on the 7-day 
reliability data, as only 6.5% of the control ‘cases’ were the comparator group 
measured at the same baseline and follow-up (6 weeks). These data are also likely to 
be associated with less within-subjects variability than that collected over the same 
time frame as the intervention, leading to false impressions of individual variance. 
There were substantially fewer subjects in the control sample, and this sample was 
not even used in the analysis of group mean differences.  
 
Whilst a meta-analysis is also reported to have been undertaken, involving 
comparisons of SDchange with another SDchange from a previously published study, 
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these SDs were compared with a Levene’s test rather than the recently presented 
calculation for quantification of inter-individual variation in response (Hopkins, 
2015). By definition, this cannot be deemed a true meta-analysis, nor appropriate 
comparison of ‘true’ inter-individual variation in response.  
 
2.4.2.4 Sprint Interval Training and Inter-Individual Variation in Response 
 
When comparing sprint interval training (SIT) with traditional endurance training, it 
was recently observed that a prevalence of 22% of individuals were ‘non-responders’ 
to high intensity training protocols (Gurd et al., 2016). However, this combination 
study reported on several investigations that were also lacking a control group with 
which to compare intervention data. In addition, use of the previously described and 
problematic use of 2 x TE as a threshold for ‘non-response’ limit the inferences 
drawn from these findings. Similar findings of variability in magnitude of response 
were reported following a crossover study comparing the adaptive response of SIT 
and endurance training (Bonafiglia et al., 2016), however, it has been discussed how 
crossover studies of this design are not without their own limitations, due to 
unknown washout periods (Williamson et al., 2017). Whilst some authors have 
claimed up to 55% of participants showed no improvements in V̇O2peak (Bakker et 
al., 2017), a lack of comparator sample and low adherence to the exercise 
intervention cast doubts upon these findings. 
 
Contrastingly, reduced prevalence of ‘non-response’ was also reported following 
high-volume interval training when compared to low volume SIT (Astorino & 
Schubert, 2014), but use of changes greater than the CV to define response limit 
these findings, given the lack of comparator sample and exclusion of random 
measurement error from the observed change.  
 
2.4.3 Quantifying Inter-Individual Variation in V̇O2max Response to Exercise – 
A Summary 
 
It is clear that concerns raised in regard to the methodological approach of much of 
the body previous research have foundation (Hopkins, 2015, Atkinson & Batterham, 
2015, Williamson et al., 2017). As is emphasised throughout this thesis, the 
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identification of factors that may explain inter-individual response variance should 
come only after true, substantial inter-individual differences in response have been 
demonstrated and quantified properly (Atkinson & Batterham, 2015, Williamson et 
al., 2017). This quantification requires an appropriate control/ comparator group, 
preferably within a randomised trial design. However, it is evident that much of the 
published literature claims substantial treatment response heterogeneity based on 
analyses of changes in outcome in a single intervention group with no inclusion of a 
comparator sample in the research design, which would provide the required 
counterfactual (Williamson et al., 2017). 
 
2.5 Energy Balance and Body Weight 
 
Weight loss is a complex trait, depending upon multifactorial influences such as 
environmental, behavioural, and genetic factors (Deram & Villares, 2009). Indeed, 
bodyweight regulation also been hypothesized to be dependent upon the axis of food 
intake, body fat stores, nutrient turnover, and thermogenesis (Martinez & Fruhbeck, 
1996, Jequier & Teppy, 1999), whilst also being dependent upon activity levels 
(Dokken et al., 2007) 
 
Current assumptions focus upon the genetic background and dietary and activity 
habits (Martinez, 2000), such as habitual consumption of a high-fat diet being 
associated with obesity. However, some individuals have followed identical diets 
and remained lean (Macdiarmid et al., 1996). Diet, aerobic exercise, and a 
combination of the two have previously been reported to be successful in producing 
clinically worthwhile (>5%) bodyweight reduction (Donato et al. 1998), although 
conversely it has been suggested that many studies fail to prescribe sufficient 
exercise intensity, frequency, or duration to produce significant weight loss and 
subsequently provide no benefit over diet only interventions (Washburn et al., 2014). 
Although it has been a heavily promoted public health approach to combat obesity, 
the role of exercise in weight management has previously been questioned. Exercise 
has beneficial effects on all-cause mortality and cardiovascular disease risk well 
above those interventions including nutritional interventions or supplementation 
(Fiuza-Luces et al., 2013). While it is generally accepted that exercise is an 
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important factor in weight loss, its exact role in the mechanism of weight control is 
still unclear (Myers et al., 2014).  
The effect of aerobic exercise without dietary restriction on body mass has been 
reported to elicit reductions, with losses of 1.5-3.0 kg typically reported over 3-18 
months (Shaw et al., 2006). However, these findings must be taken with caution, due 
to variety in study design, unsupervised exercise and self-reported adherence.  
Greater reductions in body mass have been reported under controlled (often 
laboratory) conditions when the exercise energy expenditure is larger (>2,000 
kcal/week), or when exercise is combined with dietary restriction (Ross et al., 2000), 
highlighting the importance of distinguishing between efficacy (the ability to bring 
about intended change under ideal conditions) and effectiveness (the extent to which 
change is achieved under ‘real world’ conditions). Regular aerobic exercise may be 
efficacious for weight loss under controlled conditions, but it may not be effective in 
the real world (due to poor adherence). This issue is explored further in Chapter 4. 
2.5.1 Genetics and Body Weight 
 
Given the prevalence of overweight and obesity, it is no surprise that efforts have 
been made to utilise high-tech approaches to elicit answers (Cauldfield, 2015). It has 
been suggested that genetic factors may contribute to some of the observed variation 
in body fatness (Bouchard et al., 1985, Stunkard et al., 1986a, Stunkard et al., 
1986b, Barsh et al., 2000, Martinez, 2000, Marti et al., 2004), and weight loss in 
response to dietary and surgical interventions (Kovolou et al., 2016, Resende et al., 
2018), with the FTO gene being the most predictive (Loos, 2012). However, even 
this gene is only associated with a modest amount of increased body fatness. It has 
been claimed that moderate to high heritability for obesity has been observed in 
family, twin, and adoption studies (Hinney at el., 2010). Between 25-70% of 
variation was reported to be hereditary in twin studies (Bouchard et al., 1985, 
Cardon et al., 1994), although lower figures of 25-50% in family studies have 
previously been reported (Stunkard et al., 1986a, Stunkard et al., 1986b). However, 
other data generally do not support these claims, primarily underpinning the notion 
that genetic associations generally have small effect sizes in ‘precision medicine’ 
interventions (Khoury & Galea, 2016). Indeed, all genomic markers identified have 
 36 
only shown very small effects on both BMI and the risk of obesity (Tan et al., 2014). 
Given these findings, identification of a highly predictive obesity gene or even a set 
of genes has remained elusive. Considering this, monogenic causes of obesity are, 
actually, rare (Ells et al., 2018), and it has been stated that decreased physical 
activity is more likely to be the major contributing factor (Hill & Melanson, 1999), 
with environmental factors likely affecting lifestyle choices, though the search for a 
‘obesity gene’ continues (Whalley et al., 2009). The idea that we can blame genetics 
for obesity is clearly flawed, as our genes are relatively unchanged for thousands of 
years, whereas obesity prevalence has increased dramatically only recently. Rather, 
it is likely environmental factors that provide a substantial contribution.  
 
2.5.2 Inter-Individual Variability in Body Weight Response to Exercise 
 
The concept of ‘personalized medicine’ in relation to the treatment of obesity has 
been suggested to use genetic information to inform diet, exercise, and other weight 
loss strategies (Agurs-Collins et al., 2008). Inter-individual variation in fat loss and 
weight loss in response to exercise has previously been reported (Snyder et al., 1997, 
Byrne et al., 2006, King et al., 2008, Caudwell et al., 2009, Church et al., 2009, 
Barwell et al., 2009), resulting in a prevailing opinion that exercise often results in 
less than expected weight loss (Donnelly & Smith, 2005). However, in a similar 
approach to those studies previously discussed, these inferences are almost 
exclusively drawn from studies lacking a control group. 
 
An early study investigating chronic energy deficit in twins elicited by exercise, over 
a four-month period, postulated the presence of large individual differences in 
weight loss (Bouchard et al., 1994). These findings were presented in conjunction 
with data indicating greater heterogeneity between twin pairs than within pairs. 
However, it has previously been discussed how this approach may overestimate 
heritability (Heller et al., 1993) and does not separate genetic from environmental 
pathways (Maes et al., 1997). 
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2.5.2.1 Gender Based Differences in Response 
 
Sex differences in exercise-mediated weight change have been reported (Ballor & 
Keesey, 1991, Donnelly & Smith, 2005), possibly due to exercise-induced EI 
suppression in males (Hall et al., 2011, Caudwell et al., 2012), compensatory eating 
(Finlayson et al., 2009, Unick et al., 2010, Melanson et al., 2013, Hopkins et al., 
2014), and exercise intensity below that prescribed (Doucet et al., 1999). However, 
differences in methods between studies causes problems in interpretation. It has been 
cited that the reason for a sex difference is that women are better at defending body 
weight and will therefore increase EI in response to EE. However, a recent 
systematic review found this not to be the case (Caudwell et al., 2014), with a lack of 
robust evidence demonstrating increased compensatory EI in women. In the 
HERITAGE Family Study, men were reported to lose more weight than women and 
children, and more fat than women, but no other gender differences were observed 
(Wilmore et al., 1999). Overall, in studies with no control sample, evidence for a sex 
effect on inter-individual variation in response to exercise in short-, medium-, and 
long-term exercise trials is weak (Caudwell et al., 2014). 
 
When exercise is matched, and EE is controlled, measured, and the same for both 
sexes, similar changes are observed for weight loss (McTiernan et al., 2007, King et 
al., 2010, Donnelly et al., 2013, Caudwell et al., 2012, Caudwell et al., 2014), 
appetite suppression, and hormone regulation (Hagobian & Braun, 2010), though 
large inter-individual variation in exercise-induced weight loss is still reported 
(Caudwell et al., 2012). Again, these studies are lacking a control sample; therefore, 
knowledge of the counterfactual is absent and these data should be interpreted with 
caution. When a control sample is included, although not analysed in direct 
comparison to the intervention, similar variation is observed in all conditions (e.g. 
Church et al., 2009), (Fig. 1.).  
 
2.5.2.2 Other Suggested Mechanisms 
 
Differences in the response of weight loss among individuals have been reportedly 
linked to variability in diet make-up (Senior et al., 2016), baseline respiratory 
quotient (the ratio of fat to carbohydrate oxidation). These findings may indicate that 
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fat oxidation or the ability to increase fat oxidation in response to changes in energy 
intake may affect individual weight loss (Barwell et al., 2009).  
 
Inter-individual variability in weight loss following an exercise intervention has also 
been attributed to sex-based differences in appetite hormones (Hagobain et al., 2008, 
Hagobian et al., 2009, Hagobian & Braun, 2010) and the compliance with the 
intervention (Manninen et al., 1998, Bruce et al., 2003). However, even with near 
perfect compliance, underlying compensatory responses may also affect energy 
balance (King et al., 2008), while in children, sex, age and baseline body fat, diet 
have been postulated to be possible mechanisms (Barbeau et al., 1999).   
 
For some, exercise is an unsuccessful method of weight control (King et al., 2008), 
possibly due to compensatory behaviours counteracting the benefits of exercise  
 (King et al., 2007a, Finlayson et al., 2009, Rosenkilde et al., 2012), but as the 
longer-term habitual day-to-day variability in EI and EE is as yet unclear (Stubbs et 
al., 2004), the certainty of this belief could be questioned.  
 
Compensatory adaptive mechanisms opposing negative energy balance (Stubbs et al. 
2004) such as reduced metabolic rate or increased appetite (Rosendilke et al., 2012), 
reductions in energy expended during spontaneous exercise (Goran & Poehlman, 
1992) and partial EI compensation (Blundell et al., 2003, Hopkins et al., 2014) have 
previously been noted; immediate compensatory increases in EI in response to EE 
have recently been rejected (Hopkins et al., 2016) but persisting with exercise may 
drive increased EI (Stubbs et al., 2002a, Stubbs et al., 2002b, Whybrow et al., 2008).  
 
Evidence has been offered of increased motivation to eat following longer-term 
energy deficit (Heini et al., 1998, Drapeau et al., 2007, King et al., 2007b). To 
investigate this phenomenon, 35 overweight and obese participants undertook 12 
weeks of exercise eliciting 500 kcal EE per session, 5 times per week (King et al., 
2008). While wide variability in weight (-14.7 to +1.7 kg) and fat (-9.5 to +2.6 kg) 
changes were reported, linked to metabolic and/or behavioural adjustments, no 
control sample was included. This key omission renders analysis of the spread of 
change inaccurate, due to the lack of presentation of the standard deviation of the 
change score for intervention vs control. Classification of ‘responders’ and ‘non-
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responders’ dependent upon achieving prior weight loss targets is also an unsuitable 
approach for quantifying the inter-individual variation in response.  
 
2.6 Blood Pressure and the Effects of Exercise 
 
Blood pressure is the product of cardiac output and total peripheral resistance 
(Sabbahi et al., 2018). High blood pressure is a serious public health challenge 
(Wolz et al., 2000), given that it affects 25% of the world’s population (Carpio-
Rivera et al., 2015).  There is an association between blood pressure and all-cause 
and cardiovascular mortality. According to the WHO Global Burden of Disease 
report, high blood pressure is the leading single risk factor for global burden of 
disease (Lim et al., 2012), although that is now challenged by diseases such as 
diabetes (WHO, 2016), which contributed to over 1.5 million deaths in 2012.   
 
2.6.1 Blood Pressure Reactivity 
 
Acute psychological or physiological stress is associated with factors that explain a 
number of cardiovascular related comorbidities, such as endothelial dysfunction, 
oxidative stress, the development of atherosclerosis and inflammatory reactivity 
(Huang et al., 2013). Although an increase in blood pressure is expected and a 
normal physiological response to exercise (Yzaguirre et al., 2017), it is hypothesized 
that the magnitude of cardiovascular reaction to stress is related to future blood 
pressure status and cardiovascular disease (Carroll et al., 2011), with greater 
reactivity predicting poor cardiovascular outcomes. An exaggerated systolic blood 
pressure response of more than 180 mmHg during moderate submaximal exercise or 
diastolic blood pressure of more than 95 mmHg during maximal exercise has been 
suggested to be the best predictor of new-onset hypertension at 20 year follow up 
(Yzaguirre et al., 2017). 
 
There is currently little empirical research into the inter-individual variation in blood 
pressure in response to exercise. However, it has been reported that males and 
females, whilst utilising the same pathways for stress response, appear to do so with 
a variation in results (Huang et al., 2013). Males often present larger chronic 
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Fig. 1. Comparison of individual variation in response to exercise, showing similar 
responses in control sample (Church et al., 2009). 
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2.6.1.1 Mechanisms for Gender Differences 
 
diastolic blood pressure responses to acute exercise. This observation supports the 
notion that that male responses are ‘vascular’ while female responses are ‘cardiac’ 
(Allen et al., 1993), though this has recently been countered with reports of 
continued diastolic increase throughout life in both sexes. Whereas males show 
consistently greater SBP and DBP until the sixth decade before a plateau in DBP by 
the seventh, female peak DBP appears to catch up with, and surpass, that of males 
(Sabbahi et al., 2018). Given cardiac output decreases with age, it may be that a 
blunted vasodilatory response to exercise in females is responsible for this shift in 
DBP (Sabbahi et al., 2018). Whilst these suggestions may explain chronic changes 
and may be as a result of the ‘last bout’ effect (Plowman & Smith, 2007), no 
published research is available regarding the acute inter-individual variation in blood 
pressure response to exercise. These outcome measures are addressed in Chapter 5 
(chronic blood pressure change) and Chapter 6 (acute blood pressure response to 
high intensity aerobic exercise) of this thesis. 
 
2.6.2 Heart Rate Response 
 
Individuals with higher fitness levels appear to present a smaller magnitude of heart 
rate reactivity response (Boutcher & Nugent, 1993), though the mechanisms are not 
explicitly known at this time (Lambiase et al., 2013). Potential explanations may 
come from the fact that exercise elicits noradrenaline release in a curvilinear manner 
in response to increased workload and in combination with adrenaline (Rowell & 
Shepherd, 1996) may be responsible for the magnitude of observed rise in exercise 
heart rate and blood pressure. 
 
2.6.3 Inter-Individual Variability of Blood Pressure and Heart Rate in Response 
to Exercise 
 
Little published evidence has alluded to the inter-individual variation in the response 
of blood pressure to either acute or chronic exercise. In a short study investigating 
the individual blood pressure response of 13 participants with peripheral arterial 
disease, it was reported that only 8 patients had increases of greater than 4 mmHg in 
at least one of two exercise (aerobic or resistance training) sessions (Lima et al., 
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2015), suggesting a range of responses to the intervention. The mixture of 
medication taken by participants adds a confounding variable not controlled for in 
analysis.  
 
It was recently suggested that while exercise may benefit the majority, blood 
pressure adaptation may be heterogeneous in nature (Chen, 2010, Loenneke et al., 
2014), although this has been refuted, with a suggestion that the findings were the 
result of contamination by the regression to the mean statistical artefact (Atkinson & 
Taylor, 2011, Atkinson, 2015). Re-analysis of HERITAGE Family Study data was 
also claimed to show 12.2% of the sample presenting adverse resting SBP response 
to exercise (Bouchard et al., 2012). It has been proposed that these variations in 
response are associated with gene polymorphisms (Mori et al., 2009). Those with 
angiotensin-converting enzyme (ACE), apolipoprotein E (apoE), and lipoprotein 
lipase (LPL) genotype variants (Hagberg et al., 1999) are likely positive responders 
to exercise, possibly due to the role the renin-angiotensin system plays in the 
regulation of blood pressure. A more recent genome-wide association study also 
suggests thirty loci are responsible for heart rate response to exercise (Ramirez et al., 
2018); however, it is unknown whether these findings would hold true if the 
individuals identified were exercised in an RCT-style intervention. There is currently 
no empirical evidence regarding inter-individual variation in heart rate response to 
acute exercise. Given the lack of research in this area, it is clear that this is a critical 
physiological variable that has potential for deeper investigation. 
 
2.7 True Inter-Individual Variability in Response to Exercise: Does it Exist? 
Although decades of observations regarding inter-individual variability appear 
convincing, superficially, the conclusions of the previously mentioned studies 
assume that the variability in response for a trait is solely a consequence of exercise. 
However, the individual variability often attributed to the intervention group 
(treatment), can include numerous sources of variability such as measurement error, 
random (biological and measurement) variability, between-subject variability (if 
unadjusted for baseline), subject-by-treatment interaction and within-subject 
variability.  
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A summary of the potential sources of variability are given in Table 1. The subject-
by treatment interaction, commonly known as the inter-individual variability in 
response to treatment, represents the variability in differences of training response 
between individuals. However, to adequately quantify the variability for the subject-
by-treatment interaction, confounding sources of variability should be considered. In 
a parallel group RCT, we get the individual response variance by deduction. The 
variance of the changes in the control around the mean change are made up of 
between- (B) plus within-subjects (W) variance. The variance of the changes in the 
treatment arm is given by B+W+R, where R is the true individual response variance. 
Therefore, treatment minus control = (B+W+R) – (B + W) = R, by deduction, 
assuming that in an RCT B and W are the same between groups. Only a replicate 
crossover can fully partition the sources of variance, but that design may only be 
applied to acute effects. 
For these reasons, the early studies describing individual response to exercise have 
been criticized by those who suggest that limitations in study design and analytical 
approach confound the interpretation of data and the inferences drawn (Hopkins, 
2015, Hecksteden et al., 2015, Atkinson & Batterham, 2015, Williamson et al., 
2017). Of primary concern, from a design perspective, is that these early studies did 
not include a control group, and consequently could not account for the random 
variability over time for the trait under study.  
Furthermore, despite inclusion of a control group in some study designs, many 
authors did not consider incorporating the control group data in their analysis 
(Prud’homme et al., 1984, Sisson et al., 2009, Church et al., 2009, Ross et al., 
2015); therefore the ‘true’ variability in response is not adequately quantified.  
2.8 Gaps in the Literature and Rationale for Further Research 
 
Much attention has been given to the notion of individual responses, but it is clear 
that several common limitations can be identified within many of the studies 
investigating the inter-individual variation in response to an exercise intervention. 
Almost exclusively in these studies, a control group is either absent or discarded in 
the data analysis. As highlighted, the inclusion of data from a comparator group to 
compare the inter-individual response to the given intervention is of principal 
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importance and has previously been emphasised (Atkinson & Batterham, 2015). 
Without this, the resultant data analysis is largely inaccurate and potentially 
misleading (Atkinson & Batterham, 2015), with measurement error and random or 
biological variation in response to an intervention mistaken for true individual 
differences in response (Leifer et al., 2015). Plots of individual differences in the 
baseline-to-follow up change are often presented for the exercise training study arm 
only (Sparks, 2017). Yet a very similar graph can usually be plotted for the baseline-
to-follow up change in the control group. This has been observed (Church et al., 
2009, Songsorn et al., 2016), but the resultant analysis of the control sample is often 
lacking.  
 
In an RCT, true individual differences in exercise response are present only if the SD 
of change is substantially larger in the exercise group than the control group. If not, 
the apparent individual differences in ‘response’ are nothing but baseline-to-follow 
up within-subjects’ variability, which can be large if there are many weeks (>6) 
between baseline and follow up in the study. This observation is common in most 
studies. In a critical review of a selected sample of exercise training studies with 
V̇O2max as the outcome, it was identified that very few studies included data from a 
control group in their analyses. For those studies that had a control group, there was 
little evidence that the difference in the SD of changes between intervention and 
control was clinically important, relative to an MCID of 1 MET (Williamson et al., 
2017). 
 
Determining whether there are true individual differences in the responses to 
exercise that are large enough to be clinically relevant is a crucial platform for 
precision medicine. If the individual differences in response are found to be not 
clinically important, the need to proceed to explore individual moderators and 
mediators of response is questioned, as such explorations could be wasteful in terms 
of participant time and funding money.  
 
Little research has employed this key aspect of methodology required for the 
accurate quantification of inter-individual response. Despite many of the 
aforementioned studies’ lack of comparator arm, they have provided the basis for a 
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Table 1. Potential sources of variability during exercise trials. Adapted from Bell 
et al., 2008. 
Source of 
variability 
Description Ways to account for 
variability 
Error 
Random 
variability 
Influences pre/post outcome 
values  
Comprised of:  
measurement error – the 
difference between the observed 
value and the ‘true’ value’ 
biological variability – random 
fluctuations over time 
Use 𝑆𝐷𝐼𝑅 =
√𝑆𝐷𝐼
2 −  𝑆𝐷𝐶
2 to 
separate from 
subject-by-treatment 
variability 
 
Between 
treatment 
The variation between treatments 
averaged over all patients 
Parallel group trial Between 
patient, 
Subject-by-
treatment 
interaction, 
within 
treatment 
Between-
subject 
The variation between patients 
given the same treatment 
True differences between 
individuals (i.e. baseline 
differences) 
Include baseline as 
covariates 
Subject-by-
treatment 
interaction, 
within 
treatment 
Subject-by-
treatment 
interaction 
‘True’ inter-individual variation 
in response due to 
treatment/intervention 
The extent to which the effects of 
the treatment vary from patient 
to patient 
Use 𝑆𝐷𝐼𝑅 =
√𝑆𝐷𝐼
2 −  𝑆𝐷𝐶
2 to 
properly separate 
from random 
variability in a 
chronic training 
study. Utilize 
replicate crossover 
for acute effects  
 
Within 
subject 
Reproducibility of training 
effects 
Magnitude of change within 
same subject 
Variation from occasion to 
occasion when patient is given 
the same treatment 
Use replicate 
crossover method 
Allows for 
partitioning of 
period effect 
 
 
growing body of work. Indeed, from the investigations that informed and framed the 
implementation of HERITAGE, only one (Prud’Homme et al., 1984) actually 
included a control group, and even then, more variability was observed in the control 
sample vs the intervention (Williamson  et al., 2017). 
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Not all inter-individual response may be due to these aforementioned factors. Neither 
does it confirm that this assumption of inter-individual difference in response is true 
for any particular study (Atkinson & Batterham, 2015). Small day-to-day changes 
cannot be classified as a worthwhile change, and the response must be clinically 
relevant and more than the natural biological variation between baseline and follow-
up measurements (Scharhag-Rosenberger et al., 2012). Of course, patients differ not 
only by genetics, but also by their personal history and environmental circumstances 
(Senn, 2001), and this can lead to a multitude of effects on individual response. 
There appears to be little doubt that the response to exercise training is influenced by 
multiple factors, including those not discussed herein, such as psychosocial and 
environmental. 
 
The variability in the changes in an intervention group must be assessed against the 
backdrop of this natural variability. In an RCT, the mean effect of the intervention is 
given by the mean change in the intervention minus the mean change in the control. 
This logic should be extended to the assessment of individual responses. 
 
Therefore, the primary aim of this programme of work is to quantify the clinically 
relevant inter-individual differences in the response to exercise training once 
appropriate data analysis approaches are employed. It is evident that further research 
is required to quantify ‘true’ inter-individual variation in response to exercise 
interventions. If such variation is present, and represents a clinically meaningful 
difference, identification of potential moderators and mediators would be of great 
value to the personalization of exercise prescription. This research is important if we 
are to understand the nature of ‘true’ inter-individual response to exercise, and to 
further investigate the moderators and mediators of this heterogeneity of response. 
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Chapter 3: Inter-Individual Responses of Maximal Oxygen Uptake 
to Exercise Training: A Critical Review 
 
3.1 Preface 
 
Given the review of the literature presented in Chapter 2, it is important that a 
deeper, more critical review is undertaken in order to understand, and re-analyse, 
previously published literature purporting to show inter-individual variation in the 
response of maximal aerobic capacity to chronic exercise interventions. This chapter 
takes a contructively critical view of much of the published literature, but also makes 
the point that this area is critical for understanding the reasoning for employing a 
robust approach to the quantification of inter-individual variation in response. This 
chapter is based upon a peer-reviewed research paper, published in Sports 
Medicine in (Williamson et al., 2017). 
 
3.2 Introduction 
 
Interest in the concept of individualised responses to an intervention as part of 
‘personalised medicine’ and ‘precision care’ has been growing over the last 30 years 
(Prud’homme et al., 1984, Despres et al., 1984, Lortie et al., 1984, Savard et al., 
1985, Hamel et al., 1986, Simoneau et al., 1986, Rose & Parfitt, 2007, Senn et al., 
2011, Bouchard, 2012a, Mann et al., 2014, Bouchard et al., 2015). In 
pharmacogenetics, there has been particular interest in ‘tailor-made’ drugs and 
therapies, based on the individual response of a patient and/or certain moderators and 
mediators of that response (Spear et al., 2001, Senn et al., 2011). Personalised 
medicine has also been considered in the context of inter-individual differences in 
the response of health outcomes to various exercise interventions.  
 
It has been highlighted that the majority of researchers focus upon ‘main effects’ and 
mean group changes (Bouchard & Rankinen, 2001). These statistics are useful, but 
do not allow us to distinguish between cases (Senn, 2004), may hide a wide range of 
responses (Karavirta et al., 2011) and have previously been described as misleading 
(Bouchard, 1983, Bouchard & Rankinen, 2001). True inter-individual differences in 
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the response to an intervention are less frequently reported, even though it has been 
proposed that there is large inter-individual variability in response to physical 
activity interventions (Prud’homme et al., 1984, Despres et al., 1984, Lortie et al., 
1984, Savard et al., 1985, Hamel et al., 1986, Simoneau et al., 1986, Bouchard & 
Rankinen, 2001, Hautala et al., 2003) 
 
Importantly, even in the studies in which inter-individual differences in the response 
to exercise training are considered, concerns have been levelled at the designs and 
analytical approaches in these studies (Hopkins, 2015, Atkinson & Batterham, 
2015). Therefore, it is important at this time for the claims of inter-individual 
differences in response to an exercise intervention, with a particular focus on 
maximal oxygen uptake (V̇O2max), to be scrutinised in the context of these recent 
criticisms. Consequently, I undertook this critical review on the HEalth, RIsk factors, 
exercise Training And GEnetics (HERITAGE) Family Study, as well as the studies 
that preceded it and the more recently published research. I will focus especially on 
any apparent limitations of previously adopted data analysis approaches, and how 
researchers have investigated potential moderators and mediators of the inter-
individual difference in V̇O2max response to an exercise intervention. Finally, I 
present what I consider to be an appropriate trial design and analysis approach in 
order to quantify true inter-individual differences in V̇O2max response to exercise 
interventions. My focus in this regard is on parallel group randomised controlled 
trials, as I believe that this design is more widely applicable to research questions 
addressing chronic adaptations to training. Moreover, published chronic training 
studies with V̇O2max as the outcome are exclusively before-and-after designs, either 
with or without a control group, with a single intervention period. However, it is 
acknowledged that other designs and statistical approaches have been proposed for 
quantifying individual differences in response to treatments, primarily the 
multiperiod (replicate) crossover design (Hecksteden et al., 2015, Senn, 2016).  
 
3.3 Maximal Oxygen Uptake and Precision Medicine 
 
Low cardiorespiratory fitness has been established as an independent predictor of all-
cause mortality and cardiovascular disease (Laukkanen et al., 2004, Sui et al., 2007). 
Many researchers have highlighted the favourable changes in risk factors that occur 
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following a period of exercise training (Myers et al., 2002, Church et al., 2007, 
Kelley & Kelley, 2008, Church et al., 2010). Given that one metabolic equivalent 
(MET) is the amount of oxygen consumed whilst sitting at rest, and is ≈3.5 mL.kg-
1.min-1 (Jette et al., 1990), research that 1-MET increase in cardiorespiratory fitness 
translates to a 12% reduction in cardiovascular disease and all-cause mortality risk 
has been reported (Myers et al., 2002).  
 
While a multitude of phenotypes have been investigated, V̇O2max response has often 
been the focus for authors observing the inter-individual variation in response to 
exercise. Wide inter-individual differences in the trainability of the cardiorespiratory 
system have been claimed (Lortie et al., 1984, Bouchard, 1995, Feitosa et al., 2002), 
with reports that the improvements in V̇O2max range from zero to a 40% increase 
(Bouchard, 1995). Such variation is consistent with the fact that biochemical and 
physiological functions vary in all humans (Vollard et al., 2009). Several researchers 
have also reported that some individuals show little or no improvement in markers 
such as lipolytic activity, insulin sensitivity, maximal work rate, submaximal 
exercise heart rate and respiratory exchange rate following an exercise intervention 
(Despres et al., 1984, Lortie et al., 1984, Savard et al., 1985, Hamel et al., 1986, 
Simoneau et al., 1986). Conversely, it has been proposed that physical activity may 
increase cardiovascular risk in some individuals, worsening risk factors beyond 
measurement error and biological variation (Bouchard et al., 2012b), although this 
notion is not consistent with the results of a more recent study, based upon the 
cardiovascular markers monitored (Leifer et al., 2015), although differences in 
thresholds for adverse response between these studies limit the comparisons that can 
be drawn.  
 
Prescription of exercise is often undertaken with a global approach rather than a 
personalised one, and as exercise interventions are often utilized to reduce or prevent 
age-related reduction in function or lifestyle related diseases, attention should be 
paid to the response of each participant within a study (Kainulainen, 2009). If an 
individual is likely to respond favourably to a given stimulus, he/she is more likely 
to engage with that mode of exercise. Consequently, identifying individuals likely to 
gain greatest benefit would allow practitioners to also focus on alternative exercise, 
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dietary or pharmacological options for those that may be less likely to respond 
(Rankinen et al., 2010, Timmons et al., 2010).  
 
 
3.4 A Critical Review of the Relevant Studies 
 
Via a search of the relevant literature databases, I aimed to locate all the studies in 
which inter-individual differences in the response of V̇O2max to an exercise 
intervention have been considered. I was particularly interested in ascertaining how 
many of these studies incorporated a relevant comparator sample into their design. 
Data from this sample have been deemed to be important for precise quantification 
and interpretation of inter-individual differences in response (Hopkins, 2015, 
Atkinson & Batterham, 2015). Without these data, measurement error and random or 
biological variation in the study outcome over time can compromise the 
quantification of true inter-individual differences in response (Leifer et al., 2015). 
Importantly, any physiological outcome can show substantial natural variability over 
a 4-6-month follow-up period in a control sample that does not receive the 
intervention (Leifer et al., 2015). This variation will also be present in the 
intervention group, irrespective of the additional influence of the intervention itself.  
 
3.4.1 Pre-HERITAGE Studies 
 
The seminal studies on this topic were conducted in the 1980s, with the aim of 
identifying the inter-individual response to exercise and to clarify the genotype 
dependency of the modulation of response (Prud’homme et al., 1984, Despres et al., 
1984, Lortie et al., 1984, Savard et al., 1985, Hamel et al., 1986, Simoneau et al., 
1986) (Table 2). The effects of a 20-week endurance training programme on 
maximal aerobic power (MAP), ventilatory aerobic threshold and ventilatory 
anaerobic threshold in ten pairs of monozygotic twins were initially investigated 
(Prud’homme et al., 1984). Unlike in later studies, a comparator (no-exercise 
training) group was included in this study. From the intraclass correlations (ICC) 
reported, the authors described a highly variable response to training and concluded 
that sensitivity to training is genotype-dependent. The authors estimated that 20-25% 
of training-induced variation in MAP was due to within-pair differences. 
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Nevertheless, using the approach recently described (Atkinson & Batterham, 2015), 
re-analysis of the data presented in Table 1 of this study revealed that whist the mean 
changes were 5.5 mL.kg-1.min-1 in the intervention and -0.6 mL.kg-1.min-1 in the 
control, no clinically important differences in the SD of the change scores between 
the groups (control ± 5.6 mL.kg-1.min-1, intervention ± 3.7 mL.kg-1.min-1). This 
observation indicates that there are no substantial inter-individual differences in 
response to the intervention (Atkinson & Batterham, 2015). In fact, these SDs 
indicate greater variability in response in the control group versus the intervention 
group. It has been previously argued that this phenomenon may be due to 
imprecision in the estimation of inter-individual responses with inadequate sample 
sizes and/or caused by the intervention having a ‘homogenizing’ effect on the 
outcome variable, thus reducing the SD of the changes relative to the control group 
(Atkinson & Batterham, 2015).  
 
The point estimate for the true individual response variability (SDIR) for the above 
data is -4.2 (90% confidence interval, -6.3 to 2.0) mL.kg-1.min-1 (calculated by 
𝑆𝐷𝐼𝑅 = √𝑆𝐷𝐼
2 −  𝑆𝐷𝐶
2), with the negative point estimate indicating more response 
variability in control versus intervention. Note, however, that the upper limit of the 
90% CI, which are calculated using the observed value (-4.2) plus or minus the 
standard error times 1.65 (Hopkins, 2015), for the SDIR is 2 mL.kg
-1.min-1 (implying 
more variability in response in the intervention group). This indicates an 
‘homogenising’ effect in the intervention sample. The SDIR should be doubled before 
evaluating its magnitude to reflect a comparison between a typically high (mean + 
SDIR) and typically low (mean – SDIR) responder (Hopkins, 2015). Modelling the 
variances directly (quantifying the area under the curve for the distribution of SDIR 
that is beyond 3.5 mL.kg-1.min-1), the probability that the true population effect for 2 
x upper limit of the 90%CI of the SDIR (4 mL.kg
-1.min-1) is greater than the 
minimum clinically important difference (MCID) of 1 MET is only 6% (unlikely to 
be clinically important). This analysis shows that, even allowing for the uncertainty 
in the estimate of true individual response variability in small samples, the odds 
are stacked against meaningful inter-individual differences in the response of 
maximal oxygen uptake to exercise training. 
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Further research was undertaken (Despres et al., 1984, Lortie et al., 1984, Savard et 
al., 1985, Hamel et al., 1986, Simoneau et al., 1986, Bouchard et al., 1986), with the 
study authors claiming there to be large variations in response to exercise for a 
number of phenotypes, including adipose tissue, fat cell weight, lipolytic activity, 
glucose conversion into fat cell, triglycerides, skinfolds, percentage body fat, 
anaerobic, alactic and lactic acid capabilities, fibre type, enzyme activity, sensitivity 
of muscle characteristics and aerobic endurance performance. Crucially, no 
comparator group was included in these studies.      
 
A variation in improvement in maximal aerobic performance (V̇O2peak) of between 
5 and 88% that was not correlated with a similarly wide range of 16-97% increases 
in total work output accomplished in a 90-minute ergocycle performance test was 
reported in one study (Lortie et al., 1984). Inter-individual responses were concluded 
following the observation of greater between-pair variation than within-pair variation 
in monozygotic twins, and through sex differences in those studies using mixed-sex 
cohorts (Despres et al., 1984). Genotype dependent responses for both maximal 
aerobic power and endurance performance were observed in conjunction with 
skeletal muscle enzyme changes following a fifteen-week training programme 
(Hamel et al., 1986), while inter-individual differences in anaerobic alactacid (ALC) 
and lactacid (AAC) response, fibre type changes and enzyme activity were reported 
in response to high intensity intermittent training (Simoneau et al., 1986). ALC and 
enzyme activity were said to be determined by genotype, although no such 
relationship was observed for other measured variables. The use of siblings was used 
to make inferences about the importance of genetic influence in heritability, with F-
ratios suggesting 5-10 times more variance between twin pairs than within pairs. 
Similarly, genetic determination has been claimed for several different aerobic 
performance measures from the results of studies in which brothers, monozygotic 
and dizygotic twins were compared (Bouchard et al., 1986). Changes in aerobic 
fitness ranging from 0-58% were later reported among adults aged 60-71, where a 
trend for older participants improving less than younger subjects was observed 
(Kohrt et al., 1991).  
 
The justification for the lack of a non-exercising control in the subsequent 
HERITAGE Family Study, which appears to have been continued through 
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subsequent investigations, was an observation of mean values from previously 
studied control groups remaining unchanged (Wilmore et al., 2001). However, a 
finding of no substantial change in the mean for the control group can occur in the 
face of substantial random within-subject variability in the changes in V̇O2max over 
the duration of the study. The variability in the changes in the intervention group 
must be assessed against the backdrop of this natural variability. In a randomised 
controlled trial (RCT), the mean effect of the intervention is given by the mean 
change in the intervention minus the mean change in the control. This logic should 
be extended to the assessment of inter-individual responses to an exercise 
intervention. In a parallel group RCT, one cannot say with 100% certainty whether 
or not any specific individual in the intervention group is a positive responder, as 
what would have happened to that person if, contrary to the fact, they had been in the 
control group is unknown. This is the fundamental counterfactual basis of the RCT, 
and whilst V̇O2max will not increase spontaneously, it may be impacted by changes 
in body mass in the absence of changes in absolute aerobic capacity. However, if the 
variance in the response in the intervention group is substantially greater than that in 
the control arm, then true individual responses may be inferred. The control group 
variability over the same time period as the intervention effectively provides our best 
guess of the counterfactual - what would have happened to individuals in the 
intervention group if they had been in the control arm. In parallel group RCTs, 
substantially greater response variance in the intervention group versus control is 
both necessary and sufficient for inferring true inter-individual differences in 
response to the intervention. Assuming that sample estimates are accurate estimates 
of the population values, it is incontrovertible that there must be a larger variance in 
response in intervention vs. control if true individual differences exist in response to 
treatment. Furthermore, although a parallel group RCT cannot isolate variance due to 
subject-by-treatment interaction (Senn, 2016), in this design a greater response 
variance in intervention vs. control is sufficient to infer inter-individual responses. 
As described, for any individual in the intervention arm we can then derive the 
probability of being a positive responder/ trivial responder/ or negative responder. 
 
                                                   
 Table 2. Early studies presenting inter-individual response to exercise interventions. 
 Exercise Training Program Results 
Literature 
Citation 
Subjects/Groups Mode Length Intensity/Frequency/Duration/Volume Δ BW/ V̇O2 
max/Lipids 
Other 
Prud’Homme 
et al., 1984 
n = 48 (10 pr (6M, 
4F) MZ twins & 
14 (7M, 7F) 
control) 
Cycling 20 wk 4-5d/wk; 40-45mins; 60-85% HRR Variable response 
claims that sensitivity 
to training is genotype 
dependent 
20-25% of training 
induced variation 
in MAP due to 
within-pair 
differences 
Despres et al., 
1984 
n = 22 (11M, 11F) Cycling 20 wk 4-5d/wk; 40mins; 80% MHR No Δ in fat cell 
number. Δ fat cell 
weight. Δ lipolysis 
Δ lipolysis 
response greater in 
males than 
females.  Females 
had no Δ in fat 
mass, skinfolds. 
Increased MAP 
(SDs 
=6.8/6.9/4.2/2.9). 
Lortie et al., 
1984 
n = 24 (13F, 11M) Cycling 20 wk 4-5d/wk; 40-45mins; 60-85% HRR Δ MAP/kg 33%; 
MAC/kg by 51%; 
Males Δ in MAC/kg 
50% more than 
females. 
Δ 5-88% MAP/kg 
& 16-97% in 
MAC/kg. 
Savard et al., 
1985 
n = 24 (13F, 11M) Cycling 20 wk 4-5d/wk; 40-45mins; 60-85% HRR Δ Insulin stimulated 
glucose conversion to 
triglycerides Δ in 
males, but not females. 
Similar Δ in MAP. 
Suggests Δ in 
modification of fat 
cell glucose 
metabolism. 
Hamel et al., 
1986 
n = 12 (6 prs MZ 
twins) 
Cycling 15 wks 15 wk, 3-5d/wk; 30-45mins; 60-85% HRR 
including 1/wk HIIT; 3x10mins; 80-85% 
with 5mins recovery 
Δ in aerobic enzyme 
activity in wks 8-15. 5-
10 x more variation 
No fiber type Δ 
5
4
 
  
 
between than within 
pairs. 
Simoneau et 
al., 1986 
n = 28 (14 pr 
monozygotic 
twins, (7M pr, 7F 
pr)) 
Cycling 15 wk HIIT 10 x 15-30s & 4-5 x 60-90s,;HR 
recovery to 120-130b.min efforts; 4-5d/wk. 
Δ T1 fibres, AAC, 
ALC, enzyme activity 
& T2 fibres. 
Large 
interindividual 
differences, but 
similar within 
twin. Genotype 
suggested as 
responsible for 
responsiveness to 
HIIT on several 
variables. 65% of 
ALC associated 
with genotype. 
Δ oxidation 
following HIIT. 
Fibre type changes 
independent of 
genotype. 
Δ change, BW body weight, pr pair, M male, F female, MZ monozygotic, wk week, mins minutes, MAP maximal aerobic power, MHR maximal 
heart rate, HRR heart rate reserve, MAC maximal aerobic capacity, HIIT high intensity interval training, T1 type 1, AAC lactacid, ALC 
anaerobic alactacid, T2 type 2. 
 
 
 
5
5 
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3.4.2 Recent Studies 
 
Six to nine times more variance in V̇O2max response between monozygotic twin 
pairs than within pairs has been reported (Bouchard et al., 2000). This and other 
studies were described as ‘standardized and carefully monitored’ (Bouchard, 2012a), 
with a ‘careful and constant program of quality control and assurance’ (Gagnon et 
al., 1996); yet still lack a suitable comparator sample. Nevertheless, RCTs are not 
only relevant to the investigation of main effects (Hecksteden et al., 2015). Use of 
the intervention-only arm as a basis for analysis is problematic, as similar or even 
greater variability of changes may also be observed in a control group, as was the 
case when a previous study was re-examined (Prud’homme et al., 1984). I fear that 
too much emphasis has been placed on gene relationship statistics without answering 
the initial and crucial question of whether clinically-relevant inter-individual 
differences in response exist. This question is answered by calculating the difference 
in baseline to follow-up variability between intervention and comparator groups and 
comparing this difference to a rationalised MCID (Atkinson & Batterham, 2015). 
 
More recently, large variations in V̇O2max response to exercise were reported in the 
large-scale Dose-Response to Exercise in Women (DREW) Study (Sisson et al., 
2009). A decrease in the prevalence of non-response with increased training volume 
was also observed. The authors reported a large amount of inter-individual 
variability (-33.2 to 76.0% change), citing baseline V̇O2max, age and training 
volume as predictors of non-response. The study comprised three intervention 
groups (4, 8 and 12 kcal/kg per week of exercise) alongside a control group, with a 
stated purpose of the analysis to examine the determinants of change in V̇O2max in 
response to exercise training. However, the decision to exclude the control group 
from the analysis compromised the correct quantification of the true inter-individual 
response and missed potentially vital information. Further work from the DREW 
study reported that 30% of participants experienced no improvement in V̇O2peak 
(Pandey et al., 2015). However, once again, no control group data were studied.  
 
Recent studies have been undertaken to further identify possible genotype or 
phenotype interactions responsible for moderating the magnitude of inter-individual 
response (Hautala et al., 2003, Karavirta et al., 2011, Ross et al., 2015). Large 
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variation in training response to an eight-week aerobic endurance training 
intervention was reported (Hautala et al., 2003). Interestingly, whilst a control group 
was used, the baseline to follow-up changes in this group were not used for 
comparison at all. Disregarding the control group in this manner, on the basis that 
there will be no mean change, and/or the short-term test-retest reliability is high, is 
an approach that has limitations. Differences in response were observed by dividing 
the intervention group responses by quartile, rather than retaining a continuous 
variable; this approach discards information and has previously been reported to be 
an inadequate analysis method in epidemiology (Benette & Vickers, 2012). I found 
that, during my re-analysis of these data, in contrast to the authors’ assertion of the 
differential effects of the sympathetic nervous system on the responses to the training 
protocol, it appears that there may be little true difference in the variation (SDchange) 
between each of the ‘response’ groups (SDchange range 1-2 mL.kg-1.min-1). 
 
3.4.3 Concurrent Training 
 
Investigations into the inter-individual responses to combined endurance and 
strength training in young (Hautala et al., 2006) and older adults (Karavirta et al., 
2011) have also been undertaken. The findings of these studies are in general 
agreement with much of the previously published literature, in that a range of 
training responses were observed. Nevertheless, as in an earlier study (Prud’homme 
et al., 1984), a control group was included in one study (Karavirta et al., 2011) but 
no specific comparison was made. It is also apparent from the responses reported in 
Figure 1 of this investigation (Karavirta et al., 2011) that similar variation in 
response exists in the control group as in the experimental groups, reinforcing the 
view that there is similar variability of baseline to follow-up changes across all 
groups. The participants in another study acted as their own control in a crossover 
trial (Hautala et al., 2006), however, the residual training effect of the intervention 
period on the response following the washout period is unknown.  
 
3.4.4 Biological Variability 
 
Not all inter-individual response may be due to the factors postulated in the studies 
reviewed within this article. Neither does variation in responses confirm that this 
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assumption of inter-individual difference in response is true for any particular study 
(Atkinson & Batterham, 2015). Small day-to-day changes cannot be classified as a 
worthwhile change, and the response must be clinically relevant and more than the 
natural biological variation between baseline and follow-up measurements 
(Scharhag-Rosenberger et al., 2012). Of course, patients differ not only by genetics, 
but also by their personal history and environmental circumstances (Senn, 2001), and 
this can lead to a multitude of effects on inter-individual response. There appears to 
be little doubt that the response to exercise training is influenced by multiple factors. 
 
A new focus on the quantification of true inter-individual differences and the 
moderators and mediators responsible may, therefore, have substantial clinical 
relevance, with any correctly quantified heterogeneity affording the opportunity to 
identify possible molecular determinants (Bouchard et al., 1999). Indeed, RNA 
profiling may be a potential methodology for capturing information critical to 
informing the integrated physiological response and molecular determinants 
(Timmons et al., 2010), once the presence of inter-individual variation in response 
has been confirmed.  
 
3.4.5 Identifying ‘Responders’ and ‘Non-Responders’ 
 
A further limitation of much of the previous research is the classification of 
individuals as ‘non-responders’ (Bouchard et al., 1999, Skinner et al., 2001) without 
first defining the term, although this has been partially addressed more recently when 
defined as those improving by ‘less than the natural biological variability of the 
selected variable’ (Scharhag-Rosenberger et al., 2012). Strictly, a positive response 
should be defined as an increase that is greater than the MCID. For V̇O2max, for 
example, the MCID could be defined as 1 MET, anchored to a clinically relevant 
relative risk reduction for all-cause mortality of around 12% for this value (Myers et 
al., 2002). For a given individual, the observed change in V̇O2max after the 
intervention can be combined with knowledge of the natural random variation of 
V̇O2max over the same time period (from a control group or similar reliability study) 
to derive the probability that this individual’s true response is greater than the MCID 
(Hopkins, 2015). We can then more properly describe each individual in the 
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intervention as, for example, ‘likely to be a responder’, ‘very unlikely to be a 
responder’, ‘possibly negative responder’, and so on. 
 
Similarly to previous reports (Sisson et al., 2009), further argument for the dose-
response to exercise is observed when greater exercise volume (Pandey et al., 2015) 
or intensity (Ross et al., 2015) was associated with reduced chances of being 
classified as a non-responder. While direct comparison between studies is not 
straightforward, these and similar findings suggest that some people may be more 
sensitive to dose prescription of exercise, as opposed to being non-responsive. If this 
is the case, effective identification of dose requirement or requirement for 
multimodal approaches such as concurrent training may provide a capability for 
enhancing the efficacy of an intervention (Buford et al., 2013). However, as is 
covered in this review, I suggest that an individual cannot be categorically defined as 
a ‘responder’ or other such descriptor; merely a probability (percentage chance) that 
they are such can be applied to each individual (Hopkins, 2015). Even with this 
information, in a single-period before-and-after study design, this process can only 
occur in the presence of an appropriate comparator group assessed over the same or 
very similar time period as the exercise intervention.  
 
3.4.6 The HERITAGE Family Study 
 
The large-scale, longitudinal, multicentre HERITAGE Family Study was initiated to 
investigate and identify the role of genotype in cardiovascular, metabolic and 
hormonal responses to a 20-week aerobic exercise training programme (Bouchard et 
al., 1995). The contribution of regular exercise to changes in cardiovascular disease 
(CVD) and diabetes mellitus risk factors was also investigated (Bouchard et al., 
1995, Gagnon et al., 1996). To date, 186 separate publications have resulted from the 
study, with some of these involving the comparison of various familial relationships 
to determine the relative importance of genetics (Bouchard et al., 2000, Perusse et 
al., 2000, Bouchard et al., 2011). The bulk of the research undertaken during 
HERITAGE asserts that there are no genotype-specific covariate effects on V̇O2max 
response, such as age, sex or weight (Bouchard & Rankinen, 2001, Skinner et al., 
2001, Feitosa et al., 2002). Familial aggregation was reported in response to 
maximal (Lortie et al., 1984, Bouchard et al., 1998, Bouchard et al., 1999) and 
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submaximal (Gaskill et al., 2001, Perusse et al., 2001) aerobic training, with two and 
a half times more variance reported between than within families for the V̇O2max 
response. 
 
A genetic contribution to this variance of approximately 47% has been reported 
(Bouchard et al., 1999, Bouchard et al., 2011). These data were characterized by a 
strong maternal aggregation (Bouchard et al., 1998, Bouchard et al., 1999, Perusse et 
al., 2001), with shared environmental factors also contributing to the observed 
heritabilities. The mechanisms underpinning this variance are unclear, but 
suggestions of genetic contribution from mitochondrial DNA (Bouchard et al., 1999) 
or expression of genes inherited from the mother have been presented (Perusse et al., 
2001). Correlations between spouses have led to familial environmental factors also 
being postulated as responsible for some of the variance observed in response to 
exercise (Perusse et al., 2001, Bouchard et al., 1998, Montoye & Gayle, 1978, 
Lesage et al., 1985); however, the correlations presented are small (r=0.14-0.26), 
therefore posing, rather than answering, further questions on this issue. The crucial 
question that is, again, unanswered in the absence of a comparator group is whether 
there are genetic influences on individual magnitude of random within-subjects 
variability. If this is known, then these genetic influences could be quantified.  
 
In HERITAGE studies, it is claimed that there is considerable variation in response. 
Nevertheless, it remains unclear as to whether it was the same individuals that 
showed no response for all measures, or if each individual showed differing response 
characteristics across the spectrum of physiological markers investigated. Recent 
research has attempted to elucidate this issue, observing improvements in at least one 
measured variable in every individual (Scharhag-Rosenberger et al., 2012), though 
again, this study is limited by the lack of a control group with which to compare the 
inter-individual response. Interestingly, despite methodological concerns, individuals 
with the highest response to endurance training have also shown high response to 
resistance training, but the reverse was not true (Hautala et al., 2006). This area 
opens up future avenues in which to investigate the magnitude of response, in the 
presence of proper initial quantification through comparison with a suitable 
comparator sample. 
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3.4.7 Twin Studies 
 
Previously noted criticisms of twin studies point to the fact that they may not 
necessarily separate genetic from environmental pathways (Maes et al., 1997). 
Presentation of evidence of genetic variance of numerous phenotypes through greater 
between-twin pair variance than within-pair variance is often reported through the 
use of ICCs (Prud’homme et al., 1984, Hamel et al., 1985, Timmons et al., 2010, 
Poelhman et al., 1986, Bouchard et al., 1986, Heller et al., 1993, Bouchard et al., 
1994, Hong et al., 1997, Tremblay et al., 1997) (Table 3). These observations are 
highly sample-specific, and a comparison of the ICC between studies is not without 
difficulty, due to the heterogeneity of samples. The potential for ICCs in twin studies 
to overestimate heritability has also been highlighted in that genetic and 
environmental factors have not been adequately separated (Heller et al., 1993). 
 
It is as yet unknown as to whether any relationship between genes and phenotype is 
even linear (Maes et al., 1997) and while genetic variation is not denied in this 
review, it is not clear that all observed variance is genetic (Senn, 2001). I believe that 
when analysing such a design, it would be more appropriate to use data from a 
relevant control (no-exercise) sample and a linear mixed model in order to correctly 
quantify the influence of genetics on magnitude of response. Associations could then 
be presented as a regression coefficient in the units of measurement, rather than a 
comparison of correlation values. In this way, the clinical importance of any 
association can be inferred. Common underlying environmental effects have also 
been proposed as being underestimated due to study design or low statistical power 
(Segal & Allison, 2002).  Adoption studies combined with twin studies to compare 
identical and fraternal twins and twins reared apart (Heller et al., 1993) and repeated 
assessments (Hecksteden et al., 2015) may be required to quantify some of these 
issues. 
 
3.4.8 Baseline Correlation of Changes 
 
Several authors of HERITAGE studies correlated each individual’s baseline score 
with the follow-up change to attempt to determine the contribution of baseline status 
to the inter-individual response to exercise training. From such analyses, it has also 
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been reported that age, sex, fat mass, fat-free mass, weight and race have little or no 
impact upon the inter-individual response to training or covariate effect (Bouchard & 
Rankinen, 2001, Feitosa et al., 2002), and that the initial level of the phenotype was 
a major determinant of the magnitude of response in some cases (Bouchard & 
Rankinen, 2001). Nevertheless, this correlation approach has been questioned, due to 
regression to the mean and mathematical coupling influences (Chiolero et al., 2013). 
Linear mixed effects modelling and other methods such as computing regression to 
the mean slopes and then adjusting for the random error in initial measurement, as 
previously reported (Blomqvist & Svardsudd, 1978), have been purported to be 
superior to this simple correlation approach (Chiolero et al., 2013).  
 
3.4.9 Testing Quality Control 
 
The HERITAGE intervention was described as having a careful and constant 
program of quality control and quality assurance (Gagnon et al., 1996). 
Nevertheless, this claim was based on the test-retest mean differences being small, 
although the selection of either an average of two V̇O2max test scores (where 
coefficient of variation (CV) was less than 5% between the two) or the higher score 
(if CV was greater than 5% between the two) at both baseline and follow-up 
(Shephard et al., 2004) could have led to inconsistent data. To accurately analyse the 
data, identical methodology should ideally be used for all participants. Test-retest 
reliability was reported to be 4.1-5.0% and ICCs of 0.96 to 0.97 were reported over a 
period of two days (Shephard et al., 2004) and two weeks (Skinner et al., 1999), 
implying adequate short-term reproducibility. It is my belief that reproducibility 
needs to be assessed over a longer period, preferably matching the length of the 
intervention, in order to estimate the true extent of longer-term within-subject 
variation. A better alternative is to use an RCT design, wherein the control group in 
effect acts as the perfect contemporaneous reliability study. Each of the 
investigations discussed have contained a single application of an intervention 
(single period before-and-after study). It is reiterated that the primary limitation of 
the parallel group RCT design in permitting the quantification of inter-individual 
variation in treatment response is that it does not allow the isolation of the variance 
due to true subject-by-treatment interaction (Senn, 2016). In this design, the SD for 
inter-individual responses – although free from random error - includes the subject-
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by-treatment interaction plus any within-subject variability in treatment response 
introduced by the intervention (Hecksteden et al., 2015). Indeed, the multiperiod 
(replicate) crossover study, in which participants are randomised to sequences in 
which they receive both the intervention and comparator treatments in at least two 
periods each, is the only design that can identify variance between-treatments, 
between-subjects, and the subject-by-treatment interaction (Hecksteden et al., 2015). 
However, the primary limitation of the replicate crossover, in the context of chronic 
training studies, is the long and uncertain washout periods required and hence 
potentially substantial carryover effects (Hopkins, 2015). 
 
The authors of a recent investigation into the cardiac determinants of individual 
response in change in aerobic fitness after a moderate intensity exercise intervention 
(Pandey et al., 2015) stated that they incorporated ‘well-controlled exercise trials’ in 
keeping with the HERITAGE study. Nevertheless, ‘well-controlled’ appears to refer 
to relatively short-term repeatability of measurements (over a few days) rather than 
the within-subjects variability in measurements over the duration of the intervention 
(a few months). Just because a measurement method has good short-term 
repeatability does not rectify the problem of lack of a control group, which must be 
employed in order to make a formal comparison of the variability of the change 
scores in intervention vs. control groups. 
 
Consequently, the inclusion of data from studies such as these is potentially 
misleading, and as such, participants from these studies that have been termed 
‘responders’ and ‘non-responders’ may have been selected for further investigation 
as to the potential moderators and mediators of the inter-individual response, when it 
may be nothing other than their natural biological variation that has been measured.  
 
3.4.10 N-of-1 Trials 
 
In pharmacogenetics, n-of-1 trials have been proposed (Guyatt et al., 1990, Lillie et 
al., 2011), but these single-subject trial studies have previously been linked to 
controversial issues in clinical investigation, such as carryover effects and the 
presupposition of patient-by-treatment interaction, which requires random effects 
modelling (Senn, 1993), that may confound the effectiveness of interventions. Of 
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course, if a number of n-of-1 trials are carried out, then the combined data effectively 
equates to the repeated period crossover design proposed by Hecksteden et al. 
(2015). It has also been proposed that n-of-1 data with a limited observation count 
per participant may not be compatible with statistical models that aim to identify the 
inter-individual response and may be preferential for estimating the population effect 
(Zucker et al., 2010).  
 
3.5 A Road Map for Future Study Designs and Analyses 
 
Recently, for both parallel group and replicate crossover designs, more appropriate 
and robust statistical approaches have been forwarded for the quantification of true 
inter-individual response to a treatment. Relevant sources of variability must first be 
quantified (Hecksteden et al., 2015) before any exploration is undertaken of the true 
inter-individual variation in treatment response. Additionally, without knowledge of 
the smallest worthwhile change or the MCID, no substantial inter-individual 
differences in V̇O2max response to an exercise intervention can be claimed. When 
analysing the collected data from a parallel group RCT, it has been proposed that 
comparing the standard deviation of the intervention arm of the study against the 
standard deviation of the comparator arm, using 𝑆𝐷𝐼𝑅 = √𝑆𝐷𝐼
2 − 𝑆𝐷𝐶
2, where IR = 
inter-individual responses, I= the intervention sample SD and C = the comparator 
sample SD (Hopkins, 2015, Atkinson & Batterham, 2015), provides a more accurate 
statistical analysis of the presence of inter-individual differences in response. If 
appropriate clinical inferences are to be made about the magnitude of change and 
any inter-individual response to the intervention then standard deviations, confidence 
intervals, effect sizes and magnitude-based inferences should also be interpreted 
(Hopkins, 2015, Batterham & Hopkins, 2006). Using a custom spreadsheet 
(Hopkins, 2000), and with knowledge of the typical error over the same timeframe as 
the intervention and the smallest worthwhile change, the probability (percentage 
chance) of each individual being classified as ‘very likely’, ‘likely’, ‘possibly’, 
‘possibly not’, ‘unlikely’ and ‘very unlikely’ to be a responder can be calculated. 
 
This is a more robust approach, as the standard parallel arm study design renders the 
definitive identification of specific individuals as non-responders impossible (Leifer 
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et al., 2015) and, despite recent criticisms (Sainani, 2018), magnitude-based 
inferences are a valuable advance on hull hypothesis significance testing (Hopkins & 
Batterham, 2018). For instance, individuals could be termed likely ‘positive’ 
responders if the individual probabilities were above 0.75 (75% chance, or odds of 
3:1 in favour) and the converse for ‘negative’ responders. A finding of substantial 
clinically relevant inter-individual differences in response to the intervention would 
justify further investigation of potential moderators and mediators, using more 
advanced statistical modelling.  
 
If we consider the original pre-HERITAGE study (Prud’homme et al., 1984), the 
mean V̇O2max improvement in the exercise intervention group was 
5.5 (± 3.7) mL.kg-1.min-1 and the change in the control group was -0.6 (± 5.6) mL.kg-
1.min-1. The pooled between-subjects SD for V̇O2max at baseline was 5.9 mL.kg-
1.min-1. If we define a ‘responder’ by an improvement of 1 MET, an individual 
would be required to improve by 7.4 mL.kg-1.min-1 (i.e. approximately 1.25 SDs) for 
the probability of being a true responder to be 0.75. To increase confidence, using a 
probability of 0.95 (i.e. ‘very likely’ to be a responder), the individual would be 
required to improve by 13.5 mL.kg-1.min-1, or more than 2 SDs. Therefore, an 
individual who showed an improvement of, say, 5 mL.kg-1.min-1 (a figure above the 
clinically relevant threshold for a responder of 1 MET) would have a probability of 
0.60 of being a true responder. Obviously, in this case, this is little better than 
chance. These figures demonstrate that an individual would be required to improve 
their V̇O2max substantially more than the MCID (i.e. 1 MET) in order to be deemed 
likely or very likely to be a responder. This is in stark contrast to the practice of 
classification of any individual showing improvement of 3.5 mL.kg-1.min-1 (1 MET) 
or more as a definite responder. Assuming normal distribution of the changes in the 
control group and a MCID of 1 MET, the mean and SD reveal that 23% of the 
control group would be expected to ‘improve’ by more than 1 MET and would be 
labelled conventionally as ‘positive responders’. These apparent positive responses 
in the control are due to the random variation in V̇O2max over a 20-week period. As 
highlighted, the SD of the change scores in each group reveal that there are no 
substantial inter-individual responses in the intervention group (vs. control), and any 
further investigation of the mechanisms underpinning inter-individual response from 
this study is therefore unwarranted.  
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In contrast to my proposed approach, it has been argued that a large-scale 
multiperiod crossover training study approach is a more robust method of predicting 
training response (Hecksteden et al., 2015). This approach, however, presents a 
number of challenges. Given the difficulties of recruiting the sample size required 
for a large-scale training study, this type of study is likely to be statistically 
underpowered, while the time required to run a training intervention study, complete 
with washout periods, is highly restrictive. The crossover trial methodology might 
also have less relevance in training studies than in pharmacological research, as the 
effectiveness of any washout period is unknown, and may diminish training related 
effects. This approach has been previously utilised through the use of a two-month 
washout period subsequent to a two-week intervention (Hautala et al., 2006), but the 
effects of the previous training intervention cannot be controlled for, and therefore 
each participant is potentially beginning from a different baseline. Unlike in 
pharmacological studies, where the washout period for specific drugs is defined as 
some multiple of the drug’s half-life, it cannot be stated with any certainty that a 
previous period of training or an exercise intervention has not changed the individual 
at the cellular or neuromuscular level. This problem leads to a sample that is not 
acting as its own control, and therefore presents potential differences at baseline for 
each intervention period. The multiperiod crossover design might be more applicable 
to the investigation of acute effects of short-term interventions (Karavirta et al., 
2011). There are also a multitude of sources of variability that create challenges in 
identifying true inter-individual differences in response in any research design, such 
as maturation, diet modulation, disease, lifestyle and environment to be accounted 
for, further confounding the issue (Buford et al., 2013).  
 
3.6 Conclusions 
 
To date, the investigation of inter-individual differences in V̇O2max response to 
exercise training has been conducted almost exclusively without a control group or 
comparator arm. While I do not deny that the identification of any inter-individual 
  
  
Table 3. Twin studies presenting intraclass correlations in analysis of inter-individual response to exercise interventions. These ICCs may be 
inflated due to their inability to separate genetic and environmental influences 
Literature Citation Number of twin pairs Mean (SD) age (years) Outcome Measures ICC Age/Sex adjustment 
Prud’homme et al., 1984 10 MZ (6F, 4M) 20 (2.9) MAP, VAT, VANT 0.74 Not reported 
Bouchard et al., 1986 53 MZ (mixed sex) 
33 DZ (mixed sex) 
27 male siblings 
16-34 (range) V̇O2max 0.85 
0.74 
0.55 
Yes 
Hamel et al., 1986 6 MZ (3M, 3F) 21 (4) V̇O2max 0.69 Not reported 
Simonaeu et al., 1986 14 MZ (7M, 7F) 21.1 (3.3) CK, FT proportion, 
enzymes 
Not reported Not reported 
Poehlman et al., 1986 6 MZ males 19.2 (2.3) Body comp, fat mass & 
morphology, skinfolds 
0.46 – 0.90 Not reported 
Bouchard et al., 1990 12 MZ males 21 (2) Body comp & fat 
topography 
0.4 – 0.55 Not reported 
Heller et al., 1993 46 MZA, 67 MZT; 
100 DZA, 89 DZT 
52-86 (range) Lipids 0.22 – 0.79, 0.33 – 
0.83; -0.60 – 0.47, -
0.13 – 0.49 
Dichotomous age 
categories divided at 
median age 
      
Hong et al., 1997 45 MZA, 64 MZT; 95 
DZA, 85 DZT 
 Insulin, Glucose, 
Lipids, BP 
0.5 MZ 0.15 DZ Yes 
Tremblay et al., 1997 11pr MZ males 21 (0.8) RMR, fat loss, weight 
loss, FFM loss 
0.32 – 0.69 Single sex, low SD of 
age 
*Data table with ICC is not provided in the published paper. ** Study reports twins were self-report MZ or DZ. Age not mentioned 
ICC intraclass correlation, MZ monozygotic, MAP maximal aerobic power, VAT ventilatory aerobic threshold, VANT ventilatory anaerobic 
threshold, DZ dizygotic, V̇O2max maximal oxygen uptake, CK creatine kinase, FT fibre type, MZA monozygotic twins reared apart, MZT 
monozygotic twins reared together, DZA dizygotic twins reared apart, DZT dizygotic twins reared together, FFM fat free mass, BP blood 
pressure, RMR resting metabolic rate 
6
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response to an exercise intervention is important, I maintain that the variation must 
be appropriately quantified prior to deeper investigation and recognize that a number 
of challenges exist in realising this goal. Primary among these is the proper 
quantification and determination of a threshold for meaningful magnitude of change, 
to establish the presence of clinically important differences in response (Buford et 
al., 2013). In order to quantify the inter-individual response to an exercise 
intervention, studies should contain the presence of a comparator arm, preferably as 
an RCT design. A number of variables and health outcomes should also be collected, 
as some participants may improve across some but not all physiological measures. 
However, these will come at greater research cost, and must be justified from an 
ethical standpoint. Furthermore, the correct statistical analysis and modelling must 
be used in order to identify the presence of true, clinically relevant, individual 
response, as unless true inter-individual response exists, it is futile looking for 
treatment interactions (Senn, 2004).  
 
Future work on any primary outcome in exercise intervention trials should focus 
upon a thorough systematic review of the available literature, in order to determine 
the robustness of the published data addressing inter-individual differences in 
response to exercise training. Secondary analysis of the data presented by fellow 
researchers should also be undertaken, in order to quantify inter-individual responses 
in previous trials. Only when these effects have been properly quantified, using the 
standard deviation of the change score (SDchange) after adjusting for random within-
subjects variability using the following equation:  𝑆𝐷𝐼𝑅 = √𝑆𝐷𝐼
2 −  𝑆𝐷𝐶
2 (18,19) can 
the design of experiments to further elucidate the mechanisms responsible for the 
individual response be confirmed. Supplementary investigations and robust data 
analysis must then be carried out, using a logical framework (Fig. 2) such as that 
previously proposed (Atkinson & Batterham, 2015) in order to properly identify 
whether specific moderators and mediators exist that control the likelihood of an 
individual responding to an exercise intervention, rather than looking to unravel 
complex gene responses. At this point, when included as covariates, these 
moderators and mediators may account for the inter-individual response, to the 
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extent that they reduce the magnitude of the SD for inter-individual responses 
(Karavirta et al., 2011). 
 
 
 
Fig. 2. Conceptual framework for the quantification of true inter-individual 
differences in response to an intervention.  
 
In summary, against the backdrop of suggestions of precision interventions, 
individuals may respond to treatment in a variety of ways; the intervention might be 
beneficial, ineffective, or harmful for different people. The issue of inter-individual 
differences in the response of maximal oxygen uptake following an exercise 
intervention is very important and identifying the personal characteristics that 
account for these variations in response may ultimately allow more effective 
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direction of interventions. It is clear that the body of literature purporting to claim 
inter-individual variation in response does not, at this time, do so. Common themes 
in previous trial design and data analysis are evident, such as a lack of comparator 
arm or disregarding data from the control, and the use of ICCs to quantify genotype 
dependency of inter-individual difference in the variability of V̇O2max response.   
While the subject is an important one, it is crucial that the correct quantification 
methodology is employed, together with an understanding of the clinical importance 
of any inter-individual response, before suggestions can be made in regard to 
potential moderators and mediators responsible for the observed inter-individual 
variance of V̇O2max in response to exercise training. 
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Chapter 4: Inter-Individual Differences in Weight Change 
Following Exercise Interventions: A Systematic Review and Meta-
Analysis of Randomised Controlled Trials 
 
4.1 Preface 
 
The detailed review presented in Chapter 3 casts doubts upon the claims of inter-
individual variation of maximal uptake in response to exercise training interventions. 
With this in mind, it is important to correctly quantify the inter-individual variation 
in response to exercise interventions. Whilst claims of individual variation have 
previously been made, this chapter presents a detailed systematic review and meta-
analysis of studies aiming to elicit weight loss in response to an exercise 
intervention. Inter-individual variation in weight loss will be assessed in relation to a 
clinically-determined anchor, to determine whether any observed variation is 
clinically important.  
 
Whilst this chapter discusses the findings from a weight loss meta-analysis, it is 
based upon a peer-reviewed research paper, published in Obesity Reviews in 2018 
(Williamson et al., 2018).  
 
4.2 Introduction 
 
Interest in the individualised response to a treatment intervention, and its 
applicability to medical and exercise interventions, has been growing over the last 
three decades (Prud’homme et al., 1984, Lortie et al., 1984, Hamel et al., 1986, Rose 
& Parfitt, 2007, Senn et al., 2011, Bouchard, 2012, Bouchard et al., 2014, Mann et 
al., 2014) There has been specific interest in the inter-individual differences in 
weight change in response to exercise training for around 20 years (Snyder et al., 
1997, Barbeau et al., 1999, King et al., 2008, Barwell et al., 2009, Cauldwell et al., 
2009, Cauldwell et al., 2013). Such interest has developed into a dedicated field of 
research; precision medicine – encompassing ‘tailor-made’ therapies based on the 
individual response of a patient (Senn et al., 2011). It is predicted that this individual 
approach to medicine will ultimately reduce costs and improve quality of healthcare 
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(Spear et al., 2001). It has also been suggested that personalized medicine may 
revolutionize healthcare through utilization of individual genetic information, 
thereby improving drug safety and efficacy (Katsanis et al., 2008). Nevertheless, 
associations that have been reported between genotype and treatment responses are 
often small (Khoury & Galea, 2016).  
 
A limitation of published research on the efficacy of exercise training has been 
reported to be the focus on group mean data, with inter-individual variation in 
response often being overlooked (King et al., 2008). Such a focus on mean effects 
could obfuscate important individual differences in response (Bouchard, 1983, 
Bouchard & Rankinen, 2001, King et al., 2008). If such individual differences are 
present, and predictors of individual response are identified, then targeted 
intervention strategies could be formulated to maximize weight loss for individuals. 
 
A further limitation of much of the weight loss literature is the common use of 
expected weight loss calculations using the ‘3500kcal/lb rule’, whereby an energy 
deficit of 3500kcal is predicted to induce a 1lb reduction in body weight, based on 
the calculation of body composition energy content (70:30 FM: FFM) (Wishnofsky, 
1958). This approach has been criticized due to its erroneous predictions of linear 
changes in body weight (Melanson et al., 2013), while Hall et al (2011) identified 
that EE- induced rate of weight change slows over time. Therefore, predictions based 
on this ‘3500 kcal rule’ may overestimate predicted weight loss. Likewise, models 
used to predict weight loss using energy balance based upon the first law of 
thermodynamics have been described as simplistic, inconsiderate to changes in in 
interactive components (Boutcher & Dunn, 2009) and changes in spontaneous 
physical activity (Donnelly & Smith, 2005). It is evident that there is a need to 
include body composition data and other markers of health, rather than just assessing 
the effectiveness of exercise based exclusively on body weight (King et al., 2009). 
 
The lack of statistical power to detect changes is also an issue, as it is in many RCTs. 
Most trials only have sufficient power with which to detect overall main effects 
(Egbewahel, 2015), so subgroups such as those required to detect ‘true’ inter-
individual response require even greater sample sizes to reduce the magnitude of the 
standard error and increase statistical power.  
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4.2.1 Research Design and Data Analysis Issues 
 
There have been reports of inter-individual variation in adiposity and weight 
response to exercise (Snyder et al., 1997, Barbeau et al., 1999, King et al., 2008, 
Barwell et al., 2009), including observations that exercise can cause a less-than-
expected weight loss for some individuals (Donnelly & Smith, 2005). It has been 
suggested that the response to exercise may be influenced by a multitude of 
individual characteristics, including sex (Ballor & Keesey, 1991, Donnelly & Smith, 
2005), genetics (Simoneau et al., 1986), age, and baseline status of the measured 
outcome (Sisson et al., 2009). Inter-individual response variation should be 
quantified and judged properly (Atkinson & Batterham, 2015, Williamson et al., 
2017) before the relevance of these effect modifiers of response are appraised, 
relative to a robust minimal clinically important difference (MCID). Crucially, this 
requires an appropriate control/ comparator group, preferably within a randomised 
trial design. Regrettably, substantial treatment response heterogeneity has been 
claimed from observations solely on the intervention group (King et al., 2008, 
Cauldwell et al., 2009, King et al., 2012). When the control sample is absent or 
ignored, the interpretation of response heterogeneity is prone to all the philosophical 
issues highlighted by Stephen Senn, particularly the problem of the “counterfactual” 
(Williamson et al., 2017).  
 
An appropriate method to quantify “true” individual response variability in a parallel 
group study involves the application of the following equation; 𝑆𝐷𝐼𝑅 =
√𝑆𝐷𝐼
2 −  𝑆𝐷𝐶
2 (Atkinson & Batterham, 2015, Hopkins, 2015), where SDIR is the true 
inter-individual response variability, expressed as a standard deviation, and SDI
2 and 
SDC
2 are the standard deviations of the changes in the intervention and control 
samples, respectively. The SDIR
 should be interpreted as the amount by which the net 
mean effect of the intervention (intervention minus control) differs typically between 
individuals (Hopkins, 2015). 
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4.2.2 Aims of the Review 
 
In view of the above design and analysis issues, there is uncertainty about 
previously-drawn conclusions in weight-loss studies. To date, there has been no 
published quantitative synthesis of the evidence for individual response variation in 
studies on exercise-mediated weight loss. Therefore, I aimed to conduct a systematic 
review and meta-analysis of the available research to allow for quantification of 
‘true’ inter-individual variation in weight change in response to an exercise 
intervention.  
 
4.3 Methods 
 
This study was undertaken in accordance with the ethics procedures and guidance of 
Teesside University. The review is reported according to the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) statement (Liberati et 
al., 2009). The review protocol was registered with PROSPERO, the International 
Prospective Register of Systematic Reviews (CRD42016049982). An initial scoping 
literature review was undertaken to gauge the likely number of eligible studies for 
inclusion in the meta-analysis, with the intention to identify whether there were 
sufficient studies to be able to conduct a robust meta-analysis.  
 
4.3.1 Study Question 
 
This systematic review was designed to address the following question:  
Across all the relevant studies that include a suitable comparator sample, are there 
substantial (i.e. greater than a clinically-anchored MCID) inter-individual differences 
in body mass loss in response to an exercise intervention? 
 
4.3.2 Literature Search and Study Selection 
 
This review involved a systematic electronic search of peer-reviewed original 
literature using the following commonly used databases: Centre for Reviews and 
Dissemination (York), CINAHL, Cochrane Central Register of Controlled Trials 
(CENTRAL), Cochrane Database of Systematic Reviews, Cochrane Methodology 
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Register, Database of Abstract Reviews or Effects (DARE), Database of Promoting 
Health Effectiveness Reviews (DoPHER), EMBASE, Medline (Ovid), NHS 
Economic Evaluation Database (NHS EED), PROSPERO, PubMed, SCOPUS and 
Sport Discus. These databases were first searched in December 2016, before a 
secondary search in March 2017. The search strategy was designed to include all 
articles published in the English language. Search terms comprised of “exerc*” AND 
(“train*” OR “condition*”) AND (“structure” OR “supervised”) AND (“weight” OR 
“body compos**” OR “BMI*”) AND (“randomi*” OR “RCT”). Subsequently, 
additional searches of reference lists, Google Scholar and relevant bibliographic 
hand searches with no limit of language or publication date were also completed. 
Only studies conducted in humans were considered. 
 
Studies were screened for those that would meet the inclusion criteria. Titles and 
abstracts were initially scrutinised to exclude those studies clearly beyond the scope 
of this review. For potential studies that appeared to meet the inclusion criteria, or 
those for which a decision was unable to be made based upon the title and abstract 
alone, full, published articles were obtained for detailed assessment against the 
inclusion criteria. Where multiple papers from a single study have been published, 
these were treated as a single study. Included studies were randomized intervention 
studies, reporting the standard deviation of the change in body mass in both arms. 
All studies targeting specific populations (e.g. pregnant women, children, and 
individuals suffering from specific diseases) were excluded. The remaining full-text 
articles were included in the systematic review and meta-analysis. A complete 
overview of the process is presented at Fig. 3 and a comprehensive summary of the 
studies reviewed is presented in Table 4.   
 
Two reviewers (myself and Greg Atkinson, PhD supervisor) independently assessed 
publications for eligibility. The decision to include studies was hierarchical and 
made initially upon the basis of the study title, abstract and presence of keywords. 
When a study could not be excluded with certainty, the full text was obtained for 
evaluation. Disagreements between reviewers were resolved through discussion with 
a third reviewer (Alan Batterham, PhD Director of Studies) and a consensus 
approach was used.  
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4.3.3 Study Eligibility 
 
4.3.3.1 Inclusion Criteria 
 
To be included for quantitative synthesis, studies were required to meet the 
following criteria: (1) participants were required to be aged 18 or over; (2) taking 
part in studies where the experimental arm was an exercise-based intervention; (3) 
 
Fig. 3. PRISMA flowchart detailing stages of search 
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which was designed to elicit weight loss; (4) reporting change in adiposity indices 
(body mass index, body fat or body weight); (5) with no history of diabetes, 
metabolic, cardiovascular, musculoskeletal or inflammatory disease; (6) the exercise 
intervention was required to be supervised; (7) the investigation had to be an RCT 
design; and (8) greater than six weeks in duration. Since the interventions were 
exercised-based, participants were not blinded. Studies were included if they were 
published in peer-reviewed journals or full manuscripts were available (i.e. theses 
and dissertations). Where several intervention arms were present, all data other than 
that from the control-only and exercise-only arms were excluded. Where more than 
one exercise intervention was present, results were combined to avoid double 
counting of the control sample (Ryan, 2013). The same procedure for combining 
groups was applied to studies with a single exercise intervention but with results 
reported separately for sub-groups.  
 
4.3.3.2 Exclusion Criteria 
 
Studies were excluded if they (1) included unsupervised exercise interventions, 
behaviour therapy, dietary modification, health education, surgical, drug or hormone 
treatment that did not include exercise; (2) if change in body mass/ composition was 
not a primary or secondary aim of the study; (3) if no relevant comparator sample 
were present; or (4) the full-text manuscript was written in a language other than 
English. 
 
4.3.4 Data Extraction and Synthesis 
 
DigitizeIt (Brunschweig, Germany) graph digitizer software was used to extract 
precise data in cases where data were only presented in Figures rather than text.  
 
Study characteristics such as study design, participant characteristics (age, sex, 
ethnicity), measurement methods, change scores, SDchange and information to assess 
the risk of bias were extracted by myself (see 4.3.5 Assessment of Study Quality).  
 
A standardized data extraction sheet was used to collect data on participants’ 
characteristics, study methods, sample size, prescribed intervention (frequency, 
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intensity, duration and type), outcomes assessed, loss to follow up and study type. 
The data for Table 4 was collected by myself before Professor Greg Atkinson 
verified its accuracy and the eligibility of studies for inclusion. Where data were 
incompletely or unclearly reported, the lead author contacted study authors for 
clarification. Effect sizes were calculated for the relevant measures. 
 
4.3.5 Assessment of Study Quality 
 
Methodological risk of bias was assessed and reported in accordance with the 
Cochrane Handbook (Higgins & Green, 2011) and the guidelines of the Cochrane 
Consumers and Communication Review Group (Ryan, 2013), which recommend the 
explicit reporting of the following elements for RCTs: random sequence generation; 
allocation sequence concealment; blinding (participants, personnel); blinding 
(outcome assessment); completeness of outcome data; selective reporting; and other 
sources of bias. Each item was judged as being at high, low or unclear risk of bias as 
set out in the criteria provided (Higgins & Green, 2011). A summary of risk of bias 
is presented in Figs 4 and 5, produced using RevMan software (Review Manager. 
Version 5.3. Copenhagen: The Nordic Cochrane Centre. The Cochrane 
Collaboration, 2014). 
 
Studies were deemed to be at highest risk of bias if they scored as high or unclear 
risk of bias for either the sequence generation or allocation concealment domains, 
based on growing empirical evidence that these factors are particularly important 
potential sources of bias (Higgins & Green, 2011).  
 
In all cases, risk of bias was independently assessed, with any disagreements 
resolved by discussion to reach consensus. Risk of bias results were incorporated 
into the review using standard tables and commentary about each element, leading to 
an overall assessment of the risk of bias of those studies selected for inclusion and a 
judgement about the internal validity of results. 
 
4.3.6 Meta-Analysis 
 
First, to put the results for individual response variance in context I conducted a 
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random-effects meta-analysis for the mean difference in weight loss across the 
included studies, using a restricted maximum likelihood (REML) model combined 
with the Knapp-Hartung method (t-distribution for between-study variance). Second, 
for each study I extracted the standard deviation of the changes in body mass for 
both control (C) and exercise intervention (I) groups. The true individual response 
variance (intervention minus control) was then derived as SDI
2 – SDC2. The standard 
error (SE) for this variance was calculated using the following equation:  
SE =√ [2(SDExp4/DFExp + SDCon4/DFCon)], where DFExp and DFCon are the degrees of 
freedom of the standard deviations in the exercise and control groups (Liberati et al., 
2009). Note that a negative value for the individual response variance, for either the 
point estimate or lower bound of the confidence interval or prediction interval, 
implies greater variability in the changes in body mass in the control versus 
intervention groups.  
The individual response variances with their SEs were meta-analysed using a REML 
model combined with the Knapp-Hartung method. It is important to note that the 
variances are unbiased, whereas the SD is not, and deriving a SE for the SD for 
individual responses is also problematic. Therefore, synthesising the individual 
response variances rather than the SDs for individual responses is imperative. I 
derived the point estimate for the pooled individual response variance together with 
its uncertainty expressed as a 95% Confidence Interval (CI). The point estimate and 
confidence limits were then converted to an SD metric by taking the square root. In 
the case that the lower limit of the interval was negative, I first ignored the sign, took 
the square root, and then re-applied the sign. This approach is consistent with the 
‘nobound’ option in SAS/STAT® software, which permits negative variances (SAS 
Institute Inc. 2017. SAS/STAT
 
14.3 User’s Guide. Cary, NC: SAS Institute Inc.).  
For both mean and inter-individual variation meta-analyses, between-study 
heterogeneity was quantified through the tau statistic () – a SD describing the 
typical variability in the mean effect between studies (Higgins, 2008). Using the SE 
for the pooled mean effect and the tau, a 95% prediction interval was derived to 
quantify the expected range of true effects in future studies in similar settings 
(Inthout et al., 2016). For the individual response variability, this prediction interval 
was derived for 2 × SDIR, as the SDIR should be doubled before evaluating its 
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magnitude to reflect a comparison between a typically high (mean + SDIR) and 
typically low (mean – SDIR) responder (Hopkins, 2015). The magnitude of both the 
mean weight loss and the individual response variability (2×SDIR) was evaluated 
against a minimum clinically important difference for weight loss of 2.5 kg (Jensen 
et al., 2014) by calculating the probability that the effect in a future study in similar 
settings would exceed this threshold (Inthout et al., 2016). This probability was 
interpreted using the qualitative probabilistic anchors advanced by Hopkins et al. 
(Hopkins et al., 2009). Inasmuch as we must work with the response variances, 
rather than the SDs, I first halved the minimal clinically important difference 
(equivalent to doubling the SD for individual responses), squared it (to express it in 
variance metric) and then derived the probability that the response variance in a new 
study would be clinically relevant, as described above. The threshold of 2.5 kg for 
the MCID was chosen, conservatively, as the lowest value from the range of 
clinically relevant effects presented by Jensen et al. By definition, effects smaller 
than this threshold are defined as trivial (not clinically relevant). Effects >2.5 kg but 
<7.5 kg are defined as ‘small’ (yet clinically important). ‘Moderate’ effects are 
defined as >7.5 kg but <15 kg, and ‘large’ effects as >15 kg (Hopkins et al., 2009). 
 
All statistical analyses were conducted using Comprehensive Meta-Analysis 
software, version 3 (Biostat Inc., Englewood, NJ, USA). 
 
4.4 Results 
 
4.4.1 Study Selection 
 
The initial search generated 3187 results (Fig. 3). 3061 of these were excluded based 
on titles and abstracts alone, and 66 duplicates were rejected. The complete text was 
obtained for 60 articles. A further 10 were identified from relevant reference lists and 
hand searches. Following examination of these articles, 12 were identified that met 
the eligibility criteria and are summarized in Table 4. A further 20 met all selection 
criteria, apart from the reporting of SDchange. The authors of these papers were 
contacted, but only four responses were received, and full data were not provided in 
these instances (Schuit et al., 1998, Maiorana et al., 2001, Donnelly et al., 2003, 
Potteiger et al., 2003, Schmitz et al., 2003, Takeshima et al., 2004, Toraman et al., 
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2004, Shojaee-Moradie et al., 2007, McTiernan et al., 2007, Nalbant et al., 2009, 
Coker et al., 2009, Kerksick et al., 2010, Atashak et al., 2011, Sheikholeslami 
Vatani et al., 2011, Donges et al., 2012, Tracy & Hart, 2013, Herring et al., 2014, 
Kim et al., 2015, Bittari et al., 2016, Tan et al., 2016). Contact was made by email. 
If, after four weeks, no response was received, a further email was sent. Following a 
further four-week period, papers from these authors were excluded. One paper met 
all inclusion criteria (Atlantis et al., 2006), except for the fact that median and 
interquartile range values were presented for changes in body mass, rather than 
means and SDs. No non-published studies (i.e., dissertations) were found to be 
eligible for inclusion. 
 
The included studies encompassed a 17-year publication period between 1999 and 
2016. Included studies involved a total of 1500 participants (EX: n=922, CON: 
n=578). Three trials involved outcomes of aerobic training interventions (Church et 
al., 2009, Tan et al., 2012, Donnelly et al., 2013), three involved the outcomes of 
resistance training interventions (Prabhakaran et al., 1999, Schmitz et al., 2002, 
Teixeira et al., 2003), one study involved the outcomes on separate aerobic and 
resistance training interventions (Donges et al., 2010) and five studies involved the 
outcomes of combined/concurrent training (Lockwood et al., 2008, Burtscher et al., 
2009, Vilela et al., 2015, Baillot et al., 2016, Dalager et al., 2016). The duration of 
studies ranged from 8 to 52 weeks, study sample sizes ranged from 24 to 411 and 
reported pre-intervention mean body mass ranged from 65.5 to 128.0 kg. 
 
4.4.2 Study Outcomes 
 
The pooled mean group difference in pre/post changes in weight (intervention minus 
control) was -1.4 kg (95% CI -0.3 to -2.5 kg). Substantial between study 
heterogeneity was observed (=1.5 kg: -0.4 to 2.2 kg). The prediction interval 
revealed that, were investigators to undertake a future trial, the 95% plausible range 
for mean weight change vs. control would be -5.0 to 2.1 kg. The probability (% 
chances) that the mean weight loss (intervention minus control) in a future study in 
similar settings would exceed the minimum clinically important difference of a 
reduction of 2.5 kg was 26% (‘possibly’ clinically important).  
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The pooled point estimate for the inter-individual variability in weight change in 
response to an exercise intervention (SDIR) was 0.8 (-0.9 to 1.4) kg.  The between-
study heterogeneity () was 1.0 (-1.7 to 2.2) kg. The 95% prediction interval for 2 × 
SD for true inter-individual responses was -2.8 to 3.6 kg. The probability (% 
chances) that the individual response variability (2 × SD) in a future study in similar 
settings would be clinically meaningful (>2.5 kg) is 23% - ‘unlikely’ to be clinically 
important. Therefore, the odds are greater than 3:1 against the notion that there is 
clinically relevant individual response variance. 
 
4.4.3 Study Quality and Risk of Bias 
 
Table 5 and Figs 4 and 5 present a summary of risk of bias within included studies. 
Overall, risk of bias was mostly low or of unclear risk in the outcome of interest.  
 
Fig. 4. Graph (visual summary of Table 4) detailing breakdown of risk of study 
bias, stratified by risk category. (Risk of bias determined using Cochrane 
guidelines) 
 Table 4. Studies presenting weight loss response to supervised exercise interventions. 
 Exercise training program Results 
Literature 
Citation 
Subjects/Groups Mode Length Intensity/Frequency/Duration/Volume Δ BW (kg)  SD Other 
Aerobic Training Interventions 
Church et al., 
2009 
n = 317 (EX), n = 
94 (CON) 
Aerobic 
training 
alternating 
treadmill and 
cycle 
ergometer 
26 wk 3-4/wk, CON + 3 EX groups – 4, 8, 12 
Kcal/kg BW, 50% V̇O2 alternating between 
semi-recumbent cycling and treadmills. 
EX - 4 Kcal -1.4 
(3.6), 8Kcal -2.1 
(3.5), 12 Kcal -1.5 
(3.4) Combined -
1.62 (3.5), CON -
0.9 (3.37) 
No difference between 
predicted and actual 
weight loss at 4 & 8 
Kcal/kg, 12 Kcal/kg 
lost only half predicted 
amount 
Donnelly et 
al., 2013 
n = 74 (EX), n = 18 
(CON) 
Aerobic 
training  
10 
months 
5/wk, aerobic exercise – walking/jogging on 
treadmill (20% of sessions were undertaken 
on alternative activities such as stationary 
cycling, elliptical or walking/jogging 
outside), expending 400 & 600 Kcal/session 
400 Kcal -3.9 (4.9), 
600 Kcal -5.2 (5.6), 
Combined EX -4.55 
(5.27), CON 0.5 
(3.5) 
No significant 
difference between 
exercise intervention, 
suggested some 
compensatory 
mechanisms, or when 
stratified by gender 
Tan et al., 
2012 
n = 29 (EX), n = 19 
(CON) 
Track running 8 wk 5/wk, 40 mins of running at individualized 
Fatmax HR on outdoor track 
EX -4.1 (1.6), CON 
0.3 (1.2) 
Fatmax also decreased 
fat mass, waist-hip 
ratio (both possibly 
related to change in fat 
oxidation rates), 
fasting plasma 
concentration 
(increased use of fat as 
fuel) and increased 
V̇O2max 
Resistance Training Interventions 
8
3 
 Prabhakaran 
et al., 1999 
n = 12 (EX), n = 12 
(CON) 
Resistance 
Training 
14 wk 3/wk, 45-50 mins/session, 85% 1RM, 
loading major muscle groups, 2 sets of 8 
reps, 1 set to failure, 30-60 seconds rest 
EX -0.7 (1.35), 
CON 0.49 (2.01) 
Reduction in lipids and 
body fat % in EX 
Schmitz et 
al., 2002 
n = 27 (EX), n = 27 
(CON) 
Resistance 
training  
15 wk 2/wk, 50 mins, 3 sets of 8-10 reps, 9 
exercises 
EX 0.54 (1.87), 
CON 0.49 (1.82) 
Strength training 
produced favourable Δ 
in fasting glucose, 
insulin and cancer risk 
factors 
Teixeira et 
al., 2003 
n = 117 (EX), n = 
116 (CON) 
RT, circuit and 
weight bearing 
aerobic 
exercise 
12 
months 
3/wk, RT 6-70 mins, 2 sets of 6-8 reps at 
70-80% 1RM, AT included walking, 
jogging, skipping, hopping, 10 mins as WU, 
then 20-25 mins @ 60% HRmax  
EX (with 
HRT/without HRT) 
-0.2 (2.6)/0.34 (2.5) 
combined SD 2.55, 
CON (with 
HRT/without HRT) 
0.8 (2.7)/-0.4 (3.3), 
combined SD 3.05. 
Total EX 0.07 
(2.55), CON 0.23 
(3.05) 
Δ LST in all who 
exercised and non-
exercisers not taking 
HRT, decreased FT on 
women on HRT. HRT 
appeared to protect 
against loss of LST 
Separate Aerobic and Resistance Training Interventions 
Donges et 
al., 2010 
n = 76 (EX), n = 26 
(CON) 
Aerobic and 
resistance 
training 
10 wk RT 30-50 mins, 2-4 sets of 8-10 reps @ 70-
75% of 10RM, AT 30-50 mins cycle 
ergometer 70-75% MHR  
RT 0.8 (1.5), AT -
0.8 (1.9), Combined 
– -0.06 (1.89) CON 
0.6 (1.3) 
AT > Δ in body 
composition than RT 
& CON. CRP reduced 
in RT, IL6 unchanged 
in all 
Combined/Concurrent Training 
Baillot et al., 
2016 
n = 15 (EX), n = 14 
(CON) 
Endurance and 
circuit style 
with 9 stations 
12 wk 3/wk, 80 mins - 10WU, 50-60MB (30mins 
endurance, including treadmill, elliptical, 
arm ergo cycle, 20-30mins strength), 10CD. 
Endurance at 55-85% HRR 
EX -0.92 (3.55), 
CON -0.3 (4.72) 
Pre-Surgical Exercise 
Training (PreSET) 
intervention also 
improved social 
interaction/ PA barriers 
8
4
 
 Burtscher et 
al., 2009 
n = 18 (EX), n = 18 
(CON) 
Aerobic 
training, circuit 
training 
12 
months 
2/wk, 60mins, aerobic exercise (dancing, 
walking, running, skating, swimming) 
eliciting lactate response of 2-3mmol/L, 
interspersed with higher intensity efforts. 
Circuits included 6-8 exercises, 8-12 reps. 
All participants also advised to exercise for 
30mins/day 
EX -2.58 (4.12), 
CON 0.79 (4.93) 
Counselling & 
supervised exercise 
maintained exercise 
capacity vs counselling 
alone. In EX, dietary 
goals (<BW by 5%) 
not achieved 
Dalager et 
al., 2016 
n = 89 (EX), n = 
195 (CON) 
Aerobic and 
resistance 
training 
1 yr 1/wk, 20 mins aerobic exercise (running, 
rowing, ball games) 77-95% HRmax, 30 mins 
resistance training 60-80% 1RM for three 
sets of 8 reps, recommendations to 
undertake 30mins exercise/day at 64-76% 
HRmax 
EX -0.49 (3.32), 
CON 0.08 (2.97) 
5% (ITT) and 10% 
(PPA) > Δ V̇O2max in 
EX than INT, 2.8% 
in SBP 
Lockwood et 
al., 2008 
n = 14 (EX), n = 10 
(CON) 
Aerobic and 
resistance 
training 
10 
weeks 
AT 3/wk, self-selected exercise 15-35 mins 
@ 40-70% HRR, RT 2/wk, 1 set of 8-12 
reps (or to failure) 
EX -0.3 (1.87), 
CON -0.3 (1.58) 
Individual variation in 
ad libitum EI, linked 
with compensatory EI 
in EX 
Vilela et al., 
2015 
n = 30 (EX), n = 30 
(CON) 
RT, sporting 
activity 
4 
months 
5/wk, RT including 2 days upper body 
exercises and 2 days lower body exercises. 
4 x 10mins 3 sets of 30secs work, 30secs 
recovery, 5 mins flexibility, 1 x 15 mins 
sporting activity  
EX 0.0 (2.6), CON 
0.4 (2.6) 
EX reduced body fat 
by 4.8 (1.8) %, in the 
absence of weight loss, 
suggesting increased 
lean tissue 
BW body weight, kg kilograms, SD standard deviation, EX exercise condition, CON control condition, wk weeks, mins minutes, WU warm-up, 
MB main body of exercise session, CD cool-down, HRR heart rate reserve, PA physical activity, Reps repetitions, mmol/L millimole per litre, 
Kcal Kilocalorie, V̇O2 oxygen uptake, Yr year, HRmax maximal heart rate, ITT intention to treat, PPA per protocol analysis, V̇O2max maximal 
oxygen uptake, SBP systolic blood pressure, RT resistance training, RM repetition maximum, AT aerobic training, CRP C-reactive protein, IL6 
– interleukin 6, EI energy intake, Fatmax intensity of maximal fat oxidation, V̇O2max maximal oxygen uptake, HRT hormone replacement 
therapy, LST lean soft tissue, FT fat tissue, secs seconds.
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Fig. 5. Graph detailing breakdown of risk of study bias, stratified by study and 
specific risk factor 
 
 
 Table 5. Summary descriptives of risk of bias for each of the included studies, in accordance with Cochrane guidelines.  
Literature 
Citation 
Random Sequence 
Generation 
Allocation  
Concealment 
Blinding of 
Participants 
Blinding of Outcome 
Assessment 
Incomplete Outcome 
Data Addressed 
Selective 
Reporting 
Other 
Risk Comment Risk Comment Risk Comment Risk Comment Risk Comment Risk Comment Risk Comment 
Baillot et 
al., 2016  
Low Quote “Patients 
were randomly 
allocated” 
 
Comment: 
Likely done 
Unclear Quote 
“Allocation was 
generated by a 
computer random 
sequence and 
kept in sealed 
envelopes” 
 
Comment: Likely 
done 
Low Comment: 
Exercise 
interventions 
preclude the 
blinding of 
participants 
to allocated 
group during 
the study. It 
is judged 
that this 
would not 
influence 
outcomes 
Low Comment: No 
mention of 
blinding of 
outcome 
assessment.  It 
is judged that 
this would not 
influence 
outcomes 
Low Quote: “the 
only subject 
who 
abandoned 
the research 
project was 
in the usual 
care group 
and excluded 
from 
analyses”.  
 
Comment:  
Likely done 
High  Six 
domains 
for 
WRQL in 
methods, 
only one 
reported 
in written 
format; 
others 
presented 
in table 
format.  
Low The study 
appears 
free from 
other 
sources of 
bias. 
Burtscher et 
al., 2009  
Low Quote “Patients 
were randomly 
assigned” 
 
Comment: 
Likely done 
High Comment: No 
information 
provided on 
method of 
randomization.  
 
Comment: 
Possibly not done 
Low Comment: 
Exercise 
interventions 
preclude the 
blinding of 
participants 
to allocated 
group during 
the study. It 
is judged 
that this 
would not 
influence 
outcomes 
Low Comment: No 
mention of 
blinding of 
outcome 
assessment.  It 
is judged that 
this would not 
influence 
outcomes 
Low Quote: “Due 
to financial 
problems, 
we had to 
terminate the 
exercise 
program at 
Month 12. 
To minimize 
possible 
bias, 18 
patients were 
then 
compared to 
age- and 
Low Comment: 
Study 
protocol 
available 
and all 
pre-
specified 
outcomes 
reported 
in pre-
specified 
way. 
Low The study 
appears 
free from 
other 
sources of 
bias. 
8
7 
 gender- 
matched 
patients in a 
nested 
cohort 
approach”. 
 
Comment: 
Likely done  
Church et 
al., 2009  
Low Quote “Patients 
were 
randomized to 1 
of 3 exercise 
groups or a 
non-exercise 
control” 
 
Comment: 
Likely done 
Unclear Quote “The 
randomization 
sequence is 
computer 
generated by the 
study statistician” 
 
Comment: 
Statement found 
in published 
rationale paper. 
Possibly done 
Low Comment: 
Exercise 
interventions 
preclude the 
blinding of 
participants 
to allocated 
group during 
the study. It 
is judged 
that this 
would not 
influence 
outcomes 
Low Comment: No 
mention of 
blinding of 
outcome 
assessment.  It 
is judged that 
this would not 
influence 
outcomes 
Low  Comment: 
Missing data 
relatively 
balanced 
across 
intervention 
groups. 
Additionally, 
missing data 
were 
imputed by 
carrying 
forward 
from 
previous 
observation 
(1 week) 
Low 
 
 
 
 
 
 
 
 
 
 
 
Comment: 
Study 
protocol 
available 
and all 
pre-
specified 
outcomes 
reported 
in pre-
specified 
way. 
Low The study 
appears 
free from 
other 
sources of 
bias. 
Dalager et 
al., 2016  
Low Quote “Office 
workers were 
randomized 1:1 
to a training 
group or a 
control group” 
 
Unclear Quote: “The 
participants were 
assigned with an 
arbitrary ID 
number and 
randomized 
individually, 
Low Comment: 
Exercise 
interventions 
preclude the 
blinding of 
participants 
to allocated 
Low Quote: “The 
study was a 2-
year, parallel 
group, 
examiner 
blinded RCT”. 
 
High Quote: 
“Missing 
values in 
either 
baseline or 
follow-up 
measurement 
Low 
 
 
 
 
 
 
Comment: 
Study 
protocol 
available 
and all 
pre-
specified 
Low The study 
appears 
free from 
other 
sources of 
bias. 
8
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 Comment: 
Likely done 
using a random 
number computer 
algorithm”. 
 
Comment: 
Possibly done 
group during 
the study. It 
is judged 
that this 
would not 
influence 
outcomes 
Comment: 
Likely done 
were 
substituted 
with data 
carried 
forwards or 
backwards”.  
 
Comment:  
Missing data 
unbalanced 
across 
intervention 
groups. It is 
unknown as 
to what 
impact this 
might have 
on effect 
sizes.  
 
 
 
 
 
outcomes 
reported 
in pre-
specified 
way. 
Donges et 
al., 2010  
High Quote 
“Participants 
were semi 
randomly 
assigned….80% 
were randomly 
assigned, 
however 20% 
were allocated 
according to 
matching or 
preference”.  
High Comment: No 
information 
provided on 
method of 
randomization, 
other describing 
it as ‘semi-
random’ 
Low Comment: 
Exercise 
interventions 
preclude the 
blinding of 
participants 
to allocated 
group during 
the study. It 
is judged 
that this 
would not 
influence 
outcomes 
Low Comment: No 
mention of 
blinding of 
outcome 
assessment.  It 
is judged that 
this would not 
influence 
outcomes 
Low Comment: 
No missing 
data 
apparent. 
Low 
 
 
 
 
 
 
 
 
 
 
 
Comment: 
Study 
protocol 
available 
and all 
pre-
specified 
outcomes 
reported 
in pre-
specified 
way. 
Low The study 
appears 
free from 
other 
sources of 
bias. 
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 Donnelly et 
al., 2013  
Low Quote: 
“Participants 
were 
randomized 
(2:2:1) to 
exercise or non-
exercise”.  
 
Comment: 
Likely done. 
Low Quote: 
“Participants 
were stratified by 
gender and 
randomized by an 
independent 
statistician”.  
 
Comment: 
Possibly done. 
Low Comment: 
Exercise 
interventions 
preclude the 
blinding of 
participants 
to allocated 
group during 
the study. It 
is judged 
that this 
would not 
influence 
outcomes 
Low Quote: 
“Investigators 
and research 
assistants were 
blinded at the 
level of 
outcome 
assessments”.  
 
Comment: 
Likely done. 
Unclear Comment: 
No 
methodology 
for 
approaching 
massing 
data. 
Missing data 
relatively 
balanced 
across 
intervention 
groups. 
Low 
 
 
 
 
 
 
 
 
 
 
 
Comment: 
Study 
protocol 
available 
and all 
pre-
specified 
outcomes 
reported 
in pre-
specified 
way. 
Low The study 
appears 
free from 
other 
sources of 
bias. 
Lockwood 
et al., 2008  
Low Quote: 
“Subjects were 
randomly 
assigned” 
 
Comment: 
Likely done.  
High Comment: No 
information 
provided on 
method of 
concealment.  
Low Comment: 
Exercise 
interventions 
preclude the 
blinding of 
participants 
to allocated 
group during 
the study. It 
is judged 
that this 
would not 
influence 
outcomes 
Low Comment: No 
mention of 
blinding of 
outcome 
assessment.  It 
is judged that 
this would not 
influence 
outcomes 
Unclear Comment: 
No 
methodology 
for 
approaching 
missing data. 
Missing data 
relatively 
balanced 
across 
intervention 
groups. 
Low 
 
 
 
 
 
 
 
 
 
 
 
Comment: 
Study 
protocol 
available 
and all 
pre-
specified 
outcomes 
reported 
in pre-
specified 
way. 
Low The study 
appears 
free from 
other 
sources of 
bias. 
Prabhakaran 
et al., 1999  
Low Quote: 
“Subjects were 
randomly 
assigned to 
High Comment: No 
information 
provided on 
method of 
concealment.  
Low Comment: 
Exercise 
interventions 
preclude the 
blinding of 
Low Comment: No 
mention of 
blinding of 
outcome 
assessment.  It 
Low  Comment: 
Missing data 
relatively 
balanced 
across 
Low 
 
 
 
 
Comment: 
Study 
protocol 
available 
and all 
Low The study 
appears 
free from 
other 
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 either a non-
exercising 
control group or 
a 
resistance 
exercise 
training group”.  
 
Comment: 
Likely done. 
 
participants 
to allocated 
group during 
the study. It 
is judged 
that this 
would not 
influence 
outcomes 
is judged that 
this would not 
influence 
outcomes 
intervention 
groups.  
 
 
 
 
 
 
 
pre-
specified 
outcomes 
reported 
in pre-
specified 
way. 
sources of 
bias. 
Schmitz et 
al., 2002  
Low Quote: 
“Randomized to 
no-contact 
control or 
treatment”.  
 
Comment: 
Likely done. 
Unclear Comment: 
Randomization 
stratified by 
decade (30-39, 
40-50) due to 
concerns 
regarding effects 
of hormonal 
changes.  
Low Comment: 
Exercise 
interventions 
preclude the 
blinding of 
participants 
to allocated 
group during 
the study. It 
is judged 
that this 
would not 
influence 
outcomes 
 
Low 
Quote: “Body 
weight and 
height 
measurements, 
blood draws 
and DEXA 
(body 
composition) 
were 
performed by 
clinical 
research 
nurses, 
blinded to 
treatment 
groups”.  
Comment: 
Likely done. 
Low  Comment: 
Missing data 
relatively 
balanced 
across 
intervention 
groups.  
Low 
 
 
 
 
 
 
 
 
 
 
 
Comment: 
Study 
protocol 
available 
and all 
pre-
specified 
outcomes 
reported 
in pre-
specified 
way. 
Low The study 
appears 
free from 
other 
sources of 
bias. 
Tan et al., 
2012  
Low Quote: 
“Participants 
were randomly 
High Comment: No 
information 
provided on 
Low Comment: 
Exercise 
interventions 
preclude the 
Low Comment: No 
mention of 
blinding of 
outcome 
Low  Comment: 
Missing data 
relatively 
balanced 
Low 
 
 
 
Comment: 
Study 
protocol 
available 
Low The study 
appears 
free from 
other 
9
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 allocated into 
two groups”.  
 
Comment: 
Likely done. 
method of 
randomization.  
blinding of 
participants 
to allocated 
group during 
the study. It 
is judged 
that this 
would not 
influence 
outcomes 
assessment.  It 
is judged that 
this would not 
influence 
outcomes 
across 
intervention 
groups. 
Additionally, 
reasons 
unlikely to 
affect 
outcome 
measures.  
 
 
 
 
 
 
 
 
and all 
pre-
specified 
outcomes 
reported 
in pre-
specified 
way. 
sources of 
bias. 
Teixeira et 
al., 2003  
Low Quote: 
“Subjects were 
randomly 
allocated to 
assigned to one 
year of weight-
lifting and 
weight-bearing 
exercise or to a 
group with no 
exercise.” 
 
Comment: 
Likely done.  
High Comment: 
Subjects stratified 
by HRT status.  
Low Comment: 
Exercise 
interventions 
preclude the 
blinding of 
participants 
to allocated 
group during 
the study. It 
is judged 
that this 
would not 
influence 
outcomes 
Low Quote: 
“DEXA 
technicians 
were blind to 
participants 
group 
assignments”. 
 
Comment: 
Likely done.  
Low Comment: 
No missing 
data 
apparent. 
Low 
 
 
 
 
 
 
 
 
 
 
 
Comment: 
Study 
protocol 
available 
and all 
pre-
specified 
outcomes 
reported 
in pre-
specified 
way. 
Low The study 
appears 
free from 
other 
sources of 
bias. 
Vilela et al., 
2015  
Low Quote: 
“Randomly 
distributed in 
control and 
experimental 
groups”. 
 
Comment: 
Likely done.  
Unclear Quote: 
“Randomly 
assigned drawing 
an opaque 
envelope”, with 
“names written 
on them”.  
 
Low Comment: 
Exercise 
interventions 
preclude the 
blinding of 
participants 
to allocated 
group during 
the study. It 
Low Comment: No 
mention of 
blinding of 
outcome 
assessment.  It 
is judged that 
this would not 
influence 
outcomes 
Low Comment: 
No missing 
data 
apparent. 
Low Comment: 
Study 
protocol 
available 
and all 
pre-
specified 
outcomes 
reported 
Low The study 
appears 
free from 
other 
sources of 
bias. 
9
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 Comment: Likely 
done. 
is judged 
that this 
would not 
influence 
outcomes 
in pre-
specified 
way. 
If study methodology did not explicitly state allocation was randomized, then it was deemed ‘high risk’ of bias for allocation concealment. Only 
those studies using central randomization, sequentially numbered drug containers or sequentially numbered, opaque, sealed envelopes were 
deemed ‘low risk. 
9
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4.5 Discussion 
 
The aim of this review was to synthesise the available evidence for inter-individual 
variation in weight change following an exercise-focussed intervention. This is the 
first systematic review and meta-analysis designed to address this specific aim. It 
was found that the evidence is limited for clinically relevant ‘true’ inter-individual 
variation in weight change in response to an exercise intervention, once the random 
variability in weight over time in the control group is accounted for. Also, the 
observed pooled inter-individual response variability, when compared to the pooled 
mean change in weight was small. The prediction interval ranged from small 
negative (more response variability in control group) to small positive (more 
variability in the exercise arm), revealing that the magnitude of the true individual 
response variability in a future study in similar settings is unlikely to be clinically 
important. Similarly, the prediction interval for the mean weight loss ranged from 
moderate reduction to trivial weight gain, indicating that the magnitude of mean 
weight loss in a future study in similar settings was only possibly clinically relevant.   
 
4.5.1 Aerobic Training Interventions 
 
Aerobic training has been reported to provide positive changes in body mass and 
body composition (Glowacki et al., 2004, Boutcher, 2011). In the current review, 
three studies were designed to investigate the effect of aerobic training interventions 
on weight loss, amongst other outcomes (Church et al., 2009, Tan et al., 2012, 
Donnelly et al., 2013). Although all three studies showed greater variability of 
changes in weight in the intervention arm, only one showed substantial true 
individual response variability. As part of the large-scale Mid-West Exercise Trial 2 
(MET-2), a control sample (n=18) were compared with groups engaging in 5 days 
per week of aerobic exercise eliciting 400 Kcal (n=37) and 600 Kcal (n=37) of 
energy expenditure per session (58). While group means showed substantial changes 
in body weight (400 Kcal: -3.9 kg, 600 Kcal: -5.2 kg, control: 0.5 kg), greater 
variability of changes (SD) was observed in the two intervention groups (400kcal: 
4.9 kg, 600kcal: 5.6 kg, pooled SD: 5.27 kg) than in the control sample (3.5 kg). The 
SD for individual response for this study was therefore 3.9 kg (95% CI, 1.8 to 5.3 
kg). The individual response variability in this study is clearly clinically relevant: 2 × 
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SD for individual response > minimal clinically important difference for the lower 
confidence limit. Indeed, the true individual response variance in this study was at 
least 7-fold greater than any other included study.  Nevertheless, removal of this 
study from the meta-analysis had no material effect on the pooled SD for inter-
individual variation in response (0.7 kg, vs. 0.8 kg with all studies included), and a 
negligible effect on the heterogeneity. This finding is due in part to the low weight 
afforded to this study in the analysis – just 1.03% - primarily due to relatively small 
sample size. Similarly, in the large-scale Dose Response to Exercise in Women 
DREW study, whilst some individuals did not meet their predicted weight loss 
targets, almost identical variation was observed when participants were randomized 
to either 4 kcal/kg/week exercise (n=139, 3.6), 8kcal/kg/week (n=85, 3.5) or 12 
kcal/kg/week (n=93, 3.4) and when pooled (n= 316, 3.5) when compared to the 
control sample (n=139, 3.37) (Church et al., 2009). 
 
4.5.2 Resistance Training Interventions  
The effects of concurrent training on body composition are equivocal. Weight gain 
(Glowacki et al., 2004, Dolezal & Potteiger, 1998) has been reported, but positive 
changes in other measures such as increased fat free mass (Dolzeal & Potteiger, 
1998, Binder et al., 2005, Hoffman et al., 2006) and reduced body fat (Dolzeal & 
Potteiger, 1998, Glowacki et al., 2004, Hoffman et al., 2006) have also been 
described. 
Three of the included papers were designed to investigate the effects of resistance 
training on body weight (Prabhakaran et al., 1999, Schmitz et al., 2002, Teixeira et 
al., 2003). Of these, one study showed a larger SD of body mass changes over 15 
weeks of resistance training in intervention versus control (Schmitz et al., 2002). 
This study reported trivial increases in mean body mass in both groups (Exercise: 
0.54 kg, Control: 0.49 kg). The SD of the changes was 1.87 kg in intervention vs. 
1.82 in control, resulting in a trivial SD for individual response of 0.4 kg.  
In a similar manner to that reported in the previous chapter, two studies reported 
greater variation in the control sample than in the intervention group. One study 
investigating the effects of a one year RT intervention on women with and without 
hormone replacement therapy reported between group mean differences (Texeira et 
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al., 2003); however, whilst weight change was small (EX (with HRT/without HRT) -
0.2/0.34kg, CON (with HRT/without HRT) 0.8/-0.4kg) analysis of pooled SDs 
revealed more variation in the control sample than the intervention (CON - 3.05, RT 
- 2.55).  
The second study (Prabhakaran et al., 1999), whilst investigating the effects of 3xRT 
per week, reported weight gain (0.49 kg) in RT, compared to -0.7 kg in CON. 
Analysis of the SD of the change score again revealed more variation in the control 
than the intervention sample (CON – 2.01, RT – 1.35). It appears from analysis of 
the SD of the change scores that in response to a resistance training intervention, 
greater inter-individual variation in the control group than in the intervention group 
is apparent. From these studies, it appears that body weight is not a robust outcome 
measure for a resistance training. Changes in body composition may be a preferential 
approach.  
4.5.3 Separate Aerobic and Resistance Training Interventions  
 
A single paper reported upon the impact of separate training modalities (Donges et 
al., 2010). Changes in fat mass and lean mass in a control sample (n=26), compared 
to two intervention groups comprising of resistance training (RT) (n=35) and aerobic 
training (AT) (n=41), were investigated over 10 weeks. Between group differences 
in change in body mass were observed, with aerobic training losing body mass (-
0.8kg), while both resistance training (0.8kg) and control samples (0.6kg) both 
increased body mass. The SD of the change in body mass was 1.3 kg in control, 1.5 
kg in resistance training, and 1.9 kg in aerobic training (pooled intervention SD of 
changes = 1.89 kg). The SD for individual response in this study was therefore 1.4 
kg, representing small individual response variability.  
 
4.5.4 Combined/Concurrent Training  
 
The effects of concurrent training on body composition are equivocal. Weight loss 
(Libardi, 2012) and weight gain (Glowacki et al., 2004) have been reported, but 
other health outcomes are often also positively influenced (Dolezal & Potteiger, 
1998). Five studies included in the present review were designed to examine the 
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effects of combined or concurrent aerobic and resistance exercise protocols 
(Lockwood et al., 2008, Burtscher et al., 2009, Vilela et al., 2015, Baillot et al., 
2016, Dalager et al., 2016).  
 
As part of the Pre-Surgical Exercise Training (PreSET) trial, 30 pre-bariatric surgery 
participants were randomized to concurrent training (n=15) and control sample 
(n=14) for a twelve-week intervention period (Baillot et al., 2016). Whilst the 
intervention group undertook 80 minutes of exercise, three times per week, no 
statistically different changes in weight loss were observed (CON -0.3, INT -0.92). 
However, greater variance was observed in the control sample change score SD 
(4.72) vs the intervention (3.55). Greater mean weight loss was observed in the 
intervention group (-2.58 kg) compared to a control group (0.79 kg) in a smaller 
study (Burtscher et al., 2009) than added 2 one hour combined aerobic and circuit-
type sessions per week for 12 months. Nevertheless, once again greater variance was 
observed in the control sample change score SD (4.93) vs the intervention (4.12).  
 
In a workplace-based study, 60 participants were randomized to control (n=30) or a 
Workplace Fitness and Education Program (WFEP), consisting of five fifteen-minute 
sessions per week, alternating muscular endurance and sporting activities (n=30) 
(Vilela et al., 2015). No change in body mass was reported for the intervention 
group, whilst the control group gained a mean weight of 0.4kg. The observed 
variance was identical in both groups (2.6)  
 
As part of a larger study, combined resistance and aerobic exercise was compared 
with control and exercise over a ten-week period (Lockwood et al., 2008). Whilst a 
second exercise condition with supplementation were excluded from my review, the 
two observed conditions reported identical body mass changes (-0.3) and slightly 
greater SD of the changes (INT 1.9 vs CON 1.6). 
 
Clinically relevant individual response variability was present in just one trial of an 
intervention involving 12 months of 1 hour per week combined aerobic and circuit-
style training (n=89), alongside recommendations to undertake 30 minutes of 
exercise, 6 days per week, compared to a non-exercise control group (n=194) 
(Dalager et al., 2016). Mean weight change was -0.49 kg in the intervention group 
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vs. 0.08 kg in control, with SD of the changes of 3.32 and 2.97 kg, respectively. The 
SD for individual response was therefore 1.5 kg.   
4.5.5 Limitations 
I synthesised 12 studies involving a total of 1500 participants. Small sample size is 
common in supervised exercise-based intervention trials (Keating et al., 2017), but 
this review included 4 larger (N=>100) studies (Church et al., 2009, Teixeira et al., 
2003, Donges et al., 2010, Dalager et al., 2016). Six studies recruited fewer than 20 
participants for one or more of the groups (Prabhakaran et al., 1999, Lockwood et 
al., 2008, Burtscher et al., 2009, Tan et al., 2012, Donnelly et al., 2013 Baillot et al., 
2016), and might be prone to small study bias at the individual study level.  
 
I restricted the search to RCTs incorporating exercise-only interventions; included 
studies differed by exercise mode, intensity, frequency and duration, and length of 
intervention. This intervention heterogeneity might influence mean effects and/ or 
individual response variance. There are too few studies to compare the effects in, for 
example, aerobic versus resistance versus combined interventions.  
 
Given the substantial heterogeneity of the true individual response variance, I 
derived and presented a prediction interval capturing the plausible range for the true 
individual response variability, consistent with the data and model, in a future study 
in similar settings. The prediction interval has been described as providing 
“potentially the most relevant and complete statistical inferences to be drawn from 
random effects meta-analyses” (Higgins et al., 2009). However, I must exercise due 
caution in inferences drawn from the prediction interval given the coverage issues 
identified in the simulations recently conducted (Partlett and Riley, 2017), where 
these authors reported that the coverage of the interval was particularly poor in cases 
of low effect heterogeneity and/or markedly variable sample size. With the specific 
combination of number of studies, between-study heterogeneity of individual 
response variance and mixture of study sizes in the current review (with REML and 
Knapp-Hartung estimation) these simulations indicate a maximum under-coverage of 
the derived prediction interval of 1%. Such under-coverage would have no material 
effect on the derived probability of individual response variance in a future trial 
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being clinically relevant. However, I still consider it prudent to view the prediction 
interval as approximate, as recommended by Partlett and Riley.  
 
Where multiple exercise arms were present in a study, these were combined to avoid 
double counting of the control arm. This may obscure the effect of different exercise 
doses; however, analysis of each individual exercise condition vs control, revealed 
no material difference in individual response variability.  
 
In advance of the study, I proposed various potential effect modifiers (moderators) to 
account for heterogeneity in individual response variance, including baseline body 
weight, age, and sex. However, I elected not to conduct any secondary meta 
regression analyses, as I only had access to study-level covariates (e.g., mean 
baseline weight, mean age, and proportion of males/females). This type of analysis 
has been described as ‘daft’(Fisher et al., 2017), as it has a high risk of ecological 
bias (Petkova et al., 2013); the ‘deft’ approach advocated by Fisher et al. requires 
either study level analysis of the effects of putative effect modifiers (e.g., treatment 
interaction effects with sex, age, weight etc.), or an individual-participant data meta-
analysis, with relevant interaction terms included in the model. However, obtaining 
individual participant data from study authors would likely prove to be a major 
undertaking in this, or indeed any, review.  This contention is underscored by the 
difficulties I experienced in communicating with authors merely to obtain a simple 
standard deviation of change scores from the data.  
 
Additionally, the energy expenditure induced by the exercise interventions 
undertaken in the included studies – and whether this would be sufficient, in theory, 
to induce weight loss above the minimal clinically important difference – is 
unknown. Whilst beyond the scope of this systematic review and meta-analysis, it is 
therefore unknown what effects exercise protocols with larger energy expenditures 
would elicit. 
 
To make inferences in the current study I adopted a threshold for the minimum 
clinically important weight loss of 2.5 kg – the smallest threshold of absolute weight 
loss for clinical benefit previously reported (Jensen et al., 2014). Those who disagree 
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with this choice may consider the reported prediction intervals in relation to their 
own belief in the minimum clinically important difference to make inferences.  
 
Whilst it is beyond the scope of this study to speculate, given the lack of exercise 
training quantification, such as adherence rates and fidelity it is unknown as to what 
impact this and other factors such as baseline activity/weight status may have 
impacted these findings. Future studies may look to include these outcomes in order 
to fully quantify the training response. 
 
I acknowledge that 20 possibly eligible studies were excluded due to their authors 
not providing the data requested by e-mail communication. I must, however, assume 
that these studies are missing at random, as I have no reason to believe that authors 
would withhold data pertaining to response variance.  
 
4.5.6 Findings in Relation to Current Recommendations and Future Research 
Directions 
 
This is the first systematic review to focus on the true inter-individual variation in 
weight loss in response to exercise interventions. I conducted a comprehensive 
literature search over 14 databases. Evidence in relation to the inter-individual 
response to various treatments/ interventions is growing rapidly. However, based on 
the findings of this systematic review, I find limited evidence for the presence of 
clinically important ‘true’ inter-individual variation in body mass in response to 
exercise training. Therefore, further investigation of underpinning mechanisms is 
likely not warranted, as the prediction interval reveals that individual response 
variance in a future study in similar settings is unlikely to be clinically important. A 
caveat here, as acknowledged above, is that I only synthesised 12 effects from 
heterogeneous exercise interventions. If individual differences in response to 
interventions targeting body weight are considered important from a precision 
medicine standpoint, then future randomised trials should be sufficiently sized to 
afford adequate precision of estimation for both mean intervention effects and the 
SD for individual responses. The latter would require at least 4× the sample size 
required to define the mean intervention effect with adequate power and precision, 
and even larger samples if individual response variance is trivial-small. 
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4.5.7 Conclusions 
To date, much of the research claiming to show substantial inter-individual 
differences in response to an exercise intervention has been conducted in the absence 
of a suitable comparator sample (King et al., 2008, Cauldwell et al., 2009, Cauldwell 
et al., 2013). To quantify the true inter-individual response to an exercise 
intervention, studies should include a comparator arm, preferably in a randomised 
controlled trial. Future work should employ this research design and incorporate 
sound statistical quantification of the response variance in each arm, combined with 
a threshold for the minimal clinically important difference, to determine the presence 
of clinically important individual variation in response. In summary, my findings 
constitute limited evidence for the notion of substantial inter-individual differences 
in weight loss responses to exercise interventions; individual response variability in a 
future trial in similar settings is unlikely to be clinically important. These findings, if 
replicated, confirmed, and extended, might prevent researchers wasting valuable 
resources searching for explanations of treatment heterogeneity that does not exist or 
is clinically trivial.  
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Chapter 5: A Secondary Analysis of Data from the PREMIER Study 
 
5.1 Preface 
 
Elevated blood pressure and increased body mass are important risk factors for 
diabetes, cardiovascular disease and some cancers, making lifestyle interventions to 
improve these markers especially relevant. There is purported to be substantial inter-
individual differences in how blood pressure and body mass respond to 
lifestyle/exercise interventions, but studies often lack the comparator data and 
associated analyses necessary for robust inferences. Recently, an appropriate 
approach for quantifying these inter-individual differences was described (Atkinson 
& Batterham, 2015, Hopkins, 2015). Therefore, I aimed to quantify inter-individual 
differences in the responses of weight loss and blood pressure to lifestyle 
intervention. Data from the PREMIER Trial were analysed, to quantify the effects of 
the DASH diet in combination with established treatment (ED) as well as established 
treatment (E) on systolic blood pressure (SBP), diastolic blood pressure (DBP) and 
weight loss in comparison to a comparator/advice group. 
 
5.2 Introduction 
 
5.2.1 Elevated Blood Pressure and Cardiovascular Disease Risk 
Elevated blood pressure is a common risk factor for cardiovascular disease (Appel et 
al., 2003). Lifetime risk of developing hypertension has been reported to be 
approximately 90% (Vasan et al., 2002), but even above-optimal blood pressure that 
is not classified as hypertensive can increase the risk of cardiovascular disease 
(Vasan et al., 2001). Current recommendations for the prevention and treatment of 
high blood pressure have placed an emphasis upon lifestyle modification (Whelton et 
al., 2002), such as weight loss, reduced sodium intake, increased physical activity 
and limited alcohol consumption. Reductions in SBP and DBP of ≥2 mm Hg 
can substantially reduce the incidence of CVD in both hypertensive and 
normotensive individuals, and therefore small reductions of this magnitude are 
considered clinically meaningful (Turnbull et al., 2003), whilst, a 5 mmHg reduction 
in systolic BP in the population would be predicted to result in a 14% overall 
 103 
reduction in mortality due to stroke, a 9% reduction in mortality due to coronary 
heart disease, and a 7% decrease in all-cause mortality (Whelton et al. 2002). Given 
the burden these diseases create upon the healthcare community, it is clear that 
interventions to reduce this risk are required. 
5.2.2 Gender Differences in Blood Pressure 
 
In general, men are reported to have higher blood pressure than women through 
middle age (Burl et al., 1995). Furthermore, the incidence of uncontrolled 
hypertension is also greater in men than in women (Anastos et al., 1991), possibly 
due to the role played by testosterone (Reckelhoff, 2001). 
 
5.2.3 Impact of Weight Change 
Obesity and other comorbidities continue to increase among both sexes (Mokdad et 
al., 2003). The impact of obesity remains considerable, with associated health risks 
conferring increased likelihood of the development of diabetes (Mokdad et al., 
2003), hypertension (Huang et al., 1998, Mokdad et al., 2003), cardiovascular 
disease (Poirier et al., 2006) and metabolic syndrome (Despres et al., 2008). It has 
also been suggested that dietary modification by itself reduces the risk of secondary 
myocardial infarction by about half in patients with coronary disease (de Lorgeril et 
al., 1999). Williamson et al. (2018) adopted a threshold for the minimum clinically 
important weight loss of 2.5 kg – the smallest threshold of absolute weight loss for 
clinical benefit previously reported (Jensen et al., 2014). Given this information, 
further efforts should focus on the prevention and treatment of overweight 
individuals through measures to prevent and reduce the burden of ill health, such as 
dietary modification and increased physical activity/ exercise.    
5.2.4 Use of the DASH Diet 
 
The Dietary Approaches to Stop Hypertension (DASH) trial was a randomized, 
multicentre, comparing the effect on blood pressure of 3 dietary patterns: control, 
fruits and vegetables, and combination diets, with patterns differing in selected 
nutrients hypothesized to alter blood pressure (Karanja et al., 1999). Application of 
the DASH diet as an intervention has previously been reported to contribute to 
 104 
reduced blood pressure (Stacks et al., 2001a, Svetkey et al., 2005), with greater 
improvements in vascular and autonomic function than advice alone (Blumenthal et 
al., 2010) and lowering of both LDL and total cholesterol (Obarzanek et al., 2001).  
 
5.2.5 Inter-Individual Variation in Response 
 
Interest in the concept of individual responses to exercise interventions has been 
growing over the last 30 years (Prud’homme et al., 1984, Despres et al., 1984, Lortie 
et al., 1984, Rose & Parfit, 2007, Bouchard et al., 2015, Mann et al., 2014) and it has 
been postulated, for example, that the benefits of physical activity may vary between 
age and gender groups (Peterson, 2007). Most public health and exercise research 
focuses upon mean group changes (Bouchard & Rankinen, 2001), but these may hide 
a wide range of responses (Karavirta et al., 2011) and do not allow us to distinguish 
the inter-individual variation in response (Senn, 2004). ‘True’ inter-individual 
differences in the response to an intervention are less frequently reported, even 
though it has been proposed that there is large inter-individual variability in response 
to physical activity interventions (Prud’homme et al., 1984, Despres et al., 1984, 
Lortie et al., 1984, Savard et al., 1985, Hamel et al., 1986, Simoneau et al., 1986, 
Bouchard & Rankkinen 2001, Hautala et al. 2003). 
 
Importantly, even in the studies in which inter-individual differences in the response 
to exercise training are considered, concerns have been levelled at the designs and 
analysis approaches in these investigations (Hopkins, 2015, Atkinson & Batterham, 
2016, Williamson et al., 2017). It has recently been described how the key trigger for 
further investigation into inter-individual responses is when the standard deviation of 
change (SDchange) in the intervention sample is substantially larger than the same 
standard deviation derived from a suitable comparator sample (Hopkins, 2015, 
Atkinson & Batterham, 2016, Williamson et al., 2017). Only when inter-individual 
variations in response are quantified, using the equation 
𝑆𝐷𝐼𝑅 = √𝑆𝐷𝐼
2 −  𝑆𝐷𝐶
2 (showing larger variation in the SDchange in an intervention 
group vs a control group), should further investigations into possible mediators of 
response be undertaken.  
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To this end, it was my intention to carry out a detailed and rigorous secondary 
analysis, using the methodology recently described (Hopkins, 2015, Atkinson & 
Batterham, 2015, Williamson et al., 2017) of the data collected during the 
PREMIER Trial, to correctly quantify the ‘true’ inter-individual variation in weight 
loss and blood pressure response. 
 
5.3 Methods 
 
5.3.1 The PREMIER Trial 
 
The PREMIER research design and rationale has previously been published (Svetkey 
et al., 2003). It was a multicentre randomized study, targeted at generally healthy 
adults (n=810), aged 25 years or older, with a body mass index of 18.5 – 45, and 
with above optimal blood pressure. The study was aimed at identifying the effect of 
an established intervention (a behavioural intervention that implemented traditional 
lifestyle recommendations such as weight loss, reduced sodium intake, increased 
physical activity and limited alcohol intake, n=268), and established intervention 
plus DASH diet (the same as the ‘established’ group, with the addition of dietary 
goals and strategies to achieve weight loss through implementation of the DASH 
diet, n=269) against an advice only group (who received a single, 30 minute 
individual discussion session with an interventionist, typically a registered dietician,  
following randomization, n=273). The sample size in the PREMIER trial was large, 
and the trial was powered (90%, p=0.05) to detect a difference in blood pressure 
between arms of 1.6-1.8 mmHg. However, the trial was not powered to detect 
interactions (e.g. sub-group effects) of the same magnitude, as this would require 
four times the sample size required to detect the overall main effect (the ‘rule of 4’).    
 
Baseline characteristics including age, blood pressure, height, body mass were all 
measured, and no substantial differences between arms were observed at baseline. 
Blood pressure was obtained by trained, certified individuals, where, following 5 
minutes rest, the observer measured blood pressure in the right arm, with systolic 
blood pressure defined as the appearance of the first Korotkoff sound, and diastolic 
as the disappearance of the Korotkoff sounds (Appel et al., 2003).  
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5.3.2 Statistical Analysis and Results 
 
The present investigation was run in three parts. The first was determined to be a 
reproducibility analysis, whereby I attempted to reproduce the original published 
results for systolic blood pressure (SBP), diastolic blood pressure (DBP) and weight 
change (Appel et al., 2003), by running the same analysis reported by the authors. 
Analyses were conducted using SPSS software (v23, IBM, New York, United 
States), with change in outcome from baseline to 6-months as the dependent 
variable, and intervention arm, clinical centre/cohort, and the raw baseline 
measurement of each variable as independent variables using a linear mixed model 
with random intercepts for subject.  
 
The published point estimates and 95% confidence intervals for the differences 
between trial arms in the change from baseline to 6 months were reproduced 
successfully for all outcomes (Appel et al., 2003). This is a crucial first step in 
advance of any more nuanced secondary analysis, as it provides confidence in the 
integrity of the raw data.  
 
To investigate the ‘true’ inter-individual variation in response, a linear mixed model 
was again used. The advice only group (control) provided the counterfactual for both 
men and women, allowing for the observation of response variance in the 
intervention over and above that seen in the control.  
 
I derived the SD for true individual responses using an extension of the method 
described in Atkinson and Batterham (2015). As there are two intervention arms 
(each versus control) two dummy variables are required - XVAR1 and XVAR2 – to 
allow for and quantify additional response variance in each intervention versus 
control. The XVAR1 variable has a score of ‘1’ when coincident with the 
Established group and ‘0’ otherwise, whereas XVAR2 had a score of ‘1’ when 
associated with the Established+DASH (ED) arm and ‘0’ otherwise. In a linear 
mixed model, the change in outcome from baseline to 6 months was the dependent 
variable, with sex, clinical centre/ cohort, and baseline value of the outcome as fixed 
effects. The two dummy variables were included as random slopes with no intercept. 
Using this approach, for SBP, the mean changes were E -3.7 (90%CI -5.3 to -2.1) 
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mmHg, ED –4.3 (-5.9 to -2.8) mmHg versus advice only. The SDIR for E vs advice 
was 4.4 (1.3 to 6) mmHg, compared to ED vs advice of 3.4 (-2.2 to 5.3) mmHg. For 
DBP, the mean changes were E -1.7 (-2.8 to -0.6) mmHg, ED –2.6 (-3.7 to -1.5) 
mmHg versus advice only. The pooled SDIRs were 2.1 (-1.9 to 3.5) mmHg and 2.6 (-
1.3 to 3.9) mmHg for E vs advice and ED, respectively. Given that we double these 
SDIRs before evaluating its magnitude to reflect a comparison between a typically 
high (mean + SDIR) and typically low (mean – SDIR) responder (Hopkins, 2015), if 
the MCID is 2 mmHg, then a moderate effect is 3x this = 6 mmHg, and a large effect 
is 6x this = 12 mmHg. Therefore, when compared to a relevant MCID of a 2-3 
mmHg reduction (Turnbull et al., 2003), these results (E 2*SDIR=4.2, ED 
2*SDIR=5.2) indicate small-moderate inter-individual variation in response. 
 
For weight change, the mean weight loss was -3.5 kg (90% CI -4.2 to -2.7) kg in E 
versus advice only and -4.2 kg (-5.0 to -3.4) in ED versus advice only. The pooled 
SDIR for E vs advice was -4.3 (3.7 to 4.8) kg, compared to ED vs advice of -4.5 (4.0 
to 5.0) kg. 
 
The second part of the investigation was to investigate the impact of sex on the ‘true’ 
inter-individual variation in response to the treatments; that is, does sex account for 
any of the observed treatment heterogeneity?  The linear mixed model approach was 
utilised again, although this time a sex-by-treatment interaction was included. This 
interaction term quantifies the difference between men and women in the mean 
effect of the intervention versus control. For SBP, male SBP reduced in E versus 
advice by 4.7 (95% CI -7.3 to -2.1) mmHg and females reduced by 3.1 (-5.1 to -1.2) 
mmHg. Men therefore have a greater response in E versus advice than women by 1.6 
(-1.7 to 4.8) mmHg. In ED versus advice, males reduced SBP by 5.6 (90%CI -8.1 to 
-3.2) mmHg and females reduced by -3.5 (-5.5 to -1.5) mmHg, resulting in a 2.1 (-
1.0 to 5.3) mmHg mean difference in response between men and women following 
ED.  
 
The sex-by-treatment interaction would be expected to explain at least some of the 
observed individual response variance, leading to a reduction in the SD for 
individual responses when the interaction is included in the model. However, this 
was not the case. When sex-by-treatment was added to the model, the SDIR for E vs 
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advice remained -4.4 mmHg, compared to ED vs advice of -3.4 mmHg.  For DBP, 
the SDIRs once again remained essentially unchanged. The SDIR for E vs advice was 
-2.0, compared to ED vs advice of -2.6 mmHg.  For weight change, a similar 
phenomenon was evident. When sex-by-treatment interaction was added to the 
model, a difference of 1.8 kg between men and women was observed for ED, 
compared to 1.2 kg in E. The SDIR for both intervention arms was effectively 
unchanged (4.3 kg vs 4.5 kg). 
 
The fact that sex does not explain any of the observed individual response variance, 
even though there is a difference in mean response between the genders, is 
paradoxical, as it cannot be the case that a substantial sex-by-treatment interaction 
does not account for some of the observed overall treatment heterogeneity. To that 
end, further analysis was undertaken, to try to elucidate this paradox. The third part 
of the analysis was to model the data separately, with the dataset split by gender. The 
same statistical model described above was applied, but of course with the sex-by-
treatment interaction removed. For men, in E, the SDIR was 6.2 (90% CI 2.9 to 8.3) 
mmHg, compared to 5.7 (2.4 to 7.7) mmHg in ED. For women, in E, the SDIR was 
3.1 (-2.8 to 5.6) mmHg, yet in ED alone, the SD IR was -1.3 (-4.8 to 4.5) mmHg. 
This indicates a magnitude of ‘true’ inter-individual variation in response that is 
vastly greater in men than that observed in women, and that there is more inter-
individual variation in response in the advice group than ED in women. The SDIR is 
also greater than the mean effect. Therefore, it appears that in SBP, the overall SDIR 
overestimates female SDIR and underestimated male SDIR. 
 
For DBP, when split by sex, a slightly different trend occurs. In men, in response to 
E and ED, SDIRs are 1.5 (90% CI -3.4 to 4.1) mmHg and 3.9 (-0.9 to 5.5) mmHg 
respectively, whilst in women, they are 2.2 (-2.2 to 3.9) mmHg and 1.2 (-2.9 to 3.3) 
mmHg respectively. 
 
When split by sex, inter-individual variation in weight change followed a similar 
trend to SBP. The observed variance was approximately double in men than in 
women. For men, in response to E and ED, SDIR was -4.9 (4.0 to 5.7) kg and -5.5 
(4.6 to 6.2) kg respectively. This was approximately double the amount presented as 
an MCID in Chapter 4. When interpreting the SD for individual responses we double 
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it, therefore these individual responses are classified as moderate. In women, SDIR 
was -3.8 (3.1 to 4.5) kg and -3.7 (2.6 to 4.3) kg for E and ED respectively.  
 
5.3.3 Individual Prediction Interval for a New Participant 
 
As a novel method, I propose that the individual response variance derived from an 
RCT may be used to construct a 95% individual prediction interval. This interval 
provides a plausible range for the response of a new participant undergoing the same 
intervention in a similar setting, versus what would have happened to this participant 
had they not engaged in the intervention (the counterfactual). The approach I have 
taken mirrors the method used to derive a prediction interval for a new study in a 
random effects meta-analysis (IntHout et al., 2016). As an example, consider the 
effect of the Established plus DASH intervention versus advice only in men. The 
mean effect was a reduction in systolic blood pressure of 5.6 mmHg, with a standard 
error of 1.235, and a SD for individual responses of 5.7 mmHg. The standard error 
(SE) for the individual participant prediction interval is given by: 
 
SE = √(1.2352+5.72) = 5.83. 
 
The next step is to multiply the SE by the appropriate value from the t distribution 
(1.971) for a 95% interval for the degrees of freedom (211) for this effect: 5.83 × 
1.971 = 11.5. The 95% prediction interval is then derived as the mean change minus 
11.5 to the mean change plus 11.5:  
 
-5.6-11.5 to -5.6+11.5 = -17 to 6 mmHg.  
 
Given the substantial observed treatment heterogeneity in men, the plausible range of 
effects for a new male participant undertaking the Established plus DASH 
intervention (versus a hypothetical control) spans moderate harmful (+6 mmHg; 
increased systolic blood pressure) to a large beneficial effect (-17 mmHg). It is then 
straightforward to estimate the probability that a new male participant would benefit 
from the intervention by at least the minimum clinically important difference 
(MCID) of 2 mmHg. The t value required to derive this probability is given by the 
observed mean effect minus the MCID, divided by the SE of the prediction interval: 
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(5.6-2)/5.83 = 0.617. The area under the t-distribution to the left of 0.617 is 0.73. 
Therefore, the probability (% chances) that a new male participant undergoing this 
intervention would benefit is 73%, or odds in favour of benefit of almost 3:1. Using 
the same method, for a new male participant the probability of an increase in blood 
pressure post-intervention of  >2 mmHg (the MCID) is 10%, and there is a 17% 
probability of a trivial change (within ± the MCID). These findings imply that 
around 7/10 new individuals would derive beneficial reductions in systolic blood 
pressure as a result of such an intervention, 1-in-10 would get worse, and 2/10 would 
experience no substantial change. These values are an average, with a confidence 
interval, which are subject to the uncertainty in the SDIR. Of course, further research 
is required to help explain the marked individual response variance in men and to 
identify the characteristics of participants most likely to benefit. For example, 
intervention fidelity is probably an important mediator of treatment effect, but no 
detailed data are available on this variable.  
 
5.4 Discussion 
 
My aim was to carry out secondary analysis of the data collected during the 
PREMIER trial, in order to correctly quantify the ‘true’ inter-individual variation in 
weight change and blood pressure response to advice only, established care and 
established care plus the DASH diet. The key findings were that there are large SBP 
and weight loss individual responses for men but not for women, and that an 
interesting paradox regarding the distribution of the ‘true’ inter-individual variation 
in responses was observed. 
 
5.4.1 Initial Exploratory Observation of Response Variance 
 
The SD for the raw SBP change scores was 9.9 mmHg in the intervention vs. 9.2 
mmHg in advice only. However, it is a flawed approach to think in SD units rather 
than variance and therefore assuming trivial IR. To explain fully, SQRT (9.9^2-
9.2^2) is 3.66 mmHg, which is substantial.  On initial appraisal, there initially 
appears to be a trivial difference in SDs (9.9 vs 9.2). However, when you have SDs 
of this magnitude, squaring them magnifies the difference between them (i.e. 98.01 
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vs 84.64), versus the same difference in SDchange of 0.7, with a smaller overall SD, 
for example 1.7 (2.89) in one group and 1.0 (1) in the other. This highlights the 
additional need to think in terms of differences in response variance, and then 
express the individual response variability as an SD.  
 
5.4.2 Systolic Blood Pressure 
 
The original PREMIER trial was reported to reduce blood pressure, thereby reducing 
prevalence of hypertension in the cohort (McGuire et al., 2004), suggesting that the 
DASH diet had numerous possible health benefits. The DASH diet has also 
previously been reported to substantially reduce blood pressure (Stacks et al., 2001a, 
Stacks et al., 2001b). 
 
The value of 11.99 mmHg for the individual response variance, calculated from the 
original raw PREMIER data, thereby giving an SDIR of 3.4 mmHg, from the full 
sample analysis is ‘false’. This led to an inability to explain or account for any of the 
variance when a sex by treatment interaction was entered in the model; the 
explanatory effect of the mean difference between sexes for the effect of treatment is 
actually offset by the large difference in response variance in men vs. women.  
 
This finding also applies to the raw change scores in men and women for both the 
treatment arms and the control, where the SD of the changes in women is larger for 
advice only than for ED. This phenomenon is only fully observed when sex-by-
treatment group interaction is entered in the model.  The mean difference (point 
estimate) in the effect of the treatment in men vs. women is substantial and should 
therefore show up as individual responses that would then have attenuated when a 
sex-by-treatment interaction was entered into the analysis. If a linear mixed model 
were run without this interaction, substantial individual response variance would be 
evident. When the model has the interaction term added, this variance will disappear, 
or reduce, based upon the extent to which sex explains that portion of variance.  
 
It is usually the case that substantial interaction terms cannot be present without 
observing a large inter-individual variation in response that is then at least partially 
explained by the interaction term. However, in this case, it does not explain or 
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account for any of the 11.99 mmHg individual response variance. In practice, if there 
are independent groups (such as sex), then separate analyses should be undertaken 
early in the process, in order to identify the presence of such a phenomenon. This is 
highlighted by the fact that the value of 11.99 mmHg, derived from the full model 
for the individual response variance, does not accurately apply to either men or 
women in this case, and therefore cannot be explained by any available moderators.  
 
Practically, these observed SDIR are large, when compared to a minimal clinically 
important difference (MCID) of 2-3 mmHg for reducing mortality (Turnbull et al., 
2003). When we double the SDIR, as is required to evaluate the individual variation 
in response to a clinically anchored MCID, the magnitude of individual variation in 
response is actually 3-4 times the size of the relevant MCIDs. 
 
5.4.3 Diastolic Blood Pressure 
 
Non-significant differences in DBP have been reported between both men and 
women (Jaquet et al., 1998). In the present secondary analysis, a mean difference in 
reduction of DBP of 2 mmHg was observed between men and women, with men 
showing, on average, a greater mean change. However, a divergent trend was evident 
in inter-individual variation; the observed SDIR was smaller in men in ED than 
women, whilst conversely, women had smaller SDIR in E only, compared to men. 
The observed inter-individual variation in DBP were of a magnitude of 0.75 to 1.9 
times the MCID (2 mmHg), indicating that these variations in response may be of 
clinical significance. 
 
5.4.4 Weight Loss 
 
Previous research has reported larger reductions in blood pressure with DASH or 
DASH with weight management (calorie restriction of 500 kcal) than those reported 
in the PREMIER Trial (Blumenthal et al., 2010). This may be as a result of the 
weight manipulation through calorie restriction, the addition of supervised exercise, 
or the comparatively small sample size (n=144) inflating the effect of the 
intervention. In the PREMIER dataset, whilst similar mean responses were observed 
for weight loss, the same phenomenon was observed as for SBP. The observed true 
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individual response variance in men was almost double that observed in women, 
leading to substantially greater SD for individual responses in men. These were of a 
much greater magnitude of those suggested in Chapter 4 (2.5 kg), at a conservative 
estimate, to confer positive health benefits, indicating moderate inter-individual 
variation in response. In addition, these data show that diet may confer more positive 
benefits than exercise for weight loss, with a greater effect observed in this analysis, 
compared to those previously reported (Williamson et al., 2018).  
 
5.5 Conclusions 
 
When analysing the original PREMIER trial dataset, there is ‘false’ observed overall 
individual response variability for SBP and weight change, due to the presence of 
zero/ negative individual response variance in women, but very large inter-individual 
response variance in men. Whilst the effect in women is relatively consistent and in 
men much more variable, the individual response variance for SBP (11.99 mmHg) 
estimated from the whole sample does not apply well to either men or women, 
underestimating men and overestimating women. This is why including the sex-by-
treatment interaction did not explain any of the overall SDIR, as virtually all of the 
individual response variance is in men not women. Women appear to be more 
consistent responders to the intervention than men, for some reason. The reason for 
this is unknown, but could, speculatively, be due to be higher intervention fidelity in 
women, whereby they listen to, and follow instructions, with greater accuracy than 
men. 
 
Therefore, putting a sex-by-treatment interaction in the model for this dataset does 
not account for any of the ‘true’ inter-individual response variance for SBP or weight 
change. This finding arises due to the ‘overall individual response variance being 
false. The vast difference in individual response variance between men and women 
completely overwhelms and offsets any reduction in the ‘pooled’ individual response 
variance when the sex-by-treatment interaction is included in the model, making it 
appear that sex is not a moderator of the individual response variance.  
 
This issue should provide a cautionary tale and a recommendation to all researchers 
doing these types of analyses, highlighting a crucial point that the analyses must – at 
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least initially – be stratified by sex, rather than deriving the overall sample individual 
response variance, as it may be erroneous, as it is in this instance.  
 
The use of a Prediction Interval for this analysis provides a novel approach to 
providing a plausible range for the response of a new participant undergoing the 
same intervention in a similar setting, versus what would have happened to this 
participant had they not engaged in the intervention. This approach has not been 
utilised in the secondary analysis of data and, as long as the SDIR and its associated 
confidence intervals are relatively precise, can reliably predict the likelihood of a 
positive change being conferred upon an individual in undertaking interventions in 
future settings, with the caveat that it requires a precise estimate of SDIR. 
 
This secondary analysis of the PREMIER trial data showed much larger inter-
individual variations in the response of weight loss and blood pressure control in 
men to established treatment and established treatment plus DASH diet, when 
compared to women, of a magnitude 3-4 times the MCID. The findings reinforce the 
requirement for a suitable comparator sample, as discussed repeatedly in this thesis. 
It is beyond the scope of this investigation, however, speculatively, these findings 
may be the result of greater fidelity in women. Additionally, the findings create clear 
areas for further investigation aimed at better-targeted interventions for subgroups, 
including the response and reactivity of blood pressure in response to exercise. 
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Chapter 6: Inter-Individual Differences in Acute Blood Pressure 
and Heart Rate Response to High Intensity Aerobic Exercise: A 
Replicate Crossover Design 
 
6.1 Preface 
 
Given the findings of substantial ‘true’ inter-individual variation in response of 
systolic blood pressure in response to chronic lifestyle interventions reported in 
Chapter 5, it is important to identify whether these responses may be present acutely 
following exercise challenges. Therefore, in this chapter, I aimed to quantify and 
partition the many possible elements of variation of blood pressure and heart rate 
response following bouts of high intensity ‘aerobic’ interval exercise, using a novel 
replicate crossover trial. The key to this is the use of specific coding for the analysis 
and partitioning of variance into ‘consistent’ and ‘one-time’ inter-individual 
variation in response. 
 
6.2 Introduction 
 
Blood pressure is the product of cardiac output and total peripheral resistance 
(Sabbahi et al., 2018). High blood pressure, or hypertension, affects approximately 
25% of the population (Carpio-Rivera et al., 2015), and is the major risk factor for 
cardiovascular disease (Boutcher & Boutcher, 2017). Chronic exercise is 
consistently reported to reduce blood pressure (Fagard, 2005, Cardoso et al., 2010, 
Pescatello et al., 2004a). However, it has been suggested that this finding may 
disregard the last bout effect of acute exercise if the measurement is taken close to 
the preceding exercise bout, which has been shown to reduce blood pressure (post 
exercise hypotension (PEH)) (Carpio-Rivera et al., 2015) in the period 5-60 minutes 
post-exercise.  
 
6.2.1 Post Exercise Hypotension  
 
The magnitude of hypotension in the post-exercise period is generally greater than 
observed chronically and lasts from minutes (MacDonald 2002) to hours (Pescatello 
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et al., 2004b), and differs by time of day (Jones et al., 2008), intensity and duration, 
but not by total work completed (Jones et al., 2007). Immediately post-acute 
exercise, systolic blood pressure usually normalises rapidly, though can also be 
subject to a large drop due to excessive venous pooling (Le et al., 2008), while a 
decline in acute systolic blood pressure of >10 mm Hg below resting value is 
associated with increased cardiovascular risk (Dubach et al., 1988). However, it is 
possible that chronic reduction in blood pressure may be due to the contribution of 
accumulated acute episodes of PEH (Thompson et al., 2001). Diastolic blood 
pressure remains generally unchanged or slightly decreases in normotensive subjects 
(Palatini, 1988). 
 
6.2.2 Blood Pressure Reactivity 
This PEH is preceded by an increase in post-exercise blood pressure – a 
phenomenon called blood pressure reactivity. Submaximal exercise has been 
reported to elicit similar cardiovascular responses as those observed via 
psychological stressors (Lambiase et al., 2013). Whilst SBP normally rises during 
dynamic exercise in response to increased cardiac output (Jae et al., 2015), an 
exaggerated peak SBP reactivity (defined as an increase during exercise testing to 
≥210 mmHg (Jae et al., 2006)) is an indication to stop any cardiopulmonary testing 
(Pescatello et al., 2014) and is associated with risk of developing hypertension 
(Matthew et al., 1998). 
 
6.2.3 The Mechanisms of Blood Pressure Response 
 
Higher fitness levels appear to elicit a smaller magnitude of heart rate reactivity 
response (Boutcher & Nugent, 1993), though the mechanisms for this are, as yet, 
unknown (Lambiase et al., 2013). It has been suggested that as exercise elicits 
norepinephrine release in a curvilinear manner in response to increased workload 
and in combination with epinephrine (Kaufman & Forster, 1996), these chemical 
responses may be responsible for the magnitude of the rise in exercise heart rate and 
blood pressure. 
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6.2.4 Gender Differences in Response 
 
There are reports that males and females, whilst utilising the same pathways for 
stress response, appear to differ in response (Huang et al., 2013). Males present 
larger diastolic blood pressure responses to acute exercise, which may suggest that 
male responses are ‘vascular’ while female responses are ‘cardiac’ (Allen et al., 
1993).  
 
6.2.5 Inter-Individual Differences in Response  
 
Interest in the individual response to a treatment intervention has gathered 
momentum over the last three decades (Prud’Homme et al., 1984, Lortie et al., 1984, 
Hamel et al., 1986, Rose & Parfitt, 2007, Senn et al., 2011, Bouchard et al., 2012, 
Mann et al., 2014, Snyder et al., 1997, Barbeau et al., 1999, King et al., 2008, 
Barwell et al., 2009, Caudwell et al., 2009, Caudwell et al., 2013), developing 
interest in the concept of precision medicine – incorporating ‘made-to-measure’ 
therapies based on the individual response of a patient (Senn et al., 2011). It has been 
suggested that personalized medicine may revolutionize healthcare through 
utilization of individual genetic information, thereby improving drug safety and 
efficacy (Katsanis et al., 2008). However, previously reported associations been 
between genotype and phenotype are often too small to provide sufficient evidence 
for response or phenotype prediction (Khoury & Galea, 2016).  
 
Most researchers have presented mean data, with inter-individual variation in 
response often being overlooked (King et al., 2012). This focus on mean effects may 
hide important observations that a fixed dose of exercise may have varying effects 
upon individuals (Bouchard, 1983, Bouchard & Rankinen, 2001, King et al., 2008). 
It has been suggested that belief in inter-individual variation as the cause of observed 
variation in treatment response outcomes may be due to lack of rigorous study 
design (Senn et al., 2011).  
 
 
 
 
 118 
6.2.6 Partitioning Variance Through the Replicate Crossover 
 
It has previously been described how attempts to quantify the inter-individual 
variation response to chronic exercise are hampered by a lack of a control sample 
(Atkinson & Batterham, 2015, Williamson et al., 2017). Recent insights have 
suggested a new approach in order to partition and quantify variance in trials of acute 
responses: the replicate crossover (Senn, 2016). This method is suggested to allow 
for the isolation of components of variation corresponding to patient-by-treatment 
interaction (Senn et al., 2011), as replication of both an intervention and a control 
period allows for an interaction to be determined.  
 
Given the lack of previous investigation into this subject, and in the knowledge that 
blood pressure reactivity varies with circadian rhythm (Jones et al., 2006), it is of 
interest to investigate the presence of any inter-individual variation in this reactivity. 
Whilst the replicate crossover method for attempting to partition variance was 
recently utilised (Goltz et al., 2018), no previously published studies have 
investigated the acute inter-individual variation in blood pressure reactivity to 
exercise. Additionally, the study by Goltz et al. (2017) compared three analysis 
methods, all of which were different from that proposed by Senn et al., (2011).  
Therefore, in the first replicate crossover design study to quantify inter-individual 
variability of blood pressure reactivity in response to exercise, the aim of this study 
was to identify the presence of any ‘true’ inter-individual variation in post-exercise 
blood pressure reactivity, measured by systolic and diastolic pressure, and any ‘true’ 
inter-individual variation in heart rate response, following repeated acute bouts of 
high-intensity aerobic intermittent exercise. Within the programme of work for this 
PhD thesis, this trial serves as a proof-of-concept study, which provided data with 
which to develop and refine analysis models and code to properly partition the 
variance and isolate the true individual response variability in acute exercise vs. 
control. It also serves as pilot testing of the methods, procedures and analysis for 
future, larger-scale investigations. 
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6.3 Methods 
 
6.3.1 Participants 
 
As there were six possible exercise sequences, ideal recruitment sample sizes were in 
multiples of six. The target sample size was 12, representing an adequate sample size 
for a pilot/ proof-of-concept study using a replicate crossover design. Twelve 
normotensive, physically active people (4 women, 8 men, age: 29.7  5.2 y, height: 
173.9  9.4 cm, body mass: 72.5  11.0 kg, peak oxygen uptake (V̇O2peak) 39.4  
8.6 mL.kg-1.min-1) volunteered and were recruited, by showing interest following 
internal emails and advertisements, to take part in this replicated period crossover 
design trial. Participants were randomised in blocks of two to one of six possible 
sequences of 2 control and 2 exercise replicates over four periods. Allocation was 
concealed from those assessing eligibility and recruiting participants using a 
statistical advisor.  This approach was undertaken to allow the identification of the 
subject-by-treatment interaction and thus to quantify the heterogeneity in the 
response to acute exercise. One participant was unable to attend all sessions with the 
required 72 h separation between trials and was therefore excluded from the 
experimental protocol, whilst one volunteer was excluded due to medical reasons. 
Therefore, eleven of the participants completed the study.  
 
Following a full information brief (Appendix 1), participants attended the laboratory 
on five separate occasions, each separated by >72 h. The first visit was for 
habituation purposes, completion of informed consent, and measurement of peak 
oxygen uptake (V̇O2peak). During this session, stature (m) was determined using a 
stadiometer (Seca, Hamburg, Germany), body mass (kg) was measured using an 
electronic measuring station (Seca, Hamburg, Germany), resting heart rate (HR) was 
measured using a wrist worn monitor (Polar FT1, Polar Electro Oy, Finland), paired 
with a chest-worn strap (Polar T31 coded strap, Polar Electro Oy, Finland). Heart 
rate was taken in standardised laboratory conditions, with all participants in an 
upright, seated posture. Resting blood pressure (mmHg) was measured using an 
automated blood pressure monitor and  22-32cm cuff (Omron M2, Omron, Kyoto, 
Japan). Using this validated monitor (Topouchian et al., 2011, Takahashi et al., 
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2015), following 5 minutes of complete rest in a supine position, resting blood 
pressure was taken on the left arm, with the cuff approximately 2.5cm above the 
elbow crease and the bladder centred over the brachial artery (Frese et al., 2011), and 
was determined from the mean of three measurements.  
 
The final four visits were for completion of the main experimental trials, with two 
exposures each to the intervention and the control conditions (Senn, 2016). The 
participants were randomised to one of six possible sequences of trial (C=control, 
E=exercise), and were informed of the nature of each day’s place in that sequence 
upon arrival:  
1. C-E-C-E  
2. C-E-E-C  
3. C-C-E-E 
4. E-C-E-C 
5. E-C-C-E 
6. E-E-C-C 
 
All exercise was performed on an upright cycle ergometer. Exercise was performed 
following abstinence from alcohol (24 h), caffeine (12 h) and vigorous exercise (24 
h), and all participants were requested to consume a similar diet prior to each 
attendance.  
 
All participants had no history of major illness, cardiovascular disease, were not 
taking any medications, and were engaged in habitual physical activity for general 
health and wellbeing. The study conformed to the declaration of Helsinki and was 
approved by the Institutional Ethics and Research Governance Committee. All 
participants were fully informed of the study methods prior to giving written 
informed consent (Appendix 5). Participant characteristics are presented in Table 6.  
 
6.3.2 Measurement of Peak Oxygen Uptake  
 
Peak oxygen uptake was measured by a ramp test on an electromechanically braked 
cycle ergometer (Lode Excalibur, Groningen, Holland). The ramp test was selected 
because exercise test protocols with large stage-to-stage increments in energy 
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requirements generally have a weaker relationship between measured V̇O2 and work 
rate (Balady et al., 2010). Participants performed 5 minutes of submaximal exercise  
 
Table 6. Participant characteristics 
 Recruited (n=12) Analyzed (n=11) 
Age (yrs) 29.7 ± 4.9  29.7 ± 5.2 
Stature (cm) 173.9 ± 10.1 173.9 ± 9.4 
Mass (kg) 72.5 ± 12.5 72.5 ± 11.0 
Resting SBP (mmHg) 127 ± 10 127 ± 10 
Resting DBP (mmHg) 75 ± 7 76 ± 7 
Resting heart rate (b.min) 67 ± 21 67 ± 14 
V̇O2peak (mL.kg-1.min-1) 39.4 ± 8.3 39.4 ± 8.6 
 
(50 W) as a standard warm-up. As the test commenced, beginning with no load, 
power output increased by 30 W per minute until volitional exhaustion or the subject 
could no longer maintain a pedal cadence of 70-90 revolutions per minute (RPM). 
Expired air was collected and analysed throughout (Zan 600 USB CPX, nSpire 
Health Inc., United Kingdom), whilst heart rate (HR) was monitored at rest and 
every minute using a wrist-worn monitor and coded chest strap (Polar FT1 and Polar 
T31, Polar Electro Oy, Finland). V̇O2peak was defined as the peak value of a 5-point 
average data set, meaning that the data was filtered for any anomalies and then 
averaged out for every five consecutive data points (Robergs et al., 2010). Oxygen 
uptake was then interpolated to identify the exercise work rate (power output) 
corresponding to 70% V̇O2peak using linear regression. 
 
6.3.3 Research Design 
 
All participants completed four experimental trials in a thermoneutral environment 
(18-22C). Each trial was completed in different sequence, as described above. 
Participants reported to the laboratory in the morning, and each visit consisted of two 
phases; the first consisted of 5 minutes of supine rest, which, within the time 
constraints of the study and the fact that the optimal time at rest before measurement 
is, as yet, undefined (Sala et al., 2006), was considered sufficient to remove the 
residual effects of prior activity. Following this rest period, resting blood pressure 
was measured. Based on this selected rest duration, differences in resting time should 
be taken into account when comparing BP measurements performed in future studies 
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and in different settings (Sala et al., 2006). The second phase was the experimental 
protocol. 
 
6.3.4 Experimental Protocol 
 
Participants reported to the laboratory in the morning (0830-1130), as changes in 
post-exercise blood pressure have previously been reported for both continuous 
(Jones et al., 2008) and intermittent exercise (Jones et al., 2009), with less marked 
diurnal differences observed between am and pm exercise following intermittent 
exercise than in continuous exercise (Jones et al., 2009). The experimental protocol 
consisted of two conditions. The exercise condition (EX) comprised of two 10-min 
intervals of upright cycling, at the individual’s estimated power output at 70% of 
V̇O2peak, separated by a 5-min recovery period. To ensure that participants’ work 
rate was at the correct intensity, the resistance (Watts) were constant during each 
exercise bout. A control sample, involving collection of the same data during a 
period of no exercise, was the second condition. This rest (CON) condition consisted 
of the same time periods, sat at rest on the upright cycle ergometer.  
 
6.3.5 Blood Pressure Measurements 
 
The blood pressure monitor was fitted to the upper arm in accordance with practical 
guidelines previously established (O’Brien et al., 2005). The mean of three 
measurements was obtained as the baseline measure. The blood pressure monitor 
was removed following baseline measurements and participants moved to the cycle 
ergometer, where they completed EX or CON conditions. Blood pressure was 
measured during each rest period in EX, and at the same time points during the 
protocol in CON. These measurements were repeated immediately on cessation of 
exercise following both 10-minute periods, and at the corresponding time point 
during the control condition, with the second post-exercise measurement taken as the 
final measure.  
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6.3.6 Components of Blood Pressure 
 
Blood pressure has also been reported to consist of pulsatile and steady components 
(Safar, 1989, Darne et al., 1989, O’Rourke, 1982). The pulsatile component, 
estimated by pulse pressure (PP) represents blood pressure variation and is affected 
by heart rate (Franklin et al., 1997), left ventricular ejection fraction and large-artery 
stiffness. In contract, the steady component, which is estimated by mean arterial 
pressure (MAP), is a function of left ventricular contractility, heart rate, and vascular 
resistance (Safar, 1989, Benetos et al., 1997a). Mean arterial pressure has also been 
suggested as an alternative measurement in patients for hypotension detection 
(Henry et al., 2002). 
 
Pulse pressure is defined as SBP minus DBP (Lloyd-Jones & Levy, 2007), and can 
be used reliably as a prognostic marker in clinical practice (Yildiran et al., 2010). It 
has been suggested that pulse pressure may become a more important blood pressure 
measurement that is associated with cardiovascular disease in older adults (Franklin 
et al., 1999). Average SBP, DBP, and MAP have been suggested to strongly predict 
CVD risk in younger men, whereas average PP is purported to be associated with the 
risk of CVD in both younger and older men. (Sesso et al., 2000). This corresponds 
with earlier suggestions that a wide pulse pressure is a significant independent 
predictor of all-cause, cardiovascular and coronary mortality (Benetos et al., 1997b). 
 
It has previously been claimed that individuals with lower systolic blood pressure 
response during exercise testing are at increased risk of adverse cardiovascular events 
(O’Neal et al., 2015). This risk is highest for those with exercise-induced hypotension. 
It has also been reported that males and females, whilst utilising the same pathways 
for stress response, appear to do so with a variation in results (Huang et al., 2013), 
with males showing increased diastolic pressure and total peripheral resistance, whilst 
females respond by greater changes in heart rate.  
 
6.3.7 Heart Rate Monitoring 
 
Heart rate straps were fitted around each participants’ chest (Polar T31 coded strap), 
connected to a wrist-worn monitor (Polar FT1, Polar Electro Oy, Finland). Heart rate 
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was measured immediately at the end of each 10-minute bout of exercise, and at the 
corresponding time point during the control condition. Peak heart rate was determined 
as the highest visual reading recorded at the completion of each bout. 
 
6.3.7 Statistical Analysis 
 
Data (n=11 due to one withdrawal post-randomisation) were analysed using SAS (v. 
9.4, SAS Institute Inc, Cary, NC, USA). Subsequent to blood pressure and heart rate, 
mean arterial pressure (calculated as (SBP+2*DBP)/3), pulse pressure change (the 
change in the difference between systolic and diastolic blood pressure) and rate 
pressure product (the product of heart rate multiplied by blood pressure, Gobel et al., 
1978) were also calculated and analysed. Additionally, residual error, or measurement 
error, was calculated, with its associated 90% confidence intervals. A linear mixed 
model, allowing for sex differences in the mean effect of acute exercise and 
differential period effects between conditions (by sex) was developed, elaborating 
substantially upon the following ‘possible’ code previously suggested (Senn et al., 
2011): 
 
proc mixed data=updrs 
 class period treat subject; 
 me=model score=period treat/ddfm=kr solution CL; 
 random subject subject*treat/solution; 
 lsmeans treat/pdiff cl; 
 ods output solution=randomsolutionf=fixed lsmeans=means; 
run; 
 
However, this ‘possible’ code does not adequately partition the variance and allow 
isolation of the true individual differences in response to acute exercise versus control.  
Therefore, I rewrote this code by including random effects for the participant x 
treatment interaction (by period) to partition the variance and derive the ‘true’ SD for 
individual responses. This approach allowed for portioning by period (visit 1,2,3,4, 
whether that be application of intervention or control condition), sex (male, female), 
treatment (EX, CON), and subject (2-12). In parallel with the method applied to the 
analysis of parallel group randomised controlled trials, dummy variables are required 
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to allow extra variance whenever a subject experiences a control trial (xVarC) or a 
treatment (exercise) trial (xVarT). The following code was developed and applied 
(SBP used as example analysed variable): 
 
proc mixed data=mydata covtest cl alpha=0.1 
nobound;                                                                                          
class period treatment subject sex;  
model SBP_change=period treatment sex treatment*sex treatment*period 
treatment*sex*period/ddfm=satterthwaite outp=pred cl alpha=0.1;                              
random Subject Subject*xVarC Subject*xVarT 
Subject*xVarT*Period;                                                                              
lsmeans Treatment treatment*sex period treatment*period/diff cl 
alpha=0.1;                                                                   
lsmestimate treatment*sex "exercise-control" 1 -1 -1 1/ cl 
alpha=0.1;                                                                                 
run; 
 
In the above code SBP change is the change in blood pressure from rest to the end of 
exercise, or the end of the equivalent control period. The fixed effects provide the 
overall mean effect of acute exercise versus control, and the differences between 
men and women in this exercise effect, allowing for period effects, differential 
period effects between conditions, and differences between sexes in any differential 
period effects by treatment. Differential period effects between conditions might be 
due, for example, to a different habituation effect for acute exercise compared with 
just sitting still. 
 
The sum of the xVarC*subject and xVarT*subject random effects provide the 
‘consistent’ individual differences in response to acute exercise. In addition, ‘one-
time-only’ individual response variance quantifies the different individual responses 
every time a subject experiences an exercise replicate. To explain, if, within-subject, 
each subject had the same value on each administration of exercise (but different 
values between subjects), then there would be consistent individual response 
variance but zero one-time-only individual response variance. What we see typically 
in replicate crossovers, however, is that each subject has a different value on repeat. 
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So, for example, for SBP, Subject 2 has a change score of +59 mmHg on the first 
exercise occasion and +88 mmHg on the second. So, there will be ‘consistent’ 
between-subject differences in response plus ‘one-time-only’ individual response 
variance each time a subject experiences an exercise replicate. The total individual 
response variance in a replicate crossover is therefore the sum of these two 
variances. The square root of this total individual response variance provides the 
variability expressed as a SD. The confidence interval for the total individual 
response variance was derived by squaring the standard errors from each of these 
variances, adding them together, taking the square root, and then using the normal 
distribution. This ‘total’ SDIR is interpreted as the typical difference between subjects 
in the mean change between a control trial and an exercise trial. The model also, of 
course, gives the mean difference in the change in outcome between exercise and 
control, with its confidence interval.  
 
6.4 Results 
 
6.4.1 Mean Effects 
 
The mean effect of acute exercise (versus control) on systolic blood pressure are 
presented in Table 7. The mean difference between females and males was +35 
(90%CI 9 – 62) mmHg (67 mmHg in women vs. 32 mmHg in men). 
 
The mean effect on diastolic blood pressure was -6 (-1 to 14) mmHg. The average 
difference between females and males was 13 (-3 to 28) mmHg. Mean arterial 
pressure increased by 21 mmHg (13-28), with average sex differences of 21 (6-36), 
whilst pulse pressure difference was 45 (34 to 55) mmHg, with a difference of 25 (4 
to 46) mmHg between females and males. The mean effect on rate pressure product 
was an increase of 12045 (9058 to 15032). The average difference between males 
and females was 6006 (21 to 11980), whilst the mean effect on heart rate was an 
increase of 58 (39 to 78) b.min. The average difference between males and females 
was 5 (-34 to 45) mmHg. 
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6.4.2 Consistent Inter-Individual Variation in Response 
 
With sex included in the analysis model, the consistent inter-individual variation in 
response for systolic blood pressure was 16 (± 90% Confidence Limits 21) mmHg. 
The consistent inter-individual variation in response for diastolic blood pressure was 
-10 (±15) mmHg, however, this was overwhelmed by the one-time-only inter-
individual variation in response. For mean arterial pressure and pulse pressure, 
consistent inter-individual variation in response was -4 (±13) and -13 (±23) mmHg 
respectively, however, like diastolic blood pressure, these were overwhelmed by the 
one-time inter-individual variation in response. Rate pressure product consistent 
individual responses was calculated to be 5053 (±4235), and the consistent inter-
individual variation in response for heart rate was 26 (±29) b.min. 
 
6.4.3 One-Time Inter-Individual Variation in Response 
 
The one-time only inter-individual variation in response for systolic blood pressure 
was 11 (±90% Confidence Limits 18) mmHg. The one-time only inter-individual 
variation in response for diastolic blood pressure was 17 (±19) mmHg, while for 
mean arterial pressure and pulse pressure, it was 12 (±15) and 27 (±29) mmHg, 
respectively. Rate pressure product one-time variation was calculated to be 1405 
(±1495), whilst the one-time inter-individual variation in response for heart rate was 
28 (±27) b.min. 
 
Table 7. Mean and inter-individual variations in response (consistent and one-
time), presented with 90% Confidence Intervals/Limits. 
 Mean Response (90% CI) Consistent (±90%CL) One-Time 
(±90%CL) 
SBP (mmHg) 49 (36 to 62) 16 (21) 11 (18) 
DBP (mmHg) -6 (-1 to 14) -10 (15) 17 (19) 
MAP (mmHg) 21 (13 to 28) -4 (13) 12 (15) 
PP (mmHg) 45 (-35 to 55) -13 (23) 27 (29) 
RPP 12045 (9058 to 15032) 5053 (4235) 1405 (1495) 
HR (b.min) 58 (39 to 78) 26 (29) 29 (27) 
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6.4.4 Residual Error 
 
The residual (measurement) errors for systolic and diastolic blood pressure, mean 
arterial pressure and pulse pressure were 13 (90%CI 9-23), 11 (8-19), 10 (7-18) and 
9 (6-21) mmHg, respectively. Residual error for rate pressure product (b.min-1. 
mmHg) was 480 (324-990), and measurement error for heart rate was 6 (4-14) b.min-
1. 
6.5 Discussion 
 
6.5.1 Key Findings 
 
This is the first study of its kind aimed at quantifying the ‘true’ inter-individual 
variation in response to acute exercise using this modified code to properly partition 
the variance in a linear mixed model. The key findings suggest the presence of ‘true’ 
inter-individual variation in response to acute exercise. There was a greater mean 
blood pressure and heart rate response in females compared to males, larger than 
might be expected mechanistically, yet different from those reported in Chapter 5. 
Given the small number of participants, the analysis cannot be stratified by sex, but it 
appears that there may be substantial sex differences in the acute response to 
exercise. This should be further investigated by the employment of a large, 
definitive, trial. Without sex in the analysis model, the total SDIR is 25 mmHg, made 
up of a consistent SDIR of 23 mmHg and a one-time-only SDIR of 11 mmHg. When 
sex and sex*treatment and sex*period*treatment are included in the model, the total 
SDIR goes down to 19 mmHg. This indicates that differential acute responses by sex 
explain 42% of the total individual response variance. These findings are also 
different from those presented in Chapter 5, as the same phenomenon is clearly not 
responsible for the results. Whilst sex does explain some of the observed individual 
response variance, a substantial amount remains even after accounting for sex. 
Therefore, these results imply substantial individual response variance in both men 
and women. 
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6.5.2 Cardiovascular Reactivity 
 
The association between either systolic (SBP) or diastolic blood pressure (DBP) and 
the risk of cardiovascular disease (CVD) is well established (JNC, 1997). ‘Normal’ 
responses of a rise of 8-12 (ACSM, 2012), 10 (Fletcher et al., 2013) or 20 mmHg (Le 
et al., 2008) in SBP per metabolic equivalent have been suggested. Research claims 
that an exaggerated SBP response, where an increase to more than 180 mmHg is 
observed, or DBP of more than 95 mmHg during moderate submaximal exercise has 
been suggested to be the best predictor of new-onset hypertension at 20-year follow 
up (Yzaguirre et al., 2017). However,  given that most investigations examining blood 
pressure response are derived from middle-aged, white males, it is questionable how 
generalisable these predictors may be. It has been suggested that excessive blood 
pressure increase during the early stages of graded exercise may actually be more 
relevant (Currie et al., 2018). These authors also suggest the modulating effects of age, 
sex, fitness, health status and medications should be considered as the observed 
response may be influenced by any combination of these.  
 
Conversely, reduced cardiovascular reactivity has also been reported to place 
individuals at increased risk of diseases such as obesity (Carroll et al., 2008). In this 
study, mean changes of 49 mmHg were observed, with the highest observed values of 
SBP and DBP being 195 and 120 mmHg, respectively. This mean change falls 2 
mmHg short of the most accurate discriminator reported for relative maximal exercise 
induced changes in SBP during exercise to predict incident hypertension (Jae et al., 
2015), indicating that the highest observed change in this study did not meet thresholds 
for increased future risk. However, considerable variation between males and females 
was observed, with females, on average, 35 and 13 mmHg higher, for SBP and DBP, 
respectively. Whilst mean values were observed to be greater than those previously 
reported as predictors of cardiovascular-related health, consistent inter-individual 
variation in systolic blood pressure response of 16 mmHg and heart rate of 26 b.min-1 
is large in comparison to the mean change. Consistent inter-individual variation in 
diastolic blood pressure (-10 mmHg), mean arterial pressure (-4 mmHg) and pulse 
pressure (-13 mmHg) was overwhelmed by the one-time inter-individual variation in 
response. One-time inter-individual variation in response was also substantial in all 
variables.  However, it is the total individual responses SD that is key. For example, 
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the overall effect for SBP was 49 ±19 mmHg; this means that a randomly selected 
subject in this study would be expected to increase SBP by 49 ±19 mmHg in response 
to a bout of acute exercise of this duration and intensity. 
 
6.5.3 Mechanisms of Response 
 
These data highlight ‘true’ inter-individual response that is substantial when 
compared to the mean, greater than might be expected mechanistically. Whilst it is 
beyond the scope of this chapter to identify the causes, a number of suggestions may 
shed light on these data. Whilst it is possible that baseline fitness may have been 
responsible for the observed phenomenon, as a range of fitness levels (22.6-48.2 
mL.kg-1.min-1) were observed at baseline, it is unlikely that this explains all of the 
observed variation. There is, however, a clear trend that sex has an impact upon 
these data, as all variables show greater mean changes in females than males. Whilst 
baseline testing allowed for estimation of a workload equivalent to 70% of that 
elicited at V̇O2peak, this workload may have actually been relatively more difficult 
for females than males. For some individuals, this may have fallen above maximal 
lactate steady state (MLSS), whilst for others, it may have been below this intensity. 
Similar findings have been reported with different markers of exercise stress at the 
same relative workload between trained and untrained individuals (Baldwin et al., 
2000). Alternatively, these results may be due to the fact that males and females, 
whilst utilising the same pathways for stress response, appear to differ in response 
(Huang et al., 2013), whereby males often present larger diastolic blood pressure 
responses to acute exercise. This may uphold the suggestion that male responses are 
‘vascular’ while female responses are ‘cardiac’ (Allen et al., 1993). It is not yet 
possible to confirm whether the apparent sex difference in intervention effect is due 
to sex, per se, or to differences in baseline fitness. Very large samples would be 
required to define multiple intervention interactions with adequate precision. 
 
Given the detrimental role of different causes of stressors, a variety of interventions 
for the management of stress have been proposed (Hamer et al., 2006). Chronic 
exercise is at the forefront of this approach, as it is proposed to reduce the 
sympathetic stress response (Crews & Landers, 1987). It can likely attenuate 
cardiovascular responses to stress, control physiological stress reactivity (Hamer et 
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al., 2006) and may facilitate reduction in cardiovascular disease, stroke and 
myocardial infarction risk factors (Huang et al., 2013). It has been proposed that, 
whilst little research has been carried out on the acute effects on blood pressure 
reactivity, acute exercise attenuates stress related blood pressure responses, and 
repeated exposure to acute bouts may have a positive cumulative effect on 
cardiovascular responses (Hamer et al., 2006). Additionally, each standard deviation 
reduction in stress-related BP reactivity is associated with a reduction of carotid 
artery thickness, which may confer positive benefits on acute myocardial infarction 
risk (Salonen & Salonen, 1993). 
 
6.5.4 Statistical Model for Analysis of Replicate Crossover Data 
 
As previously described, the parallel group RCT is best for evaluating treatment 
heterogeneity in chronic adaptations. By successfully partitioning the ‘consistent’ 
and ‘one-time’ inter-individual variation in response to exercise, this study has 
confirmed that the replicate crossover is ideally suited to quantifying the inter-
individual variation in acute responses that wash out fully between conditions.  
 
The model used for analysis of these data provides ‘consistent’ individual responses 
(from the xVarC*subject and xVarT*subject) and ‘one-time-only’ individual 
responses (xVarT*subject*period), which are both random effects. One-time-only 
individual response variance quantifies the different individual responses each time a 
subject experiences an EX replicate.  
 
The aforementioned one-time-only individual response variance represents extra 
physiological variability plus technical error of measurement in the exercise 
condition at that location. In noisy settings (e.g. difficult data collection) the one-
time-only response variance can swamp the consistent individual responses such that 
the latter cannot be estimated robustly. In this study, as expected, there was more 
noise in the exercise condition, because of variability of the subject from one bout of 
exercise to the next and/or because there is more error in the exercise condition – a 
combination of biological variability and technical error. This is highlighted in the 
measures (diastolic blood pressure, mean arterial pressure and pulse pressure) where 
consistent inter-individual variation in response were overwhelmed by the one-time 
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when using the statistical model, due to the inherent measurement error in relation to 
the observed change when collecting blood pressure data in exercise studies. This is 
likely due to the relatively small observed changes in these measures, but future 
studies may look to replicate this with different blood pressure monitoring 
techniques, such as continuous blood pressure monitoring. 
 
Whilst SAS analysis code has previously been forwarded to try to partition variance, 
the elaboration of ‘possible’ code suggested by Senn et al., (2015) presented in this 
chapter provides a robust, accurate model for the partitioning of variance and the 
quantification of ‘true’ inter-individual variation in response to acute exercise 
interventions.  
 
6.5.5 Limitations 
 
A number of strengths and limitations are evident upon completion of this study. 
Limitations could be identified through the measurement method for blood pressure 
within this study. Blood pressure is a notoriously noisy measure, and the blood 
pressure monitor used was prone to produce occasional error readings. Whilst this was 
piloted prior to the study, technical issues may still have contributed to the observed 
variation presented within these data. Most variables had wide confidence 
intervals/limits due to small participant numbers. However, as a proof of concept, by 
partitioning the ‘consistent’ and ‘one-time’ individual variation, these data show the 
code produced for the statistical modelling is robust and holds great promise for the 
future application in larger scale replicate crossovers. In addition to overall N being 
small (just 11 analysed), the sample contained both men and women, with very few 
women. Therefore, sex by treatment interactions are purely exploratory and 
confidence are wide. Wider recruitment for future studies aimed at developing these 
results would better enable replication efforts and generalisation of the physiological 
aspect of these data to the wider population. Whilst this study was limited by a small 
sample, given the observed variability in responses, it is likely that the intensity was 
sufficient to elicit a range of responses, but as previously stated, may have been 
relatively more difficult for some than others. Therefore, identification of an exercise 
intensity that ensured that all participants underwent the same relative intensity may 
be more appropriate. Quantifying the SD for individual responses with adequate 
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precision requires large sample sizes, often many time larger than those required for 
defining mean effects precisely.  
 
6.6 Conclusions 
 
This is the first study of its kind aimed at using this modified code to properly partition 
the variance in order to quantify the ‘true’ inter-individual variation in response to 
acute exercise. While the parallel group RCT is best for evaluating treatment 
heterogeneity in chronic adaptations, the replicate crossover is ideally suited to acute 
responses that wash out fully between conditions. The key findings suggest the 
presence of substantial inter-individual variation in response. The results also 
highlight the success of the approach in partitioning the different components of 
variation. Whilst we cannot stratify the analysis by sex, because the numbers are too 
small, it appears that there may be substantial sex differences in the effect of the acute 
exercise. To confirm this, a subsequent large definitive trial should be employed, 
recruited from a wider population, with a focus on blood pressure outcomes utilizing 
the same analysis procedures.  
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Chapter 7: Discussion 
 
7.1 Introduction 
 
The main aim of this PhD has been to investigate the appropriate quantification of 
inter-individual differences in the response to exercise interventions, as well as the 
exploration of putative moderators and mediators of both the mean intervention 
effect and the individual response, where appropriate. 
 
7.2 Brief Overview of Literature 
 
The current research sits within the context of repeated reports of marked 
heterogeneity in the effects of regular exercise training (Hecksteden et al., 2018), 
with inter-individual variability in various phenotypes, such as less than expected 
weight loss for some individuals, or ranges of V̇O2max response of no change to 
40% improvement (Lortie et al., 1984, Bouchard & Rankinen, 2001). Nevertheless, 
recently concerns were raised in regard to the methodological approach of much of 
the previous body of research (Hopkins, 2015, Atkinson & Batterham, 2015, 
Williamson et al., 2017). The bulk of the literature reports these findings in the 
absence of a true control sample, often comparing within-group data, or comparing 
to a spurious statistic such as technical error (TE). The description of variability in 
response to chronic exercise interventions should only come following comparison 
with a suitable comparator sample, preferably within a randomised trial design, and 
comparison of the standard deviation of the change score (SDchange) for each group. 
 
Further investigation of possible moderators and/or mediators that may be 
responsible for ‘true’ inter-individual response variance should come only after these 
inter-individual differences in response have been quantified properly (Atkinson & 
Batterham, 2015, Williamson et al., 2017); an approach that has been lacking in the 
majority of the literature.  
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7.3 Primary Findings 
 
The primary findings from this programme of work are that, when quantified 
appropriately, chronic exercise interventions appear to elicit limited ‘true’ inter-
individual variation in response in peak oxygen uptake and weight loss. However, 
there appear to substantial inter-individual variations in blood pressure and heart rate 
responses to acute, high intensity ‘aerobic’ bouts of exercise.  Additionally, there 
appear to be substantial individual responses for chronic blood pressure adaptation in 
men. Furthermore, substantial individual responses for weight loss with 
multifactorial interventions in both men and women have been identified. It is 
particularly important to highlight these findings, as they are vastly differing 
findings to those presented in Chapter 4, where there is a relative lack of individual 
response variance for weight loss in response to exercise training alone. 
 
7.4 Thesis Objectives 
 
7.4.1 Thesis Objective 1 
 
The first objective was to critically review the literature on inter-individual variation 
in maximal aerobic capacity response to exercise. Whilst there have long been 
claims of inter-individual response to exercise (Prud’homme et al., 1984, Despres et 
al., 1984, Lortie et al., 1984, Savard et al., 1985, Hamel et al., 1986, Simoneau et 
al., 1986), it was found that the vast majority of previous investigations of inter-
individual differences in V̇O2max response to exercise training has been conducted 
almost exclusively without a control group or comparator arm. However, it is the 
case that the observed variation must be appropriately quantified prior to deeper 
investigation. This evaluation requires a number of approaches, including the 
determination of a threshold for meaningful magnitude of change, to establish the 
presence of clinically important differences in response (Buford et al., 2013). In 
order to quantify the inter-individual response to an exercise intervention, studies 
should contain the presence of a comparator arm, preferably as an RCT design. This 
methodological approach is vital, in order to understand the counterfactual, giving 
our best ‘best guess’ as to what would have happened to the intervention subjects, 
had they been, ‘contrary to the fact’, in the control condition. Furthermore, the 
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correct statistical analysis and modelling must be used in order to identify the 
presence of true, clinically relevant, individual response, as unless true inter-
individual response exists, it is futile looking for treatment interactions (Senn, 2004). 
Only when these effects have been properly quantified, using the following 
equation: 𝑆𝐷𝐼𝑅 = √𝑆𝐷𝐼
2 −  𝑆𝐷𝐶
2 , where IR = individual responses, I = intervention 
or treatment group, and C = control or comparator group (Hopkins, 2015) can the 
design of experiments to further elucidate the mechanisms responsible for the 
individual response be confirmed. Indeed, when this approach is taken with data 
from published research claiming inter-individual variability in response 
(Prud’homme et al., 1984), it was actually observed that there was greater variability 
in the control sample vs the intervention sample (control ± 5.6 mL.kg-1.min-1, 
intervention ± 3.7 mL.kg-1.min-1). 
 
It may also be prudent to measure a number of variables and health outcomes. It may 
be the case that some participants may improve across some but not all physiological 
measures, but this approach should be tied to robust hypotheses.  
 
7.4.2 Thesis Objective 2 
 
The second objective of this thesis was to undertake a systematic review and meta-
analysis of the weight change literature, with a focus upon quantifying the inter-
individual variation in weight loss in response to exercise training. This was the first 
systematic review and meta-analysis designed and published to address individual 
variation in response.  
 
The primary findings indicate that evidence is limited for clinically relevant ‘true’ 
inter-individual variation in weight change in response to an exercise intervention, 
once the random variability in weight over time in the control group is accounted for.  
 
When the pooled inter-individual response variability (0.8 kg) is doubled (1.6 kg), as 
we must for comparison of individual responses, is compared to the pooled mean 
change in weight (1.4 kg), it is evident that effect sizes are trivial, indicating that 
there are minimal ‘true’ inter-individual variation in response to exercise.  
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A novel concept in meta-analyses is the use of the prediction interval, to quantify the 
expected range of true effects in future studies in similar settings. The prediction 
interval for the mean change in weight revealed that, were investigators to undertake 
a future trial, the 95% plausible range for mean weight change vs. control would be -
5.0 to 2.1 kg ('possibly' clinically important; probability 26%). For the individual 
response variability, the prediction interval ranged from small negative (more 
response variability in control group) to small positive (more variability in the 
exercise arm), revealing that the true individual response variability in a future study 
in similar settings is unlikely to be clinically important (23% chance).  
 
To date, in a manner consistent with the bulk of the literature investigating peak 
oxygen uptake, much of the research reporting substantial inter-individual 
differences in response to an exercise intervention has been conducted in the absence 
of a suitable comparator sample (King et al., 2008, Cauldwell et al., 2009, Cauldwell 
et al., 2013).  As discussed, in order to quantify the true inter-individual response to 
an exercise intervention, studies should include a comparator arm, preferably in a 
randomised controlled trial.  
 
7.4.3 Thesis Objective 3 
 
The third objective of the thesis was to conduct a rigorous and detailed secondary 
data analysis of previously published data set from the PREMIER trial. This analysis 
showed much larger inter-individual variations in the response of weight loss and 
blood pressure control (to established treatment and established treatment plus 
DASH diet) in men, when compared to women, of a magnitude of 3-4 times the 
MCID. Stratified analyses by sex were undertaken further to the observation of a 
specious individual response variance for SBP and weight loss from the full model, 
which was not even partially accounted for by including a sex-by-treatment 
interaction term in the model. An attenuation of the individual response variance was 
expected, given the possibly substantial differences in mean treatment effect in men 
vs. women revealed by the full model. The fact that no such attenuation was 
observed is a warning sign that the model is mis specified. The paradoxical finding 
was due to the marked sex differences in individual response variance. The observed 
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effect in women is relatively consistent, whilst in men it is much more variable. This 
finding leads to the conclusion that the initially calculated individual response 
variance for SBP (11.99 mmHg) estimated from the whole sample applies poorly to 
both men and women, as it underestimates in men and overestimates in women.  
 
The above paradoxical finding reinforces the critical importance of thorough 
exploratory data analysis before undertaking the primary analysis. I propose that 
separate analyses by sex should be conducted routinely, to reveal such phenomena. 
In the PREMIER data set, the large differences in response variance between sexes 
both overwhelms and offsets any reduction in the observed ‘pooled’ individual 
response variance when the sex-by-treatment interaction is included in the model. 
This finding gives the false impression that sex is not a moderator of individual 
response variance.  
 
To reiterate, given these observations, researchers and practitioners should therefore 
be aware that when conducting this type of analysis, care must be taken to 
investigate and present ‘true’ inter-individual variation in response by sex, rather 
than pooling the overall sample, due to the possibility that this phenomenon may be 
applicable to further datasets.  
 
7.4.4 Thesis Objective 4 
 
The fourth, and final, objective of the thesis was to design and undertake a pilot/ 
‘proof-of-concept’ investigation to investigate the acute inter-individual variation of 
blood pressure and heart rate variables in response to high-intensity aerobic interval 
training, using a replicate crossover design. This was the first study of its kind aimed 
at quantifying the ‘true’ inter-individual variation in response to acute exercise. This 
objective was achieved by properly partitioning components of variance using a 
linear mixed model. The key findings suggest the presence of substantial ‘true’ inter-
individual variation in response. Although there were large sex differences in mean 
response, with greater blood pressure and heart rate response variables in females in 
comparison to males, stratified analyses of individual responses by sex were not 
possible, due to the small number of each in this proof-of-concept trial. In a replicate 
crossover trial, the total individual response variability is composed of consistent and 
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one-time-only individual responses. For diastolic blood pressure, mean arterial 
pressure, and pulse pressure the consistent individual response variance was 
overwhelmed by the one-time inter-individual variation in response. One-time inter-
individual variation in response was also substantial in all variables and consistent 
inter-individual variation in systolic blood response and heart rate response was large 
when compared to the mean change. Caution must be used during trial design, as this 
approach should only be utilised when measuring continuous outcome variables 
 
The large difference in mean response between men and women may indicate that 
whilst baseline testing allowed for identification of a workload equivalent to 70% of 
that elicited at V̇O2peak, this workload may have actually been relatively more 
difficult for females than males. Speculatively, these data may uphold the suggestion 
that male responses are ‘vascular’ while female responses are ‘cardiac’ (Allen et al., 
1993). 
 
7.5 Methodology in Relation to Current Research 
 
The findings of this programme of work clearly suggested that many of the 
inferences drawn from previous research might be suspect. Reporting the presence of 
inter-individual variation in response from an intervention-only trial – or ignoring 
the control data - clearly lacks the comparator sample with which to compare 
SDchange. This vital component allows us to assess the presence of ‘true’ inter-
individual variation in response.  
 
Whilst it has been argued recently that repeat testing of outcome measures 
throughout the duration of the intervention can help account for within-subject 
variability by comparing segmental slopes of change scores for shorter durations 
across the treatment period (Hecksteden et al., 2018), this approach is also limited. 
Primarily, the close temporal proximity of the measures may lead to high amounts of 
autocorrelation and a violation of the assumption of random errors. Additionally, it is 
not clear if training adaptions are linear over the course of an intervention. Also, 
repeated measures may be both expensive and impractical for some interventions. 
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Whilst “possible” analysis code for SAS® software has previously been forwarded to 
try to partition variance in a replicate crossover trial (Senn et al., 2015), it must be 
acknowledged that this code does not properly partition the response variance in 
intervention and control conditions, and therefore does not quantify individual 
response variance appropriately.  
 
The analysis code developed and presented in this thesis now permits the proper 
partitioning of response variance to isolate ‘true’ inter-individual variation in response 
to acute interventions, and also has the flexibility to account for sex and period effects. 
The model separates ‘consistent’ individual responses and ‘one-time-only’ individual 
responses, which quantifies the different individual responses each time a subject 
experience a treatment (exercise) replicate. This one-time-only individual response 
variance represents extra physiological variability plus technical error of measurement 
in the exercise condition at that location. In noisy settings (e.g. difficult data 
collection) the one-time-only response variance can swamp the consistent individual 
responses to such an extent that consistent individual responses cannot be robustly 
quantified. To reiterate, the total individual response variance in a replicate crossover 
is the sum of these two variances, and the square root is then taken to get the response 
variability as an SD, as has been previously described (Atkinson & Batterham, 2015).  
 
7.6 Findings in Relation to Literature 
 
The key findings from this thesis indicate that in response to chronic exercise, 
evidence is limited for the presence of substantial ‘true’ inter-individual variation in 
response for peak oxygen uptake and weight loss. This observation is due to the fact 
that natural random variability over time is similar for intervention and comparator 
samples, and that little or no extra variance is observed in intervention groups. As 
previously described, this finding highlights the requirement for a comparator 
(counterfactual) sample, in order to make firm inferences. 
 
Although it has been suggested that training studies consistently report a high 
variability in the effects of regular exercise training (Hecksteden et al., 2018), and 
large inter-individual differences in the trainability of the cardiorespiratory system 
have been claimed for over 30 years (Lortie et al., 1984, Bouchard, 1995, Feitosa et 
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al., 2002), re-analysis of the data upon which the majority of these inference are 
made reveal no clinically important differences in the SD of the change scores 
between the groups (control ± 5.6 mL.kg-1.min-1, intervention ± 3.7 mL.kg-1.min-1), 
(Williamson et al.,. 2017). This observation indicates that there are no substantial 
inter-individual differences in response to the intervention. In fact, these SDs 
indicate more than double the response variance in the control group versus the 
intervention group. Such a phenomenon can result when an intervention has a 
harmonising effect on the outcome variable in question. 
 
Despite claims of inter-individual variation in fat loss and weight loss in response to 
exercise that were previously reported (Snyder et al., 1997, Byrne et al., 2006, King 
et al., 2008, Caudwell et al., 2009, Church et al., 2009, Barwell et al., 2009), which 
result in a prevailing opinion that exercise often results in less than expected weight 
loss (Donnelly & Smith, 2005), the findings of this PhD study indicate that this is not 
the case. Mean weight loss of 1.4 (95% CI -0.3 to -2.5) kg, and ‘true’ inter-individual 
variation in response of 0.8 (-0.9 to 1.4) kg indicate that any observed inter-
individual variation in response does not even meet a conservative minimally 
important difference threshold.  
 
7.7 Recommendations to Policy Makers and Practitioners 
 
Precision medicine might improve population health, given that we may require both 
individual and public health approaches to improve health. Population health 
planning requires directing efficient use of resources toward those most at risk. Past 
successes of genomics and precision medicine indicate that they can yield population 
health benefit. 
 
However, precision interventions may not improve population health due to the 
nature and complexity of disease pathogenesis, particularly for common chronic 
diseases. Therefore, the promise of precision medicine to identify predictors of 
disease that can help guide personalized interventions may not be easily fulfilled. 
Additionally, the precision medicine agenda could shift resources from other areas, 
and its appeal may lead to hype and premature expectations that may cause long-
term disillusionment and erosion of public confidence in health sciences.  
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A major challenge ahead is figuring out how to best use the available large-scale data 
ranging from genomic to environmental information sources. These data should only 
be utilised if they will help us better understand determinants of population health 
and interventions that will improve health outcomes in subpopulations. Given the 
findings presented here, it is highly likely that for many phenotypes, interventions 
that work ‘on average’, targeted to whole populations (i.e. the mean response) will 
suffice until further evidence accumulates (Harrell, 2018), as the evidence for 
substantial chronic inter-individual response variation is limited.  
 
Whilst wide scale DNA collection and analysis has been proposed for identifying 
inter-individual variations, even the large scale and well-funded All of Us 
programme in the United States has struggled. Despite $1.5bn in funding over ten 
years, in its first three years, not a single set of DNA has been sequenced. This 
further highlights the problem surrounding this approach. Due to its complexity, is 
this funding the best use of resources? Should the funding instead go to research 
conducting truly applied and innovative science? 
 
Therefore, for the vast majority of outcomes, the idea that a personalised approach is 
necessary seems questionable. It also seems unlikely that, given the complexity of 
the biological and social contributors to weight loss, increased physical activity etc., 
that small lifestyle tweaks based upon information regarding very small numbers of 
genes will provide a benefit over and above those elicited from following general 
lifestyle guidance. There is also little evidence that the provision of information 
regarding inter-individual variation in response, or genetic risk information, will 
actually motivate the individual to undertake behaviour change. Given these facts, it 
may be more prudent to use alternative approaches, such as risk magnification, 
which has been described as providing the largest absolute risk reduction (Harrell, 
2018) This approach uses statistical tools and standard clinical variables to improve 
medical and public health decision making, therefore cutting costs in comparison to 
precision medicine. 
 
Genetics-informed approaches and precision medicine have gained a toehold in the 
consciousness of exercise professionals, medical researchers, and large-scale funders 
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in recent years, built upon the principle of health care revolution. This increase in 
awareness has been necessary for scientists and research institutions to obtain 
research funding from public and private organisations but, as yet, there is little 
beyond unproven hype. Whilst continuing research may be worthwhile, focus should 
be directed upon evidence-based basic scientific principles of mechanistic 
adaptation, rather than genetic testing for risk profiling, athlete development, and 
predictions of response by body type.  
 
Ultimately, precision interventions to target those who may display inter-individual 
variations in response are just a small tool in the box. Whilst with further research it 
may facilitate better outcomes, without the correct quantification methods to inform 
research and practice, ultimately it may cause more harm than benefit. Therefore, for 
chronic exercise interventions, practitioners should utilise the RCT approach, in 
combination with the analysis of SDchange of the intervention sample vs. the control. 
Alternatively, to identify the presence of inter-individual variation in response to 
acute bouts of exercise, the replicate crossover approach, using the code and analysis 
presented herein to fully partition the observed variance. It is also vital that 
practitioners ensure selection of valid, reliable measurement tools and high levels of 
inter- and intra-rater reliability in order to minimise measurement error in exercise 
trials.  
 
There have yet to be any examples of true precision interventions with successful 
outcomes. Population-wide approaches focusing on physical and social 
environments should also be considered. Clearly, policy makers and practitioners 
should understand the value of high-quality research, and inferences drawn from 
such; care should be taken when practical recommendations are suggested from 
research not utilising the methodology and statistical analysis recently suggested 
(Hopkins, 2015, Atkinson & Batterham, 2015, Williamson et al., 2017, Williamson 
et al., 2018).  
 
7.8 Strengths of the Thesis 
 
A number of strengths are clear in this current body of research. In Chapter 4, I 
presented the first systematic review and meta-analysis of individual response 
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variance. In order to make inferences from the data extracted and analysed in this 
meta-analysis, I adopted a threshold for the minimum clinically important weight 
loss of 2.5 kg – the smallest threshold of absolute weight loss for clinical benefit 
previously reported (Jensen et al., 2014). This was a very conservative estimate of an 
MCID, and if a less conservative MCID were to be used, the argument against the 
observation of ‘true’ inter-individual variation in weight loss would be further 
strengthened.  
 
The subject matter for the meta-analysis, and the inclusion of the prediction interval, 
for an indication of what may happen in any future similar trial, are both novel. 
Additionally, the primary data collection presented in Chapter 6 is a novel approach. 
This was the first study of its kind designed specifically to investigate the inter-
individual variation in response to acute exercise.  
 
Finally, the statistical model used to analyse the data collected in the acute replicate 
crossover trial was proved to be a robust model, due to its ability to accurately 
partition variance, and identify both the consistent and the one-time only inter-
individual variation in response.  
 
7.9 Limitations of the Thesis 
 
A number of limitations are also evident upon completion of this programme of 
work. In regard to the meta-analysis presented in Chapter 4, the energy expenditure 
induced by the exercise interventions undertaken in the included studies – and 
whether this would be sufficient, in theory, to induce weight loss above the minimal 
clinically important difference – is unknown. It is therefore unknown what effects 
exercise protocols with larger energy expenditures would elicit. The literature search 
was restricted to RCTs incorporating exercise-only interventions; included studies 
that differed by exercise mode, intensity, frequency and duration, and length of 
intervention. This intervention heterogeneity may have influenced mean effects and/ 
or individual response variance. However, there were too few studies to compare the 
effects in different intervention types.  
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In relation to the acute exercise trial, most effects had wide confidence intervals/limits 
due to small participant numbers. However, as a proof of concept, these data show the 
code produced for the statistical modelling is robust and holds great promise for the 
future application in larger-scale replicate crossovers.  
 
Additionally, whilst using the model suggested, a differential period effect between 
control and exercise conditions was observed, due to a different habituation effect for 
acute exercise compared with sitting still. This effect is evaluated by adding a 
treatment x period fixed effect to the model and getting the least-squares means for 
the interaction.  
 
7.10 Original Contributions to Knowledge 
 
In this thesis I have undertaken a meta-analysis of 1500 participants in exercise 
intervention studies. The key original contribution to knowledge is that, across 12 
studies, while mean weight change was -1.4 kg, the individual response variability 
(SD) was only 0.8 kg, highlighting very limited evidence for the notion of individual 
variation of weight change in response to an exercise intervention. This novel 
analysis utilised, for the first time in this field, a prediction interval for inter-
individual variation, which identified that the likelihood of ‘true’ inter-individual 
variation in response to an exercise intervention is limited, with only a 23% chance 
that in a future study in similar settings any observed response variation would be 
clinically relevant.  
 
These findings have already been published in the high-quality, peer reviewed 
journal Obesity Reviews (Williamson et al., 2018). This research has thus provided 
an original, robust protocol that has provided an important insight into how to 
quantify inter-individual variation in response to exercise and to implement a 
prediction interval for future studies in similar settings.  
 
In addition, a further original contribution to knowledge comes through the 
development of a model with which to partition individual variation in response for 
acute effects in replicate crossover designs. Using the model with interactions to 
identify ‘consistent’ individual responses (xVarT*subject) and ‘one-time-only’ 
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individual responses (xVarT*subject*period), provides a robust, accurate model for 
the partitioning of variance and the quantification of ‘true’ inter-individual variation 
in response to acute interventions when measuring continuous outcome variables. 
 
7.11 Future Research Considerations 
Whilst it is well documented that long-term systematic resistance training causes 
increased skeletal muscle size and strength in both men and women of different ages, 
resistance training-induced gains in muscle size and strength are often claimed to be 
variable between individuals. Large variability in both muscle size and strength gains 
in response to resistance training between individuals has been previously reported 
(McGlory & Phillips, 2015). In a large study, men and women were reported to 
exhibit wide ranges of strength gain (1 RM: 0 to +250%) and skeletal muscle 
hypertrophy (cross-sectional area: -2 to +59%) in response to 12 weeks of resistance 
training (Hubal et al., 2005), indicating individual training responses may vary 
widely dependent on factors such as genetic heritage. Whilst approximately 6% 
showed practically no gains in muscle size, no control group was utilised in this 
study, so it is difficult to interpret the results presented without the availability of a 
suitable comparator.  
Other resistance training studies have reported that, in some subjects, muscle size 
gains are either minimal or non-existent following a training intervention (Bamman 
et al., 2007, Davidsen et al., 2011, Raue et al., 2012, Mitchell et al., 2013, Phillips et 
al., 2013). Similarly to muscle size responses, gains in muscle strength during 
resistance training are also highly individual (Hubal et al., 2005; Erskine et al., 
2010). However, the range of individual responses to resistance training in people of 
different ages has not yet been elucidated. This question is particularly relevant 
considering how people respond to a resistance-training programme based on 
physical activity recommendations for health. In each of these studies, the recurring 
theme of no comparator group is evident. These are interesting findings and 
highlight that further study is warranted in this domain. 
Given the findings of the proof-of-concept study reported in Chapter 6, in order to 
replicate these findings, it is of prime importance to develop this methodology, and 
undertake a similar trial on a larger scale, focusing on blood pressure outcomes and 
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utilizing the same analysis procedures. These findings, if replicated through a large-
scale research study, may have important implications on practice and policy for 
clarification of inter-individual variation of blood pressure reactivity in response to 
an acute bout of exercise. Furthermore, if these findings are replicated, detailed 
investigation of possible moderators and mediators for the reported findings will be 
warranted. Therefore, further research should be focused upon the elucidation of 
these contributing factors to any observed inter-individual variation.  
 
Future work should employ the research designs suggested in this thesis, 
incorporating sound statistical quantification of the response variance in each arm, 
combined with a threshold for the minimal clinically important difference, to 
determine the presence of clinically important individual variation in response. 
Whether these future studies observe the presence of ‘true’ inter-individual variation 
in response or not, this should be disseminated through peer-reviewed publications, 
in order to add to the body of literature pertaining to this current hot topic. 
 
7.12 Summary of Evidence  
 
In summary, the studies undertaken in this research project have highlighted the 
consistent lack of a comparator sample within previous research purporting to show 
inter-individual variation in response. When re-analysis of rare control sample data 
presented by these authors is undertaken, more variation is observed in the control 
group in comparison with the intervention group. The systematic review and meta-
analysis revealed that when studies containing a comparator sample within an RCT 
design are meta-analysed, there is limited evidence for substantial inter-individual 
variation in weight loss response to exercise training. Furthermore, when previous 
data from a large-scale lifestyle change trial is re-analysed, whilst individual 
response is apparent, further scrutiny of the initial findings reveal that the observed 
individual response is inaccurate for both men and women. Further analyses 
stratified by sex are required, revealing substantial inter-individual variation in blood 
pressure response in men, compared to women.  
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Finally, in response to acute exercise, a newly-designed analysis model for replicate 
crossover studies with continuous outcome variables allows for the accurate 
partitioning of ‘one-time’ and ‘consistent’ inter-individual variation in response. This 
analysis reveals the presence of ‘true’ inter-individual variation in response.  
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Appendix 1 – Participant Information Sheet 
 
Participant Information Sheet 
Research title: Individual differences in the acute physiological responses   to 
intermittent exercise: A replicated crossover study 
 
I, Phil Williamson, am a PhD student in the School of Health and Social Care. I would 
like to invite you to take part in our research study. Prior to deciding to participate, 
please read the following information and discuss it with others if you wish. Please 
ask me if you have any questions.   
 
What is the purpose of the study? 
The study aims to quantify clinically-relevant inter-individual differences in blood 
pressure responses to sub-maximal intermittent exercise. 
 
Who is responsible for the study? 
The researchers are Philip Williamson (PhD student, HSCI), Prof Alan Batterham 
(Supervisor, HSCI) and Prof Greg Atkinson (Supervisor, HSCI). 
 
Why have I been invited to take part? 
You have been invited because you are a student at Teesside University, and I 
wondered if you may be interested in taking part. To participate in the present study, 
you must be healthy and aged 18 or older.  Importantly, you are not eligible if you:  
 have any diagnosis or symptoms of cardiovascular or metabolic diseases (e.g. 
heart disease, diabetes) 
 present an injury requiring alterations of the established exercise protocol 
 are physically unable to complete the intervention 
 have been advised by a health professional to avoid physical exercise or 
activity 
 are taking any medication 
 are pregnant or 
 do not have a satisfactory score on the attached PARQ+. Please read through 
this yourself to see if you are eligible and your score will be re-checked at 
your first attendance if you want to take part 
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Please, feel free to show a copy of this invitation to anyone else who may wish to take 
part. Anyone who meets the eligibility criteria is most welcome to express an interest 
in participating.  
 
Do I have to take part? 
No. It is your personal choice whether or not you decide to participate. You are also 
free to withdraw the study at any time if you want to up to the point of completing 
your final data collection session in the laboratory. If at any point you wish to 
withdraw from the study, we ask that you contact Prof Alan Batterham, the Director 
of Studies, in the first instance (A.Batterham@tees.a.c.uk). As data will be 
anonymised, it is requested that you keep your individual participant information sheet 
upon enrolment, as this will be used to retrieve and remove any coded data pertaining 
to your involvement, should you wish to withdraw at any time.  
 
What will happen to me if I take part? 
You will be invited to attend laboratory sessions on five occasions taking place in the 
Exercise Physiology Laboratory in the Olympia Building/Constantine Building at 
Teesside University. To avoid alcohol (24h) and caffeine (12h) consumption, and 
strenuous exercise (24h) prior each visit is required. At the first session, we will check 
your responses on the attached PARQ+ to ensure that you may take part. 
 
At the first session, you will be given a physical activity questionnaire to complete. 
Once it has been confirmed that there are no medical conditions precluding your 
participation in the research project, an informed consent form to be completed. On 
the same occasion, you’ll be asked to complete a familiarisation session, and 
demographic information involving your height, weight, gender, age, and resting 
blood pressure will be recorded. Peak oxygen uptake shall then be assessed on a cycle 
ergometer. Subsequently, you’ll be assigned to each of the two experimental 
conditions of sub-maximal and no exercise to be completed in a random order. Each 
visit is characterised by two phases. Firstly, your blood pressure will be measured 
during a 30-min supine resting. Secondly, in the exercise condition, you’ll perform 
three 10-min cycling at 70% of your peak oxygen uptake interspersed with 5-min 
recovery periods. Measurements of your blood pressure will be repeated during each 
resting interval. Similarly, we’ll adopt the same procedures regarding blood pressure 
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measurements when you are assigned to the control condition, but you’ll remain sat 
on the cycle ergometer without undertaking any physical exercise. As mentioned 
previously, each condition will be repeated twice. Overall, each experimental session 
should take approximately 90 minutes. 
 
What are the possible disadvantages or advantages of taking part? 
There are certain risks to participating, such as discomfort or injury from 
undertaking intermittent exercise. There are no direct benefits from participating, 
although V̇O2peak is an established method for appraising cardiorespiratory fitness 
which may be of interest.   
 
Confidentiality 
All the collected information during the study will be kept strictly confidential. None 
of the measurements will be in the public domain as the data is anonymised. All 
electronic data will be stored on a password protected Teesside University server. 
Your non-identifiable data will be kept confidential and stored for up to 20 years at 
Teesside University and could be used in future studies having obtained the required 
ethical approval from a designated Research Governance and Ethics Committee. 
 
How will the data be used? 
The results of this study will be included in our PhD theses and future scientific articles 
submitted for publication in peer-reviewed journals and conference presentations. 
Collected data and results will be anonymous and no identifiable information will be 
revealed. 
 
What happens if there are any problems? 
The methods used in this study have been safely adopted in previous clinical 
investigations, although the present study is covered by University’s insurance 
policies. If you felt you had been harmed in anyway by taking part in this study you 
should contact the Associate Dean for Research and Innovation in the School, Prof 
John Dixon (John.Dixon@tees.ac.uk) in the first instance if you should have any 
complaints about the study. 
 
Who approved the study? 
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This project has been reviewed and approved by the School of Health & Social Care 
Research Governance and Ethics Committee at Teesside University. The Chair of this 
committee is Dr. Alasdair Macsween. 
 
Who can I contact for more information? 
If you have any queries or you would like to receive more information please contact: 
Philip Williamson at P.Williamson@tees.ac.uk. 
Additionally, you can contact Professor Greg Atkinson via e-mail 
(Greg.Atkinson@tees.ac.uk) albeit not directly involved in booking appointments for 
data collection. 
 
 
Thank you for reading this information sheet and for your consideration on 
taking part in the study. 
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Appendix 2 – Initial Contact Email 
 
Hello,  
 
My name is Philip Williamson and I am a PhD research student at Teesside. I am 
writing to ask if you would consider taking part in my research project.  I want to 
investigate the acute inter-individual responses of blood pressure to intermittent 
exercise and the acute changes in ankle brachial index.  The title is, Individual 
differences in the acute physiological responses to intermittent exercise: A 
replicated crossover study. 
 
I have attached a participant information sheet which explains the study and if you 
are interested please do read it.  Please don't be put off by the words intermittent 
exercise; you won't be expected to suffer! I have also attached an initial PARQ to 
enable me to assess your medical eligibility for inclusion in the study. 
 
I will be sending out two reminder emails about the study - one in two weeks and 
then again two weeks later.  Doing this has been shown to greatly improve 
recruitment to studies.  Please accept my apologies in advance if you have already 
decided you don't want to take part when you receive those.  
 
If you have any questions and/or would like to express an interest in taking part, then 
please contact myself on P.Williamson@tees.ac.uk.  You can also contact my 
supervisor Alan Batterham and Greg Atkinson on A.Batterham@tees.ac.uk or 
Greg.Atkinson@tees.ac.uk 
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Appendix 3 – Initial Course Lead Contact 
 
Hello,  
 
My name is Philip Williamson and I am a PhD research student at Teesside. I am 
writing to ask if you would please help me by forwarding the invitation e-mail and 
Participant Information Sheet (attached) to all your students?  I want to investigate 
the acute inter-individual responses of blood pressure to intermittent exercise and the 
acute changes in ankle-brachial index. The title is, Individual differences in the 
acute physiological responses to intermittent exercise: A replicated crossover 
study. 
 
I will be sending out two reminder emails about the study - one in two weeks and 
then again two weeks later.  Doing this has been shown to greatly improve 
recruitment to studies.  If you will not forward our email on to your students and you 
don't want to receive any reminders, please let me know and I won't send them to 
you.  
 
Thank you for considering helping us to recruit. 
 
Please don’t hesitate to contact me if you have any questions on 
P.Williamson@tees.ac.uk.  You can also contact my supervisor Alan Batterham and 
Greg Atkinson on A.Batterham@tees.ac.uk or  
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Appendix 4 – Initial Invite via Subject Lead 
 
Hello,  
 
My name is Philip Williamson and I am a PhD research student at Teesside. Your 
Subject Lead obtained your contact details from their database and has sent you this 
on our behalf. I do not know who they have contacted, no information about you, nor 
your contact details have been given or shown to me. I would like to ask you if you 
would please consider taking part in my research project?  I want to investigate the 
acute inter-individual responses of blood pressure to intermittent exercise and the 
acute changes in ankle-brachial index. The title is: Individual differences in the 
acute physiological responses to intermittent exercise: A replicated crossover 
study. 
 
I have attached a participant information sheet which explains the study and if you 
are interested please do read it.  Please don't be put off by the words intermittent 
exercise; you won't be expected to suffer! I have also attached an initial PARQ to 
enable me to assess your medical eligibility for inclusion in the study. 
 
I have asked your Subject Lead to send out two reminder emails about the study - 
one in two weeks and then again two weeks later.  Doing this has been shown to 
greatly improve recruitment to studies.  Please accept our apologies in advance if 
you have already decided you don't want to take part when you receive those.  
 
If you have any questions and/or would like to express an interest in taking part then 
please contact me if you have any questions on P.Williamson@tees.ac.uk. You can 
also contact our  supervisor Alan Batterham and Greg Atkinson on 
A.Batterham@tees.ac.uk or Greg.Atkinson@tees.ac.uk 
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Appendix 5 – Informed Consent 
 
Individual differences in the acute physiological responses to intermittent 
exercise: A replicated crossover study 
Researcher: Phil Williamson  
Supervisor: Professor Alan Batterham 
 
Please put your initials in the boxes to indicate your agreement with the 
corresponding statements. 
 
 
I have read and understood the information sheet for the above study and         
have had the opportunity to ask questions. 
 
I meet the inclusion criteria for participation in the study. 
 
I know that I have the right to withdraw any data collected from  
me up until the final (third) data collection session is complete. 
 
I agree to my data being stored on a password protected server 
 
I agree to take part in this study 
 
 
 
 
----------------------------  --------------------  -------------------- 
Name of Participant   Date   
 Signature 
 
 
----------------------------  --------------------  -------------------- 
Name of Witness   Date              Signature 
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Appendix 6 – Adverse Event 
CONFIDENTIAL 
 
ADVERSE EVENTS FORM 
 
Subject  
ID: 
   
Subject 
Initials: 
   D.O.B    
Age: 
 
   Gender:  M  /  F 
 
Were there any Adverse 
Events? 
 
   
(Please check appropriate box)   
Visit 1 Visit 2 Visit 3 Visit 4 Visit 5 
 yes 
 
 no 
 
 yes 
 
 no 
 
 yes 
 
 no 
 
 yes 
 
 no 
 
 
yes 
 
 no 
 
If no Adverse Events (AE) were reported, no signature from the PI is required. Any 
adverse event will be reported to and reviewed by Prof Alan Batterham (Director of 
Studies) as soon as possible. Where relationship to experimental procedures is scored 
2-5, the event will be reported to Marion Grieves and Alasdair MacSween as soon as 
possible.  
 
 
Severity 
1 = Mild  
2 = Moderate 
3 = Severe 
 
 
 
 
Relationship to experimental procedures 
1 = Definitely not related 
2 = Probably not related 
3 = Possibly related 
4 = Probably related 
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5 = Definitely related  
 
Action taken 
1 = Discontinued from study 
2 = Hospitalized 
3 = None 
4 = Other (Comment) 
 
 
 
 
 
 
Outcome at date ceased 
1 = Recovered 
2 = Recovered with sequelae 
3 = Died (Comment) 
4 = Other (Comment) 
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ADVERSE EVENTS FORM 
 
Adverse Event Date of Onset 
dd/mm/20  
Date Ceased 
dd/mm/20
 
Severity Action taken Outcome 
 /  /     
 /  /     
 /  /     
 /  /     
 
Signature: 
Examiner: 
_____________________________________________________________
 
 Date:_
 
 
   
PI:
 _________________________________________________________
____  Date:_
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Appendix 7 – Risk Assessment  
 
This form should be used for all modules (including those delivered in colleges or 
other sites) which include a practical element (e.g. physical activity, 
practical/creative skill development, interactive skill development activity e.g. 
counselling techniques).  Risk is determined by cross-referencing the hazard effect 
and probability on the following chart.  Each module leader should ensure that 
potential risks specific to their module are identified in the ‘Potential risk’ column 
and the level of risk assessed.  This should include risks to students, staff and 
equipment.  The form should be kept in the module ‘box’.  This form is in addition 
to risk assessments carried out in relation to building and environment. 
 
 Hazard Effect 
Probability Low  Medium High 
Very Low Trivial Risk Trivial Risk Low Risk 
Low Trivial Risk Low Risk Medium Risk 
Medium Low Risk Medium Risk High Risk 
High Medium Risk High Risk Intolerable Risk 
 
Hazard Effect: 
Low  Superficial wounds or temporary ill health. 
Medium More serious wounds and ill health leading to permanent, minor 
disability. 
High Fatality, life threatening wounds and life shortening diseases. 
 
Probability: 
Very Low So unlikely that probability is close to zero. 
Low Unlikely but conceivable. 
Medium Could occur several times. 
High Occurs repeatedly and could be expected. 
 
Part One: 
Work Area/Job: Student Research study   
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Location: C1.12, Constantine Research Lab, Teesside University, Olympia 
Physiology Labs 
 
Study Title: Individual differences in the acute physiological responses to 
intermittent exercise: A replicated crossover study 
 
Completed by: Philip Williamson 
 
Part Two: 
 
Potential Hazard Present Cause of Hazard Hazard 
Effect 
Probability Risk 
 Yes No  Low/Med
/High 
Very Low/Low/ 
Med/ High 
Trivial/Low/ 
Med/High/ 
Intolerable 
Injury from 
undertaking 
intermittent 
exercise 
X  Exercising above 
habitual levels 
Low Low Trivial 
Injury from 
measurement of 
ABI  
X  Pressure Low Low Trivial 
Cross infection 
from gas analyser 
X  Cross infection Low Low Trivial 
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Risk Assessment Record 
Part Three 
 
 
Result of Risk Assessment: Trivial   X Low  Medium 
     
    High  Intolerable 
 
Safety procedures implemented (if result is Medium, High or Intolerable). 
 
N/A 
 
Final result of Risk Assessment after safety procedures implemented. 
 
Trivial   X 
 
Low 
 
Medium 
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Appendix 8 – PAR-Q 
 
Name DoB 
 
Male  Female  
 
Contact no. Email 
Address 
 
 
 
 
Emergency Contact 
Name Relationship 
Contact no. 
 
Medical contact details 
Doctor Contact no. 
 
Physical activity readiness questionnaire (PAR-Q) 
Questions Yes No 
Has your doctor ever said you have a heart condition and can only perform 
exercise that has been recommended by a doctor? 
  
Do you feel pain in your chest when you exercise?   
Have you felt any chest pain when you are not exercising within the last 
month? 
  
Do you lose your balance due to dizziness or do you lose consciousness?   
Do you have any joint or bone issues that may be made worse due to a 
change in exercise habits? 
  
Are you currently being prescribed any medication by your doctor for a 
blood pressure or heart related condition? 
  
Do you know of any other reason why you may not participate in exercise?   
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Outcome 
Medical clearance not necessary  
Medical clearance recommended  
Medical clearance required  
 
I confirm that I have read the questions fully and answered each question 
honestly. If there are any changes in my health I will inform the investigators 
immediately. 
Signature Date 
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Appendix 9 – Data Collection Sheet 
 
Initials:   ID Code:  EX/CON:  1/2 
 
Power required (EX ONLY): 
 
Resting BP:       Resting HR: 
 
Pre exercise BP (dorsalis pedis):    (posterior tibial): 
 
 
After 1st interval BP (brachial):    After 1st interval HR: 
 
After 1st interval RPE: 
 
 
 
After 2nd interval BP (brachial):    After 2nd interval RPE: 
 
After 2nd interval BP (dorsalis pedis):   (posterior tibial): 
 
After 2nd interval HR: 
 
 
Post exercise BP (brachial):     Post exercise HR: 
 
Post exercise BP (dorsalis pedis):    (posterior tibial): 
 
Post exercise RPE: 
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Appendix 10 – Abstract 1 (Conference Abstract) 
 
Inter-Individual Differences in the Responses of V̇O2max to Physical Activity 
Counselling 
 
Presented at The International Sports Science and Sports Medicine Conference, 
2016. 
 
Abstract 
 
Low cardiorespiratory fitness (V̇O2max) is an important risk factor for diabetes, 
cardiovascular disease and some cancers, making lifestyle interventions especially 
relevant. There is purported to be substantial inter-individual differences in how 
V̇O2max responds to lifestyle/exercise interventions. Recently, we described the 
appropriate approach for quantifying these inter-individual differences. Therefore, 
we aimed to apply this approach to quantify inter-individual differences in the 
responses of V̇O2max.  We re-analysed data from the influential ‘Activity Counselling 
Trial’ (ACT), which was designed to determine the effects of general lifestyle 
assistance as well as formal counselling on physical activity and V̇O2max in 479 
men and 395 women. Importantly, an appropriate comparator group was also present 
in order to quantify ‘true’ inter-individual differences in V̇O2max response. For 
women, the ‘true’ inter-individual responses in V̇O2max (expressed as a SD) were 
found to be ± 129 (95% Confidence interval: -40 to 187) ml/min in the general 
lifestyle assistance group and ± 93 (-91 to 160) ml/min in the formal lifestyle 
counselling group. For men, true individual differences in response were ± 116 
(95%CI: -130 to 210) ml/min and ± 148 (-105 to 234) ml/min in the assistance and 
counselling groups, respectively. 
Although the mean increase in V̇O2max was greater in women, this increase 
corresponded to a trivial effect size. This application of the appropriate analyses to 
the ACT dataset indicate that, on average, the effects of activity counselling on 
V̇O2max were small, although there were moderate ‘true’ inter-individual differences 
in the V̇O2max response in women (0.34 SD) and small ‘true’ inter-individual 
differences in men (0.27 SD). Further genotype investigation may therefore be 
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warranted in order to determine the mediators of this observed heterogeneity in 
response. 
Appendix 11 - Abstract 2 (Conference Abstract) 
 
Inter-Individual Responses of Maximal Oxygen Uptake to Exercise Training: A 
Critical Review 
 
Also published in Sports Medicine. 2017;47:1501-13. 
 
Abstract 
 
It has recently been reported how to quantify inter-individual differences in the 
response to an exercise intervention using the standard deviation of the change 
scores, as well as how to appraise these differences for clinical relevance. In a 
parallel-group randomised controlled trial, the key trigger for further investigation 
into inter-individual responses is when the standard deviation of change in the 
intervention sample is substantially larger than the same standard deviation derived 
from a suitable comparator sample. ‘True’ and clinically relevant inter-individual 
differences in response can then be plausibly expected, and potential moderators and 
mediators of the inter-individual differences can be explored. We now aim to 
critically review the research on the inter-individual differences in response to 
exercise training, focusing on maximal oxygen uptake (V̇O2max). A literature search 
through the relevant bibliographic databases resulted in the identification of six 
relevant studies that were published prior to the influential HEalth, RIsk factors, 
exercise Training And Genetics (HERITAGE) Family Study. Only one of these 
studies was found to include a comparator arm. Re-analysis of the data from this 
study, accounting for random within subjects variation, revealed an absence of 
clinically important inter-individual differences in the response of V̇O2max to 
exercise training. The standard deviation of change was, in fact, larger (±5.6 mL.kg-
1.min-1) for the comparator than the intervention group (±3.7 mL.kg-1.min-1). We 
located over 180 publications that resulted from the HERITAGE Family Study, but 
we could not find a comparator arm in any of these studies. Some authors did not 
explain this absence, while others reasoned that only inter-individual differences in 
exercise response were of interest, thus the intervention sample was investigated 
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solely. We also found this absence of a comparator sample in on-going studies. A 
perceived high test–retest reliability is offered as a justification for the absence of a 
comparator arm, but the test–retest reliability analysis for the HERITAGE Family 
Study was over a much shorter term than the length of the actual 
 raining period between baseline and follow-up measurements of V̇O2max. We also 
scrutinised the studies in which twins have been investigated, resulting in concerns 
about how genetic influences on the magnitude of general within-subjects variability 
has been partitioned out (again in the absence of a comparator no-training group), as 
well as with the intra-class correlation coefficient approach to data analysis. Twin 
pairs were found to be sometimes heterogeneous for the obviously influential factors 
of sex, age and fitness, thereby inflating an unadjusted coefficient. We conclude that 
most studies on inter-individual differences in V̇O2max response to exercise training 
have no comparator sample. Therefore, true inter-individual differences in response 
cannot be quantified, let alone appraised for clinical relevance. For those studies 
with a comparator sample, we found that the inter-individual differences in training 
response were not larger than random within-subjects variation in V̇O2max over the 
same time period as the training intervention. 
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Appendix 12 - Abstract 3 
 
Inter-Individual Differences in Weight Change Following Exercise 
Interventions: A Systematic Review and Meta-analysis of Randomised 
Controlled Trials 
 
Published in Obesity Reviews. 2018;19:960-75. 
 
Abstract 
 
Previous reports of substantial inter-individual differences in weight change 
following an exercise intervention are often based solely on the observed responses 
in the intervention group. Therefore, we aimed to quantify the magnitude of inter-
individual differences in exercise-mediated weight change. We synthesized 
randomised controlled trials (RCT) of structured, supervised exercise interventions. 
Fourteen electronic databases were searched for relevant studies published up to 
March 2017. Search terms focused on structured training, RCTs and body weight. 
We then sifted these results for those RCTs (n=12, 1500 participants) that included 
relevant comparator group data. Standard deviations (SD) of weight change were 
extracted, thereby allowing the SD for true inter-individual differences in weight-
loss to be calculated for each study. Using a random effects meta-analysis, the 
pooled SD (95% CI) for true individual responses was 0.8 (-0.9 to 1.4) kg. The 95% 
prediction interval (based on 2SDs) for true inter-individual responses was -2.8 to 
3.6 kg. The probability (% chance) that the true individual response variability would 
be clinically meaningful (>2.5 kg) in a future study in similar settings was 23% 
(‘unlikely’). Therefore, we conclude that evidence is limited for the notion that there 
are clinically important individual differences in exercise-mediated weight change. 
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Appendix 13 - Abstract 4 (Conference Abstract) 
 
Inter-Individual Differences in Acute Blood Pressure Response to High 
Intensity Exercise: A Replicate Crossover Design 
 
Presented at The European College of Sport Science Congress, 2018. 
 
Introduction 
Acute blood pressure responses to physical activity predict hypertension and other 
cardiovascular-related comorbidities (Atkinson et al., 2013). Robust quantification 
of individual differences in this blood pressure reactivity requires a controlled 
replicate crossover design to isolate the participant x condition response variance 
(Senn, 2016; Goltz et al., 2017). Our aim was to conduct the first appropriately 
designed experiment on individual differences in acute blood pressure reactivity to 
exercise. 
 
Methods 
After baseline assessment of peak oxygen uptake, twelve normotensive adults (4 
women) with mean (SD) age: 29.7 (4.9) y, height: 173.9 (10.1) cm, body mass: 72.5 
(12.5) kg were randomized in blocks of 2 to one of 6 possible sequences of 2 control 
and 2 exercise replicates over 4 periods. The exercise comprised two 10-min bouts of 
cycling at 70% of the power output exhibited at peak oxygen uptake, separated by a 
5-min recovery period. In the control condition, participants rested on the cycle 
ergometer for the equivalent time. Blood pressure was measured at rest and 
immediately after the last exercise bout (or at the end of the control period). Data 
(n=11 due to one withdrawal post-randomization) were analysed using a linear 
mixed model, allowing for sex differences in the mean effect of acute exercise and 
differential period effects between conditions (by sex). We included random effects 
for the participant x treatment interaction (by period) to partition the variance and 
derive the true SD for individual responses.  
 
Results 
The mean effect of acute exercise (versus control) on systolic blood pressure was an 
increase of 49 (90% CI, 36 to 62) mmHg (67 mmHg in women vs. 32 mmHg in 
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men). The consistent SD for individual responses – the typical inter-individual 
difference between participants in the mean change between a control trial and an 
exercise trial - was 16 (±90% Confidence Limits - 21) mmHg. The one-time inter-
individual variation in response was 11 (±18) mmHg. 
 
Discussion 
In the first replicate crossover study quantifying inter-individual variability in 
response to exercise, we have shown a very large typical difference between 
participants in the mean effect of acute exercise on systolic blood pressure. We 
emphasize that although individual response variance was substantial, such a finding 
does not imply, necessarily, that there are ‘responders’ and ‘non-responders’ – in the 
current study all participants were responders to acute exercise.  This model can be 
applied to future replicate crossover trials to quantify the presence of inter-individual 
variation in response to acute exercise.  
 
References 
Atkinson G, Batterham AM, Kario K, et al. Eur J Appl Physiol. et al. 2014;114:521-
9. 
Goltz FR, Thackray AE, King JA, et al. Med Sci Sports Exerc. 2018. Ahead of 
Press. DOI: 10.1249/MSS.0000000000001504 
Senn S. Stat Med. 2016;35:966
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Appendix 14 – Peer-Reviewed Paper – Inter Individual Responses of Maximal 
Oxygen Uptake to Exercise Training; A Critical Review 
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Appendix 15 – Peer-Reviewed Paper – Inter Individual Differences in Weight 
Change Following Exercise Interventions: A Systematic Review and Meta-
Analysis of Randomized Controlled Trials
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